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I .  INTRODUCTION
Statem ent o f the  Problem
Tardive dysk inesia  (TD) i s  a d e b i l i ta t in g  s id e  e f fe c t  o f 
an tip sy ch o tic  m edications th a t i s  la te  in  o n -se t and o ften  i r r e v e r s ib le  
(Je s te  e t  a l . ,  1979). Hie e tio lo g y  o f TD, as w ell as the  trea tm ent fo r  
TD, remain e lu s iv e , although h eav ily  researched  ( J e s t e & W yatt, 1979). 
Before comprehensive and conclusive resea rch  on the e tio lo g y  and, 
th e re fo re , trea tm en t o f TD can be accomplished, c o n s is te n t find ings 
about d is tin g u ish in g  c h a ra c te r is t ic s  o f TD p a tie n ts  a re  needed in  o rder 
fo r i t s  p recu rso rs  to  be id e n t i f ie d .  I t  i s  the  purpose o f th is  study 
to  in v e s t ig a te  some o f the c h a ra c te r is t ic s  which d esc rib e  p a tie n ts  w ith 
TD. An attem pt w i l l  be made to  answer the  question  "Are th e re  aspec ts  
of TD p a t ie n ts ' drugs and beh av io ra l h is to r ie s  which d is tin g u ish  them 
from p a tie n ts  w ithout TD?" The d e sc r ip tiv e  c h a ra c te r is t ic s  in v e s t i ­
gated were h is to ry  o f extrapyram idal s id e  e f f e c ts ,  i n i t i a l  p sy c h ia tr ic  
behavior p a t te rn , p sy c h ia tr ic  behavior p a t te rn s ,  h is to ry  o f a n tip sy ­
ch o tic  d rugs, h is to ry  o f an tip a rk in so n  ag en ts , h is to ry  o f polypharmacy, 
h is to ry  o f d ru g -free  p e rio d s , ra c e , eye co lo r, and d en ta l s ta tu s .
Need fo r  the  Study
Prevalence fig u res  c le a r ly  in d ic a te  th a t  TD i s  no t uncommon 
among p sy c h ia tr ic  p a t ie n ts .  S ta t i s t i c s  r e f le c t in g  prevalence vary  from 
study to  study depending upon th e  in te n s i ty  o f measurements used
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(Klawans, 1979). Reports have ranged as high as 367. (Fann e t  a l . ,
1972) and 567. (Jus e t  a l . ,  1976) fo r  In p a tie n ts .  P reviously  
re sea rch ers  assumed th a t  TD occurred p rim arily  among in p a tie n ts .
However, w ith  the  advent o f d e in s t i tu t io n a l iz a t io n  and long-term  a n t i ­
psychotic  maintenance regimens, th e re  a re  a lso  increasing  re p o rts  of 
TD in  the  o u tp a tie n t popu la tion . Asnis e t  a l .  (1977) found a 437. 
prevalence o f TD among o u tp a tie n ts  and Chouinard e t  a l .  (1979) found 
a 31% prevalence among th e i r  o u tp a tie n t sample. The development o f TD 
o ften  reduces a p a t i e n t 's  a b i l i ty  to  a d ju s t to  community l i f e  as i t s  
symptoms can be s o c ia l ly  and v o ca tio n a lly  d isab lin g ; a lso , p a tie n ts  
"may have to  remain in  the  h o sp ita l  because o f  a com plication o f the  
therapy designed to  g e t them out of th e  h o sp ita l"  (Ayd, 1970, p . 306). 
Furtherm ore, TD has been a sso c ia ted  w ith  reduced l i f e  expectancy 
(Mehta e t  a l . ,  1978) and su ic id e  (Klawans, 1979).
Due to  the  p o ss ib le  i r r e v e r s ib i l i ty  o f  TD, i t s  growing in c i ­
dence, and the  adjustm ent problems i t  causes, i t  is  im perative th a t  the  
d e sc r ip tiv e  c h a ra c te r is t ic s  o f TD p a tie n ts  a re  c o n s is te n tly  d e lin ea ted  
in  o rder to  id e n tify  the  p recurso rs o f TD, fo r  severa l reasons.
Primary i s  the  fa c t  th a t  no c o n s is te n tly  e f fe c t iv e  treatm ent fo r  TD has 
been d iscovered , thus the  c u rre n t emphasis i s  on preventing severe  forms 
of TD through prompt reco g n itio n  of e a r ly  s igns (B aldessarin i & Tarsy, 
1978). However, e a r ly  warning signs a re  d i f f i c u l t  to  e s ta b lish  due to  
the  syndrome's in s id io u s  o n -s e t , in d iv id u a l d iffe ren ces  in  c l in ic a l  
d isp lay  o f symptoms, and the  a b i l i ty  o f an tip sy ch o tics  to  mask th e  
c l in ic a l  s igns o f  TD. Consequently, research  on the d e sc r ip tiv e
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c h a r a c te r is t ic s  o f p a tie n ts  w ith  TD i s  needed to  id e n tify  p recu rso rs  
and ev en tu a lly  p a tie n ts  a t  high r is k  fo r  developing TD. With such 
id e n t i f ic a t io n s  made, p recau tions can be taken to  prevent the  syndrome's 
o n -se t r a th e r  than dealing  w ith the syndrome a f te r  i t s  occurrence.
Alexopoulos (1979) found th a t  the  o u tp a tie n t sch izophrenics 
diagnosed as having TD in  h is  study d id  no t complain about th e i r  
symptoms to  th e i r  th e ra p is t  and only h a l f  o f them were even aware o f 
th e i r  symptoms. S im ila rly , Smith e t  a l .  (1979) re p o rt th a t  only 87. of 
th e i r  in p a tie n ts  diagnosed as having moderate TD were aware o f th e i r  
symptoms and only 3.5% reported  d is t r e s s  about the  symptoms. Due to  
in c reas in g  d e in s t i tu t io n a l iz a t io n ,  non-m edical personnel such as 
p sy ch o lo g is ts , counselors, and so c ia l workers a re  coming in to  g re a te r  
co n tac t w ith o u tp a tie n ts  on a n tip sy ch o tic  regim ens. These mental 
h e a lth  workers have the  g re a te s t  co n tac t w ith  o u tp a tie n ts  and, in  l ig h t  
o f the  fin d in g s  of Alexopoulos and Smith e t  a l .  (1979), a lso  have an 
in c reas in g  re s p o n s ib i l i ty  to  be aware o f  the  d e sc r ip tiv e  c h a ra c te r is t ic s  
o f p a tie n ts  w ith  TD, the  p recurso rs o f  TD, and the  symptoms o f TD. This 
knowledge could g re a tly  a id  in  reducing the  incidence and/or s e v e r ity  
o f TD thus in c reas in g  community placement and adjustm ent fo r  p sy c h ia tr ic  
p a t ie n ts .  With the  id e n t i f ic a t io n  o f th ese  c h a r a c te r is t ic s ,  and subse­
quen tly  the  p recu rso rs  o f TD, non-medical mental h e a lth  workers could 
p lay  an im portant ro le  in  id e n tify in g  p a tie n ts  a t  high r i s k  fo r  
developing TD. R eferra ls  to  the  s t a f f  physician  could then be made 
w ith  consequential p recau tionary  s tep s  being taken . An e f f ic ie n t  and 
e f fe c t iv e  m u lti-d isc ip lin a ry  approach to  th e  p revention  and cu rta ilm en t
o f TD could r e s u l t .
Although th e re  have been sev e ra l ep idem iological s tu d ie s  o f  TD, 
th e re  have been few c o n s is te n t find ings due to  sev e ra l m ethodological 
problem s. Ananth (1978), in  reviewing e t io lo g ic a l  s tu d ie s ,  p o in ts  out 
th a t  co n tro l groups a re  seldom used and suggests th a t  "a more f r u i t f u l  
approach would be to  understand the  d iffe ren ces  between those who 
develop dysk inesia  and those who do no t"  (p . 34). Simpson e t  a l .
(1978) a s s e r t  th a t  m erely using  a co n tro l group i s  inadequate and th a t  
matching on age, sex, d iag n o sis , and length  of h o s p i ta l iz a t io n  is  
necessa ry , although seldom done, fo r  adequate ep idem io log ical s tu d ie s  
o f  TD as " d ire c t  compariosn . . . w ith in  matched p a tie n ts  should y ie ld  
more d e f in i t iv e  r e s u l t s "  (p. 119). The proposed study meets th ese  two 
m ethodological needs as a matched co n tro l group w i l l  be used . There 
a re  sev e ra l reasons matching between experim ental and co n tro l su b jec ts  
on these  co n tro l v a r ia b le s  i s  recommended. The f i r s t  l i e s  in  the  
c o n s is te n t find ings concerning these  demographic v a r ia b le s ,  which a re  
d iscussed  in  d e ta i l  in  Chapter 3. The second reason  i s  a r e s u l t  o f  the 
r e s t r i c te d  sample s iz e s  re tro s p e c tiv e , ep idem iological s tu d ie s  o f TD 
demand due to  th e  enormous amount o f d a ta  involved in  studying  such 
v a ria b le s  as drug and behav io ral h i s to r i e s .  A choice  must th e re fo re  
be made between having many s u b je c ts , unmatched, o r having few­
e r  su b jec ts  who are  matched. The former choice has been made fo r  th is  
study as the v a ria b le s  under study e i th e r  have n o t been s tu d ied  w ith  
c o n s is te n t depth and b read th —i . e . ,  the drug v a r ia b le s , o r they have 
no t been stud ied  a t  a l l —i . e . ,  the  b eh av io ra l v a r ia b le s .  Consequently,
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l ik e  M allya e t  a l .  (1979), the  "sm all sample . . . d isadvantage [w ill]  
a t  l e a s t  be p a r t i a l ly  o f f s e t  by c a re fu l matching of c o n tro ls "  (p . 648). 
Id e a lly  the  fu tu re  w i l l  see la rg e  matched groups in  ep idem iological 
s tu d ie s  o f  TD as the c u rre n t trend  in  mental h o sp ita ls  i s  toward 
com puterized s to rag e  o f drug in form ation .
T h e o re tic a l R ationale
Em pirical j u s t i f i c a t io n  fo r  p re d ic tin g  and resea rch in g  the 
s p e c if ic  d e sc r ip tiv e  c h a r a c te r is t ic s  p rev iously  d e lin ea ted  i s  gained 
from a review  o f ep idem iological research  on TD. R ep lica tio n  o f the 
fin d in g s  on a l l  v a r ia b le s  under study i s  needed since  matched co n tro l 
groups were used in  on ly  th ree  previous s tu d ie s  (Mallya e t  a l . ,  1979; 
Simpson e t  a l . ,  1978; Pryce & Edwards, 1966). The m a jo rity  of 
ep idem iological re sea rch  is  d e s c r ip tiv e , o fte n  rep o rtin g  fin d in g s  in  
percen tages (Fann e t  a l . ,  1972) and n o t te s t in g  fo r s t a t i s t i c a l  
s ig n if ic a n c e . Recent fin d in g s  have a lso  ra is e d  some qu estio n s  as to  
the accuracy of some o f the  previous fin d in g s and in d ic a te  a l te rn a t iv e  
d a ta  c o lle c t io n  methods, such as c u tt in g -o f f  d a ta  c o lle c tio n  w ith the 
emergence of TD symptoms (Jus e t  a l . ,  1976). Chapter 2. covers in  
depth th e  l i t e r a tu r e  as re la te d  to  each v a r ia b le  being s tu d ie d , thus 
p rov id ing  f u l l  em p irica l ju s t i f i c a t i o n  and fu r th e r  th e o re t ic a l  
r a t io n a le .
Sample and Data G athering Procedures
Two samples o f  p sy c h ia tr ic  in p a tie n ts  were s tu d ie d , each w ith 
26 s u b je c ts .  This sample s iz e  i s  considered adequate as th e  s tu d ies
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found th a t  used matched co n tro ls  had sample s iz e s  o f 21 (Pryce &
Edwards, 1966), 28 (Mallya e t  a l . ,  1979), and 40 (Simpson e t  a l . ,
1978). The TD sample p rim arily  includes p a t ie n ts  a t  Eastern  S ta te . 
H osp ital id e n tif ie d  by the m edical s t a f f  in  June, 1979 as having TD 
and who were concommitantly b lin d - ra te d  by a p s y c h ia tr i s t  as having 
TD. The No-TD sample was randomly se le c ted  from a l l  remaining 
in p a tie n ts  a t  E astern  S ta te  H o sp ita l on the  b a s is  o f  the co n tro l 
v a ria b le s  o f the  TD sample; namely, age, sex, and d iag n o sis . They 
were a lso  b lin d - ra te d  by the  p s y c h ia tr i s t  to ensure the  absence of 
TD.
The follow ing inform ation  was obtained from the  h o s p ita l  
records and ward ch arts  o f a l l  su b jec ts : i n i t i a l  adm ission d a te  ( in
order to  determ ine the  i n i t i a l  p sy c h ia tr ic  behavior p a t te rn ) ,  h is to ry  
o f a n tip sy ch o tic  m edications, h is to ry  o f an tip a rk in so n  ag en ts , h is to ry  
o f polypharmacy, h is to ry  o f d ru g -fre e  p e rio d s , h is to ry  o f ex trap y ra ­
midal symptoms (EPS), i n i t i a l  p sy c h ia tr ic  behavior p a t te rn , p sy c h ia tr ic  
behavior p a t te rn , ra c e , eye c o lo r , d e n ta l s ta tu s ,  d iag n o sis , b i r th  
d a te , sex , and ( in  o rd er to  determ ine d a ta  c u t-o ff )  the  d a te  o f the  
f i r s t  recorded TD symptom mention o r d iag n o sis . This re sea rch er c o l­
le c ted  a l l  d a ta  l i s te d  above, excepting the  ra tin g s  o f i n i t i a l  
p sy c h ia tr ic  behavior p a tte rn  and p sy c h ia tr ic  behav io r p a tte rn . 
A ss is ta n ts , b lin d  to  th e  hypotheses o f th is  study and the  group 
membership o f the  su b je c ts , c o lle c te d  d a ta  on and ra te d  th ese  v a r ia b le s . 
This was deemed necessary  as th e  re sea rch er is  no t b lin d  to  e i th e r  o f 
these  fa c to rs ;  thus a b lin d  r a t e r  was employed to  guard ag a in s t any
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system atic  b ia s  th a t  may have o therw ise occurred .
D e fin itio n  o f Terms
Tardlve dysk inesia  (TD), a n eu ro lo g ica l s id e  e f f e c t  o f a n t i ­
psychotic  m edications, I s  an In vo lun tary , h y p e rk in e tic  motor d iso rd e r . 
Two major s u b c la s s if ic a tio n s  o f symptom complexes w ith in  the  syndrome 
o f TD have been d is tin g u ish ed  by B ell & Smith (1978) on the  b a s is  of 
anatomy area and population  most a ffe c te d . The f i r s t  type involves 
the b u cca l-lin g u a l-m as tic a to ry  t r i a d  in  which tongue p ro tru s io n , l ip  
smacking, and f a c ia l  t i c s  a re  common m a n ife s ta tio n s . This symptom 
complex is  found most commonly among e ld e r ly  p a t ie n ts .  The second 
type involves p rim arily  the  neck, tru n k , and ex tre m itie s  in  which 
choreoatheto id  movements occur and is  more p rev a len t a m an ife sta tio n  
among younger p a t ie n ts .
Extrapyram idal symptoms (EPS) a re  re v e rs ib le  invo lun tary  motor 
d is tu rbances which a re  a lso  s id e  e f fe c ts  o f a n tip sy c h o tic s . They 
occur e a r l i e r  in  treatm ent than TD and u su a lly  a re  one o f two types. 
Tremor and a k a th is ia  a re  th e  h y p e rk in e tic  ty p es; a k in e s ia , r ig id i ty ,  
and dyston ic  re a c tio n s  a re  th e  hypok inetic  types (Choudhard e t  a l . . ,  
1976)* The symptom complex o f trem or, r ig i d i ty ,  and ak in es ia  i s  o ften  
re fe rre d  to  as parkinsonism  o r pseudoparkinsonism due to  i t s  s im i­
l a r i t y  to  the  symptoms o f id io p a th ic  P ark inson 's  d isea se  (Donlon & 
Stenson, 1976).
" I n i t i a l  p sy c h ia tr ic  behavior p a tte rn "  r e fe rs  to  b ehav io ra l 
n o ta tio n s  made upon th e  p a t ie n t s ' f i r s t  adm ission to  a  p s y c h ia tr ic
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f a c i l i t y .  Ihese  a re  located  in  the  h o s p ita l  records under "Admission 
N otes."
"P sy ch ia tr ic  behavior p a tte rn "  r e fe rs  to  b ehav io ra l n o ta tio n s  
recorded by the s t a f f  a f t e r  th e  p a tie n ts  were p rescrib ed  an tip sy ch o tic  
m edications. S ince th ese  m edications d id  no t begin  to  be used u n t i l  
1952 (B a ld essa r in i, 1978), only no tes recorded a f t e r  th i s  time w il l  be 
used in  th is  s tudy . These no tes a re  located  in  the  records under 
" In te rd is c ip l in a ry  Notes" and "Semi-Annual Summaries"; th e i r  con ten ts 
were ra te d  beginning January , 1953 un less  a su b jec t was adm itted 
subsequent to  th is  time in  which case d a ta  c o lle c tio n  s ta r te d  w ith 
the  f i r s t  ad m in is tra tio n  o f an tip sy ch o tic s  to  th is  p a t ie n t .
A ntipsychotics a re  used p rim arily  to  t r e a t  sch izophrenia and 
o th e r psychoses. They a re  no t c u ra tiv e  agents b u t ra th e r  t r e a t  the  
symptoms of the  i l ln e s s e s  such as d e lu sio n s , h a l lu c in a tio n s , thought 
d iso rd e rs , com bativeness, a g i ta t io n ,  psycho tic  excitem ent, and a t  
tim es, sec lu s iv en ess . Improvement in  in s ig h t ,  judgment, memory, and 
o r ie n ta t io n , however, is  le s s  l ik e ly  (B a ld e ssa r in i, 1977). Although 
th e  mechanisms o f  ac tio n s  o f the  an tip sy ch o tic s  a re  not completely 
understood, they a re  c u rre n tly  thought o f  as dopamine a n tag o n is ts . 
A ntipsychotics a re  be lieved  to  b lock  dopamine recep to rs  and p o ssib ly  
dopamine re le a s e  o r transm ission  which co n trib u te s  to  th e i r  an tipsycho­
t i c  e f fe c ts  (B a ld essa r in i, 1977). A n tipsychotics a re  a lso  re fe rre d  to  
as n e u ro le p tic s .
A ntiparkinson m edications a re  used to  t r e a t  extrapyram idal s id e  
e f f e c t s .  These agents a re  a n tic h o lin e rg ic s  which can produce th e i r
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own s id e  e f f e c t s ,  thus they should be used w ith  some cau tio n . C urrent 
p ra c tic e  involves only p re sc rib in g  them rtien the  EPS emerges, ra th e r  
than p ro p h y la c tic a lly , and then fo r  no longer than two months 
a t  the  lowest p o ss ib le  dose. This p ra c tic e  p a r t i a l ly  r e s u l t s  from 
th e i r  re c e n tly  being im plicated  in  worsening TD or p o ssib ly  c o n tr i ­
bu ting  to  the  r i s k  o f developing TD (B a ld essa r in i, 1977).
Polypharmacy re fe rs  to  th e  use o f m edication com binations. In  
examining the  m edication h is to r ie s  o f  the  su b je c ts , two types o f 
polypharmacy were in v e s tig a te d . The f i r s t  i s  the  number o f a n tip a r -  
k in so n  agents and an tip sy ch o tic s  p rescrib ed  to  the  su b je c ts . The
second i s  the  summation o f incidences where the  su b jec t was s im u lta ­
neously p rescrib ed  two d if f e r e n t  drugs in  various com binations, one 
o f which was an a n tip sy c h o tic . The four d i f f e r e n t  forms o f th is  
type o f polypharmacy a re  d e lin ea ted  in  Appendix A.
L im itations
An ex post fa c to  design  has an in h e ren t l im ita tio n  concerning 
the  estab lishm ent o f  c a u s a li ty . The independent v a r ia b le  (TD) has 
a lready  occurred n a tu r a l i s t i c a l ly ,  thus i t  cannot be m anipulated—i . e . ,  
i t  i s  u n co n tro lled . S ince id e n t i f ic a t io n  of re la tio n sh ip s  between th e  
independent and dependent v a r ia b le s  is  being accomplished on an 
a f te r - th e - f a c t  b a s is ,  c a u sa li ty  cannot be e s ta b lish e d ; ra th e r  
d e sc r ip tiv e  c h a ra c te r is t ic s  unique to  the  TD group a re  sought in  an 
e f f o r t  to  id e n tify  a reas  in  need o f more d i r e c t  te s t in g .  Thus, even 
when p red ic ted  re la tio n sh ip s  a re  found an assum ption of c a u sa li ty
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was not made. In stead  the conclusion'jwas drawn th a t  the
d e sc r ip tiv e  c h a ra c te r is t ic s  found unique to  the TD group a re  in d ic a tiv e
o f p o te n tia l  precursors which need to  be more d i r e c t ly  te s te d .
Another l im ita tio n  is  the  th re a t  s e le c tio n  causes fo r  in te rn a l  
v a l id i ty  as group membership w a s  determ ined by the c r i te r io n  of 
presence o r absence o f TD. The assumption was thus made in  
c o n tra s tin g  the  groups th a t  they would have been eq u iv alen t on the 
dependent v a ria b le s  i f  X (TD) had no t occurred . However, " th e re  a re  
. . . no form al means o f c e r tify in g  th a t  the  groups would have been 
equ ivalen t had i t  no t been fo r  the  X" (Campbell & S tan ley , 1963, p.
12). A lso, an tip sy ch o tic s  can c l in ic a l l y  mask symptom m an ifesta tio n s  
o f TD thus causing d iag n o stic  v a l id i ty  problems fo r  the  absence o f TD 
in  the  co n tro l su b je c ts . Thus, viewing find ings as d e sc r ip tiv e  ra th e r  
than in d ic a tiv e  o f causa tion  is  fu r th e r  in d ic a ted .
In  the  case o f e x te rn a l v a l id i ty ,  any re la tio n sh ip s  found can 
be r e l ia b ly  gen era lized  to  s im ila r ly  aged in p a tie n ts ,  w ith  severe TD, 
and h o sp ita liz e d  in  s ta t e  mental i n s t i tu t io n s .  The ra t io n a le  fo r  such 
r e s t r i c te d  g e n e ra liz a tio n s  l ie s  in  the  fa c t  th a t  any p a tie n ts  who were 
re leased  from the  h o s p ita l  a re  no t included in  th is  study . To inc lude  
such in d iv id u a ls  i s  c le a r ly  beyond the  scope of th is  study due to  the 
amount o f time i t  would involve to  tra c e  down such su b jec ts  in  o rder 
to  ensure they have no t developed TD o r been tre a te d  fo r p sy c h ia tr ic  
d is tu rbances s in ce  th e i r  re le a s e  and consequently have in cu rred  the  
r i s k  of developing TD. Tha ro le  th a t  chronic in s t i tu t io n a l iz a t io n  may 
play  in  th e  development of TD can th e re fo re  no t be addressed in  th is
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study . As Crane (1973) po in ts  o u t, i t  Is  probably sa fe  to  assume th a t  
" the  c h ro n ic ity  o f a d isea se  and/or In s t i tu t io n a l iz a t io n  w ith  the  
a tten d an t emotional and physica l d ep riv a tio n "  (p . 395) I s  not respon­
s ib le  fo r  motor abnorm alities such as TD. This assumption Is  backed 
up by sev e ra l s tu d ie s . Pryce & Edwards (1966), In  studying In p a tie n t 
sam ples, found th a t  th e  Incidence o f TD and abnormal movements s im ila r  
to  TD was h ig h e r fo r p a tie n ts  tre a te d  w ith an tip sy ch o tic s  than fo r 
s im ila r  p a tie n ts  not t re a te d  w ith a n tip sy ch o tic s . Thus, TD has come 
to  be understood as a r e s u l t  o f an tip sy ch o tic  m edications ra th e r  than 
a r e s u l t  o f  c h ro n ic ity  o r I n s t i tu t io n a l iz a t io n .  Furtherm ore, TD does 
occur among o u tp a tie n t populations no t p rev iously  h o sp ita liz e d  (Asnls 
e t  a l . ,  1977; Chouinard e t  a l . ,  1979). Given the  s ta t e  o f u n c e r ta in ty , 
however, concerning the  e tio lo g y  o f TD—even in  l ig h t  o f  the  above 
f in d in g s—the  find ings o f th is  study can be g en era lized  r e l ia b ly  to  
s im ila r ly  aged p a tie n ts  who have severe  TD, and a re  s t i l l  i n s t i tu t io n ­
a liz e d .
General Hypotheses
There w i l l  be d iffe ren c es  between a group o f in p a tie n ts  w ith 
TD and a group o f in p a tie n ts  w ithout TD on the  d e sc r ip tiv e  c h a ra c te r­
i s t i c s  of h is to ry  o f a n tip sy ch o tic  m edications, h is to ry  o f an tip ark in son  
ag en ts , h is to ry  o f polypharmacy, h is to ry  of d ru g -free  p e rio d s , h is to ry  
o f extrapyram idal symptoms (EPS), i n i t i a l  p sy c h ia tr ic  behavior p a tte rn , 
p sy c h ia tr ic  behavior p a t te rn , ra c e , eye c o lo r , and d en ta l s ta tu s .
II. REVIEW OF RELATED LITERATURE
Summary o f R ationale  and R ela tionsh ip  to  Problem
In  1973 the  American College o f Neuropsychopharmacology, Food 
and Drug A dm inistra tion  Task Force published e d i to r ia ls  in  p sy c h ia tr ic  
and m edical jo u rn a ls  concerning th e  s id e  e f fe c ts  o f a n tip sy ch o tic  
m edications. U n til th is  time c o n s is te n t d e f in i t io n s ,  d e sc r ip tio n s , and 
la b e ls  fo r  the  s id e  e f fe c ts  d id  n o t e x is t .  The e d i to r ia ls  served the 
purpose of i n i t i a t in g  much research  on the  e tio lo g y  o f TD as a su cc in c t 
d e f in i t io n  o f the syndrome and acknowledgement o f  i t s  ex isten ce  was 
provided. P r io r  to  th is  tim e many authors had published work about the  
syndrome, bu t under a v a r ie ty  o f d if f e r e n t  terms (Edwards, 1970; 
Roxburgh, 1970). The main th ru s t  o f i n i t i a l  research  on TD concerned 
proving i t s  ex is ten ce  and r e la t in g  i t s  occurrence to  a n tip sy ch o tic s . 
Crane (1973) published the  f i r s t  review of l i t e r a tu r e  on TD c i t in g  the 
in co n s is ten c ie s  in  p revalence fin d ings due to  d iffe ren c es  in  d e fin in g  
the  syndrome, in  a sse ss in g  th e  syndrome, in  c o lle c tin g  in fo rm ation , and 
in  the  p a tie n t p opu la tions. Not much o f th is  has changed in  the  p ast 
seven years as d isc rep an c ies  s t i l l  e x is t  in  the  methodology and 
fin d ings o f  research  about TD. However, the  syndrome o f TD i s  more 
c le a r ly  d e fined , i t s  ex is ten ce  i s  no longer questioned , and i t s  
occurrence i s  a t t r ib u te d  to  a n tip sy ch o tic  m edications. This a t t r i ­
bu tio n  is  derived  from prevalence s tu d ie s  f in d in g  th e  syndrome to  be 
r e la t iv e ly  common in  d ru g - tre a te d  populations and r e la t iv e ly  r a re  in
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u n trea ted  populations (Crane, 1973). What remains u n c lea r, however, Is  
how TD develops and which In d iv id u a ls  a re  a t  high r is k  fo r  developing 
the  d iso rd e r . U n til these  a re  understood, e f fe c t iv e  p reven tion  
s t r a te g ie s  fo r  ta rd lv e  dysk inesia  w i l l  remain, as they have to  d a te , 
unc lear and evasive ( J e s te  & W yatt, 1979).
Although ta rd lv e  dysk inesia  I s  understood as a s id e  e f fe c t  o f 
a n tip sy ch o tic s , I t  Is  no t known fo r  c e r ta in  how th e  m edications cause 
the  syndrome. I t  I s  u n lik e ly  th a t  th is  w i l l  be  known u n t i l  the  
mechanisms by which an tip sy ch o tic s  op era te  a re  more c le a r ly  understood. 
C u rren tly , a n tip sy ch o tic  m edications a re  thought to  fu n c tio n a lly  d ep le te  
dopamine by blocking th is  n e u ro tra n sm itte r 's  recep to rs  a t  sev e ra l s i t e s  
In  the  b ra in  (B a ld essa r in i, 1977). This framework d eriv es  from the 
dopamine su rp lus theory  of sch izophren ia , which Is  only one theory 
o f the e tio lo g y  fo r  th is  p sychosis, w herein the  psychosis Is  under­
stood as a neurochemical d iso rd e r (Lehman, 1975). However, th is  theory 
a lso  provides a b a s is  fo r  understanding the  development o f TD. I f  
sch izophrenia Is  a s ta t e  o f dopam ine-surplus and an tip sy ch o tic s  a c t 
by reducing dopamine, then TD can be understood as a dopamine le v e l 
d is tu rb an ce . This Is  hypothesized as r e s u lt in g  from a " s ta te  of 
denervation  s u p e rs e n s l t lv l ty  of . . . dopamine re c ep to rs"  (J e s te  &
W yatt, 1979, p . 252) due to  a "prolonged blockage o f dopaminergic 
mechanisms by the  a n tip sy ch o tic  drugs" (B a ld essa r in i, 1977, p . 4 7 ). 
Consequently, sev e ra l ep idem iological s tu d ie s  have focused on the  drug 
h is to r ie s  o f p a t ie n ts  w ith  TD expecting to  fin d  th a t  they  had received  
increased  amounts o f a n tip sy c h o tic s , e i th e r  in  dosages o r  length  of
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a d m in is tra tio n s , to  account fo r  the  hypothesized dopamine su p ersen si­
t i v i t y .
Even i f  TD is  proven to be a r e s u l t  o f a n eu ro lo g ica l 
imbalance caused by the  in g estio n  o f a n tip sy c h o tic s , no exp lanation  
would be given as to  why some in d iv id u a ls  develop TD w hile o th e rs  do 
n o t. Consequently, ind iv id u a l d iffe ren c es  in  s u s c e p t ib i l i ty  a re  
hypothesized (B a ld essarin i & Tarsy, 1978; Crane, 1978). Epidemio­
lo g ic a l s tu d ie s  have in v estig a ted  c h a r a c te r is t ic s  o f in d iv id u a ls  w ith 
TD in  an e f f o r t  to  d e lin e a te  p recurso rs  o f the syndrome. However, 
research  on the  re la tio n sh ip s  of d i f f e r e n t  v a ria b le s  to  the occurrence 
o f  TD o fte n  encounters d a ta -g a th e rin g  and m ethodological d i f f i c u l t i e s .  
In c o n s is te n t fin d in g s  may, th u s , fo llow  from th ese  design  flaw s and 
may be fu rth e red  by in te rven ing  v a r ia b le s ,  such as b eh av io ra l 
v a r ia b le s , which have been overlooked o r inadequately  examined. For 
example, v a ria b le s  such as age and sex have been found to be system at­
ic a l ly  re la te d  to  TD (Smith e t  a l . ,  1978). However many in v e s tig a tio n s  
o f v a ria b le s  re la te d  to  TD do no t tak e  these  c o n s is te n t fin d in g s  in to  
co n sid era tio n  by n eg lec tin g  to  use  co n tro l groups which a re  matched on 
th ese  v a r ia b le s . The follow ing l i t e r a t u r e  review focuses on methodo­
lo g ic a l d i f f i c u l t i e s  w hile summarizing find ings on the  re la tio n s h ip  of 
drug h is to r ie s  and in d iv id u a l c h a r a c te r is t ic s  to  th e  development o f TD.
Drug H is to r ie s
A. A ntipsychotic  Dosages
Four an tip sy ch o tic  dosage and a d m in is tra tio n  v a ria b le s  a re  o f 
research  in te r e s t :  cum ulative dose, cum ulative leng th  o f ad m in is tra -
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t lo n , d a ily  dose, and maximum dose received  per y ear. In te rp la y  can 
and does occur between the  f i r s t  two v a r ia b le s . For example, two 
p a tie n ts  can have the  same cum ulative dose bu t one p a tie n t had high 
d a ily  doses fo r  a sh o rt period  o f tim e w hile the  o th e r had low 
d a ily  doses fo r  a long period o f tim e. An a l te rn a t iv e  method involves 
exam ination o f mean d a ily  dosages (Simpson e t  a l . ,  1978). Data on 
cum ulative dose and leng th  o f a d m in is tra tio n  o f an tip sy ch o tic s  must 
s t i l l  be co lle c ted  and th e re  a re  many problems in  ob ta in ing  drug 
h is to r ie s  exact enough to  determ ine d a ily  dose averages fo r  a n t i ­
p sy ch o tics . Record-keeping p ra c tic e s  a re  in c o n s is te n t and many 
p a tie n ts  a re  h o sp ita liz e d  in  sev e ra l lo ca tio n s  w ith th e i r  p a st records 
no t being forwarded to  th e i r  c u rre n t in s t i tu t io n .  Consequently, many 
s tu d ie s  look only a t  the  c u rren t m edications received  (B ell & Smith, 
1978; Fann e t  a l . ,  1972) o r choose n o t to examine drug h is to r ie s  a t  
a l l  (Asnis e t  a l . ,  1977). Maximum a n tip sy ch o tic  dosage per y ear i s  
ano ther drug v a ria b le  re c en tly  rece iv in g  re sea rch  a t te n t io n  (Smith e t  
a l . ,  1978). This v a r ia b le  avoids confounding in te ra c t io n s  which may 
occur among gross drug v a r ia b le s  and which can obscure s p e c if ic  
d if fe re n c e s .
Q uestions remain as to  the  n e c e ss ity  and su ffic ie n cy  o f 
v a r ia b le s ,  such as th e  amount o f a n tip sy ch o tic  dosage and the  length  
o f a n tip sy ch o tic  ad m in is tra tio n , fo r  the  development o f TD. On the  
b a s is  o f the  dopamine-blockage h y p o th esis , one could expect TD 
p a tie n ts  to  have had h ig h er cum ulative dosages o f  an tip sy ch o tic s  than 
co n tro l p a t ie n ts .  This has no t been c o n s is te n tly  found. The paradox i­
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c a l a b i l i t y  o f an tip sy ch o tic s  to  mask TD symptoms, as w ell as cause 
them, may c o n trib u te  to  th e  d iv e r s i ty  o f fin d ings (Turek e t  a l . ,
1972). Some su b jec ts  in  the  co n tro l samples could, fo r  example, 
a c tu a l ly  have TD, b u t th e i r  symptoms may be masked by h ig h e r doses of 
a n tip sy c h o tic s . This could a lso  exp la in  why co n tro l groups have 
sometimes been found to  have h ig h e r cum ulative dosages o f a n tip sy ­
ch o tic s  .
Another ex p ec ta tio n , emerging from the  dopamine-blockage 
h y p o th esis , i s  th a t  the  TD su b jec ts  w i l l  have longer h is to r ie s  o f 
a n tip sy ch o tic  ad m in is tra tio n  than  co n tro l s u b je c ts . There a re  
in c o n s is te n t re la tio n sh ip s  rep o rted  here  as w e ll. U n fo rtunate ly , only 
one study reviewed ( J e s te  e t  a l . , 1979) has made an a ttem pt to  stop  
d a ta  c o lle c t io n  w ith  the  f i r s t  emergence o f TD. A ll o th e r s tu d ie s  
thus have both  pre-TD and post-TD drug d a ta  in  th e i r  an a ly ses. This 
c le a r ly  confounds the  d a ta  as a n tip sy ch o tic s  a re  o fte n  ad ju sted  in  
response to  a p a t ie n t  developing TD. Id e a lly , the  a n tip sy ch o tic  
dosage would be lowered o r the drugs d iscontinued  (J e s te  & W yatt,
1979). Thus, lower cum ulative and d a ily  doses of a n tip sy ch o tic s  and/or 
sh o r te r  lengths o f a n tip sy ch o tic  a d m in is tra tio n  may be found among TD 
s u b je c ts , co n tra ry  to  ex p ec ta tio n , due to  t h e i r  m edications being 
ad ju sted  once TD was recognized . M ethodological problems r e s u l t  when 
th is  p o s s ib i l i ty  i s  not d e a lt  w ith  by re sea rch ers  as d iffe ren c es  in  
dosage in g estio n s  and d u ra tio n s  between the  two groups, which may have 
e x is ted  p r io r  to  th e  development o f  TD, a re  obscured. Recently Smith 
e t  a l .  (1978) have recognized such a dilemma and recommend th a t  " i t  may
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be more im portant to  examine the schedule and con cen tra tio n  o f a n t i ­
psychotic  ad m in is tra tio n  . . .  r a th e r  than th e  to t a l  amount o f 
m edication a p a tie n t has received" (p . 1403).
There a re  sev e ra l types o f  in d iv id u a l d iffe ren c es  which can 
a lso  a c t  as in te rv en in g  v a ria b le s  in  th e  study of th e  re la tio n s h ip  o f 
drug h is to ry  to  TD development. In d iv id u a ls  d i f f e r  g re a tly  in  the 
abso rp tion  o f m edications in to  th e i r  c e n tra l  nervous and blood systems 
and " th e  m illigram s ingested  may no t g ive a to ta l ly  accu ra te  in d ic a tio n  
of what i s  a c tu a lly  occurring" in  the p a t ie n ts ' physiology (Simpson 
e t  a l . ,  1978). In d iv id u a ls  who develop TD may have a lower to le ran ce  
to  a n tip sy ch o tic  in g e s tio n , and thus a lower TD th re sh o ld , than 
in d iv id u a ls  who d o n 't  develop TD. Thus find ings on a n tip sy ch o tic  
usage may be con tra ry  to  th e  expecta tions generated  by the  dopamine- 
blockage hyp o th esis . To determ ine the ex isten ce  o f  such a s i tu a t io n  
would re q u ire  an tip sy ch o tic  plasma m onitoring as an assessm ent device 
which, perhaps, the  fu tu re  w il l  see (J e s te  & W yatt, 1979). In d iv id u a l 
d iffe ren c es  in  non-compliance w ith  a n tip sy ch o tic  drug regimens is  
another p o ss ib le  in te rv en in g  v a r ia b le . O ften p a tie n ts  s u r re p t i t io u s ly  
do no t take  the  m edications adm inistered  to  them (Van P u tten , 1974).
The dosages recorded as adm inistered may no t be an accu ra te  r e f le c t io n  
o f the  amount a c tu a lly  ingested  by the  p a t ie n t .  These two in d iv id u a l 
d iffe re n c e  fa c to rs  remain beyond experim ental co n tro l a t  th is  tim e, 
y e t a re  worthy of mention due to  th e i r  explanatory  value concerning 
c o n f lic tin g  fin d in g s .
Cumulative Dose
Three s tu d ie s  (Mallya e t  a l . ,  1979; Pryce & Edwards, 1966; 
Simpson e t  a l . ,  1978) have examined the d iffe ren c es  In  cum ulative 
a n tip sy ch o tic  dose le v e ls ,  comparing a TD sample to  a No-TD sample.
The groups were matched on age, sex , and d iag n o sis . Pryce & Edwards 
and Simpson e t  a l .  a lso  matched on leng th  o f h o s p i ta l iz a t io n .  Pryce 
& Edwards (1966) were the  only re sea rch ers  to  find  a s ig n if ic a n t  
d if fe re n c e  between th e  two groups; the  TD sample received  h igher 
cum ulative dosages than  th e  No-TD sample. Simpson e t  a l .  (1978) found 
no s ig n if ic a n t  d iffe ren c es  between th e i r  TD and No-TD groups; In f a c t ,  
the  No-TD group a c tu a lly  had a s l ig h t ly  h ig h e r cum ulative dosage 
(TD = 1266g.; No-TD * 1313g.). Pryce 6c Edwards (1966) and Simpson e t  
a l .  (1978) used drug h is to r ie s  beginning In  the  e a r ly  1950s. Hie 
c o n f lic t in g  find ings o f th ese  two s tu d ie s  could be explained by th e i r  
using  d if f e r e n t  methods to  q u an tify  cum ulative dose; chlorprom azine 
converstion  e q u iv a len ts , which a re  re a d ily  a v a ila b le  to  to d a y 's  
re se a rc h e rs , were j u s t  emerging in  1966. S im ila r ly , Mallya e t  a l .
(1979) found no s ig n if ic a n t  d iffe ren c es  between the two groups. Again 
the  co n tro ls  had a s l ig h t ly  h igher cum ulative dosage (TD = 616g.;
No-TD = 644 g .). T heir fin d in g s  a re  lim ited  as they only s tud ied  
cum ulative dosages of four a n tip sy c h o tic s . Mallya e t  a l .  a lso  d id  not 
mention how many years of drug d a ta  were g a thered , b u t i t  appears th a t  
about e ig h t years were u t i l i z e d .  One exp lanation  o f the  c o n f lic tin g  
fin d in g s  may be th a t  i t  was no t re a liz e d  u n t i l  the  e a r ly  1970s th a t  
a n tip sy ch o tic  dosages should be reduced o r  the  drugs d iscon tinued  w ith
the  occurrence o f TD (Crane, 1973). The TD su b jec ts  In  th e  1978 and 
1979 s tu d ie s  more than l ik e ly  Incurred  a n tip sy ch o tic  dosage reductions 
once TD was recognized; th is  was probably no t the  case fo r  the  su b jec ts  
o f Pryce & Edwards' (1966) s tudy . Also during the  1960s, one method 
o f t r e a t in g  TD was the  a d m in is tra tio n  of Increased  amounts o f a n t i ­
psychotics due to  th e i r  a b i l i ty  to  mask TD symptoms being m isunderstood 
as e ra d ica tio n  o f the symptoms. None o f th e  s tu d ie s  determ ined the  
o n -se t of TD in  o rder to  avoid confounding th e  drug d a ta  w ith post-TD 
drug in fo rm ation . Simpson e t  a l .  (1978) d id  no te  th a t  d iffe ren c es  
in  dosage in g estio n  may have ex is ted  p r io r  to  the  development o f TD 
as they could no t determ ine the  time o f o n -se t o f TD.
Two s tu d ies  examined the  d iffe re n c e  in  cum ulative an tip sy ch o tic  
dose between unmatched TD and No-TD groups. Brandon e t  a l .  (1971) 
d id  n o t f in d  a s ig n if ic a n t  re la tio n s h ip  between the  to t a l  amount of 
an tip sy ch o tic s  adm inistered and the  r i s k  o f developing TD. Likewise, 
Jus e t  a l .  (1976) found no s ig n if ic a n t  d iffe ren c es  between the  TD and 
No-TD samples on cum ulative a n tip sy ch o tic  dose. Again, n e ith e r  study 
c u t-o f f  d a ta  in p u t according to  the  o n -se t o f  TD. Jus e t  a l .  (1976) 
e x p l ic i t ly  s ta t e  th a t th is  probably a ffe c te d  th e i r  fin d in g s on th is  
v a r ia b le .
Three s tu d ie s  used only TD su b jec ts  in  an attem pt to c o r re la te  
a n tip sy ch o tic  dosage w ith  TD symptom s e v e r ity . Crane & Smeets (1974) 
found a p o s it iv e  re la tio n s h ip  between to ta l  a n tip sy ch o tic  in tak e  and 
TD s e v e r i ty . P a tie n ts  \rtiose cum ulative dosages were above the  group 
median had s ig n if ic a n t ly  more pronounced TD symptoms than p a tie n ts
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Whose cum ulative dosages were below the  group median. Turek e t  a l .  
(1972) reported  th e  lack  of a re la tio n s h ip  between symptom se v e rity  
and to t a l  m illigram s of an tip sy ch o tic s  in g ested . However, they only 
used d a ta  from the  p a t ie n ts ' cu rren t h o s p i ta l iz a t io n  which could have 
c le a r ly  confounded the  r e s u l ts  i f  many o f the  su b jec ts  had the 
m ajo rity  o f th e i r  d ru g -tre a te d  years on a previous h o s p i ta l iz a t io n .  
Smith e t  a l .  (1978) a re  th e  only resea rch ers  to  fin d  th a t  TD was 
s ig n if ic a n t ly  n eg a tiv e ly  re la te d  to  the  to ta l  amount o f an tip sy ch o tic s  
a p a tie n t rece ived ; however, they only  u t i l i z e d  drug d a ta  from 1968 on.
Crane (1970) appears to  have conducted the  c lo se s t th e re  has
been to  a p ro sp ec tiv e  study in  th is  f i e ld .  He was ab le  to  randomly
ass ig n  p a tie n ts  to  drug regimens o f placebo, h igh dose a n tip sy ch o tic s , 
o r low dose a n tip sy c h o tic s . S ix months l a t e r  the  p a tie n ts  were 
assessed  fo r  the  presence o f TD. He found th a t  th e  p a tie n ts  rece iv in g  
high doses o f an tip sy ch o tic s  had a s ig n if ic a n t ly  h ig h e r inc idence  of 
TD. Findings about the  ro le  cum ulative an tip sy ch o tic  dose may play 
in  the development o f  TD a re  in c o n s is te n t. This v a r ia b le  m erits  
fu r th e r  re sea rch , designed w ith  regard  to  the  m ethodological flaws o f 
previous s tu d ie s .
Length o f A ntipsychotic  A dm in istra tion
Since TD is  l a t e  in  o n -se t compared to  o th e r n eu ro lo g ica l s id e
e f fe c ts  (ACN-FDA, 1973), i t  seems th a t  sev e ra l years o f trea tm en t w ith
an tip sy ch o tic s  may be necessary  b e fo re  the  syndrome emerges. This 
appears supported by the  incidence o f  TD sharp ly  in c reas in g  over the
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age of 50, which i s  o ften  believed  to  in d ica te  c h ro n ic ity  (Chouinard 
e t  a l . ,  1979; Fann e t  a l . ,  1972; Jus e t  a l . ,  1976). I t  can thus be 
expected th a t  p a t ie n ts  who develop TD w ill  have a longer h is to ry  o f 
an tip sy ch o tic  m edication  treatm ent than  p a tie n ts  who d o n 't  develop 
TD (Crane, 1973). The l i t e r a tu r e  has fa ile d  to  support such an 
ex p ec ta tio n , however.
In  one o f th e  th re e  s tu d ie s  using  co n tro ls  matched on the 
v a ria b le s  p rev io u s ly  d e lin e a te d , longer drug h is to r ie s  fo r  TD su b jec ts  
were noted. Pryce & Edwards (1966) reviewed e n t i r e  drug h is to r ie s  and 
found 19 o f th e  21 TD su b jec ts  had been on an tip sy ch o tic s  from 30 -  500 
weeks compared to  only  8 o f th e  21 No-TD su b je c ts . Mallya e t  a l .
(1979) reviewed about e ig h t years o f trea tm en t, b u t examined only four 
a n tip sy c h o tic s . They found no s ig n if ic a n t  d iffe ren c es  between the 
two groups although the TD su b jec ts  tended to  have longer m edication 
h i s to r ie s  (97.5 mo.) than the co n tro ls  (96 m o.). Simpson e t  a l . ,
(1978), studying 23 years o f drug h i s to r ie s ,  d id  not f in d  s ig n if ic a n t  
d iffe ren c es  between the two groups (TD =■ 11.6 y r s . ;  No-TD = 12.5 y r s . ) .  
These l a s t  two (p o s t - e a r ly  1970s) s tu d ie s ' f a i lu r e  to  end data  
c o lle c tio n  w ith  th e  emergence o f TD may explain  th e i r  f a i lu r e  to  fin d  
longer a n tip sy c h o tic  h is to r ie s  fo r  th e  TD groups.
Four s tu d ie s ,  using unmatched co n tro l groups, a lso  in v e s tig a te d  
the  re la tio n s h ip  between TD and an tip sy ch o tic  trea tm en t d u ra tio n . 
Brandon e t  a l .  (1971), u t i l i z in g  e n t i r e  drug h i s to r i e s ,  found no 
a sso c ia tio n  between the  incidence o f TD and the  to t a l  d u ra tio n  o f 
a n tip sy ch o tic  tre a tm en t. Jus e t  a l .  (1976) examined f i f t e e n  years o f
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drug h is to r ie s  and re p o r t th a t  the  mean number o f months o f trea tm en t 
d id  not d i f f e r  s ig n if ic a n t ly  between th e  TD and No-TD groups. Two 
s tu d ie s  in v e s tig a te d  o u tp a tie n t popu la tio n s . Asnis e t  a l .  (1977) 
found th a t  the  mean number o f years on an tip sy ch o tic s  was a c tu a lly  
s l ig h t ly  le s s  in  the  TD group (TD = 4.59 y r s . ;  No-TD » 5.50 y r s . ) .  
However, the m ajo rity  o f th e i r  su b jec ts  had received  m edications fo r  
le s s  than two y e a rs . Chouinard e t  a l .  (1979) found th a t  th e  v a r ia b le  
of length  of an tip sy ch o tic  ad m in is tra tio n  d id  no t e n te r  in to  th e i r  
reg ress io n  equation as s ig n if ic a n t  in  p re d ic tin g  the inc idence  of 
TD. Y et, they d id  n o t examine the  e n t i r e  drug h is to r ie s  o f th e i r  
su b je c ts .
Three s tu d ie s  d id  no t use co n tro l groups in  th e i r  exam ination 
o f th is  v a r ia b le . Turek e t  a l .  (1972) did no t f in d  a re la tio n s h ip  
between TD se v e r ity  and years on m edications. Crane (1973) rep o rted  
th a t  18 out o f 184 p a tie n ts  he examined tw ice a year fo r  the  presence 
o f TD developed TD w ith in  th a t y e a r . F if te e n  o f th ese  p a t ie n ts  had 
been on an tip sy ch o tic s  fo r  f iv e  years o r lo nger; th re e  fo r  only 3 
y e a rs . This f in d in g  does support the  con ten tion  th a t some h is to ry  o f 
an tip sy ch o tic  a d m in is tra tio n  i s  involved in  the  development o f TD, 
b u t does not address th e  is su e  o f TD su b jec ts  having longer drug h i s ­
to r i e s .  Fann e t  a l .  (1972) le n t  support to  th e  con ten tion  th a t  TD 
is  more p rev a len t in  chronic p a tie n ts  as 64% of th e  p a t ie n ts  w ith  TD 
had been h o sp ita liz e d  longer than ten  y e a rs , Ihey d id  not d i r e c t ly  
t e s t  th e  v a r ia b le  o f a n tip sy ch o tic  m edication d u ra tio n , although 
lengthy h o s p ita l iz a t io n s  may be thought o f as in d ic a tiv e  o f equally
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lengthy drug h i s to r i e s .
D espite  th e  length  of tim e on an tip sy ch o tic s  In v e s tig a te d , 
a l l  o f the  s tu d ie s  (1966) f a i le d  to  show a s ig n if ic a n t  a s s o c i­
a tio n  between trea tm en t d u ra tio n  and th e  development o f TD. I t  Is  
p o ss ib le  th a t  th e  p ra c tic e  of an tip sy ch o tic  d isco n tin u a tio n  fo r  
p a tie n ts  w ith  TD Is  an In terven ing  v a r ia b le  no t c o n tro lled  fo r  by 
ending d a ta  c o lle c tio n  a t  the p o in t o f  TD emergence. The fa c t  th a t  
p a tie n ts  over 50 a re  a t  g re a te r  r i s k  fo r  developing TD may r e f l e c t  
an In te rv en in g  v a r ia b le  o f c h ro n ic lty , which would imply longer 
an tip sy ch o tic  trea tm ent d u ra tio n s . However, th i s  assumes th a t  
in d iv id u a ls  over 50 have been h o s p ita liz e d  fo r  many y e a rs , which i s  
not n e c e s sa r ily  the  case.
Another v a ria b le  th a t could In te rvene  i s  age a t  i n i t i a t i o n  
of a n tip sy ch o tic  trea tm en t. Brandon e t  a l .  (1971) concluded th a t  
age was the  most s ig n if ic a n t  fa c to r  in  determ ining the r i s k  o f TD 
as th e  r is k  increased  d ram atica lly  fo r  the  su b jec ts  over 50. Jus e t  
a l .  (1976) brought more s p e c i f ic i ty  to  th is  conclusion in  fin d in g  th a t  
the p revalence of TD was s ig n if ic a n t ly  h ig h e r i f  the mean age was 
h igher a t  th e  beginning o f trea tm en t w ith a n tip sy c h o tic s . They 
b e lie v e  th a t  in d iv id u a l s u s c e p t ib i l i ty  probably in c reases  w ith age 
in  con junction  w ith  changes o f dopamine metabolism in  the  b ra in  due to 
aging. The dopamine balances o f  e ld e r ly  in d iv id u a ls  may be more e a s i ly  
d isru p ted  so th a t  the  o ld e r p a t ie n ts  a re  a t  treatm ent i n i t i a t i o n s ,  the  
more l ik e ly  they  a re  to  develop dopamine re c ep to r s u p e rs e n s i t iv i ty  in  
response to  a n tip sy ch o tic  m edications. In  f a c t ,  Gerlach (1977), in  an
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attem pt to  c la r i f y  th e  pathogenesis o f TD, concluded from h is  study 
" th a t the neuro tox ic  e f fe c t  o f n e u ro le p tic s  i s  r e la te d  to  age- 
dependent changes in  the  . . .  b a sa l gan g lia"  (p . 784) \rtiich would 
a f f e c t  the dopam ine-choline biochem ical b a lance , perhaps in  favor 
o f the  development o f  TD.
Mean D aily Dose
In  an e f f o r t  to  avoid in te rv en in g  in te ra c t io n s  between length  
o f an tip sy ch o tic  a d m in is tra tio n  and cum ulative an tip sy ch o tic  dose, the  
mean d a ily  dose is  a v a r ia b le  th a t  may provide more s p e c if ic  in fo r ­
m ation. Crane (1974) s tud ied  th e  re la tio n s h ip  between d a ily  dosages 
o f an tip sy ch o tic s  and the  development o f  TD in  samples of p a tie n ts  
over 55 and younger than  55. He found th a t  TD prevalence and d a ily  
doses over 200 mg. were s ig n if ic a n t ly  c o rre la te d  fo r  p a tie n ts  over 55.
A trend  was noted fo r  the  younger p a tie n ts  w ith TD prevalence in c re a s ­
ing w ith dosages over 1,000 iqg. per day. He concluded th a t  th e  maximum 
d a ily  dose o f a n tip sy ch o tic s  i s  p o s it iv e ly  a sso c ia ted  w ith TD. Simpson 
e t  a l .  (1978) examined 23 years o f drug h i s to r ie s  fo r  a TD group and 
a matched co n tro l group, A s ig n if ic a n t  d if fe re n c e  was no t found 
between the two groups on mean d a ily  dose, although the  TD group d id  
have a s l ig h t ly  h ig h e r mean dose (TD * 298mg/day; No-TD = 289mg/day). 
Due to  these  c o n f lic tin g  fin d in g s  and the  need fo r  more inform ation 
on th e  ro le  s p e c if ic  drug v a ria b le s  p lay  in  th e  development o f  TD, 
th is  v a r ia b le  m erits  fu r th e r  in v e s t ig a tio n . P rec ise  and s p e c if ic  
drug d a ta  i s  extrem ely time-consuming to  g a th er and o fte n  u n av a ilab le , 
thus i t  i s  understandable  th a t  o th e r g ross drug v a ria b le s  a re  s tu d ied
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more freq u e n tly .
M axirmim A ntipsychotic  Dosage Per Year
The maximum an tip sy ch o tic  dosage per year i s  ano ther measure 
o f  th e  re la tio n s h ip  between drug h is to ry  v a ria b le s  and the  development 
o f TD. This i s  an im portant v a ria b le  as the  concen tra tion  o f a n t i ­
psycho tic  ad m in is tra tio n  may be more in form ative than o th e r more 
g enera l drug v a r ia b le s . Two s tu d ie s  have examined th is  v a r ia b le  and 
th e  outcomes a re  c o n s is te n t.
Crane (1974) found a s ig n if ic a n t ly  p o s itiv e  a sso c ia tio n  between 
maximum dose o f an tip sy ch o tic s  and TD ( p a r t i a l  c o rre la tio n  r  = + .1 9 ). 
Smith e t  a l .  (1978) d id  not f in d  the  t o t a l  amount o f a n tip sy ch o tic  
m edication a p a t ie n t  had received  over many years  to  be the  main 
v a r ia b le  re la te d  to  TD s e v e r ity . However, they d id  f in d  a s ig n i f i ­
c an tly  p o s it iv e  a sso c ia tio n  between th e  maximum amount of 
a n tip sy ch o tic s  a  p a t ie n t  had received  in  any year and TD s e v e r ity  
( p a r t i a l  c o r re la t io n  r  = + .1 7 ). This l a t t e r  study only examined 
th e  v a r ia b le 's  re la tio n s h ip  to  TD s e v e r ity ;  however, th e  f a c t  th a t  
they found the  a sso c ia tio n  to  be p o s it iv e  and s ig n if ic a n t ,  which had 
no t been th e  case fo r  cum ulative a n tip sy ch o tic  dose, in d ic a te s  th a t  
equally  c lo se  sc ru tin y  should be c a r r ie d  o u t in  any study o f  the 
r e la t io n s h ip  o f drug v a ria b le s  to  the  development o f TD. Although 
th ese  s tu d ie s  were c o rre la tio n a l and w ithout matched c o n tro ls , they 
do in d ic a te  a need to  examine th is  v a r ia b le  more in te n se ly .
B. A ntiparkinson Agents
P rev iously  an tip a rk in so n  agents were t r i e d  as a  form of
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treatm ent fo r  TD because they worked w ell in  reducing parkinsonism  
which, l ik e  TD, involves the extrapyram idal system . However, i t  was 
soon re a liz e d  th a t  these  drugs d id  no t improve TD (Turek e t  a l . ,
1972) and a c tu a lly  aggravated the  syndrome in  some cases ( J e s te  &
W yatt, 1979). In  f a c t ,  in  an in v e s tig a tio n  o f c u rre n t m edications,
B ell & Smith (1978) found th a t p a t ie n ts  rece iv in g  an tip a rk in so n  agents 
tended to  have h igher dysk inesia  sco res . B orison (1979) a s s e r ts  th a t 
an tip a rk in so n  agents may promote the  development o f TD by in c reasin g  
dopamine recep to r h y p e rs e n s i t iv i ty , c u rre n tly  hypothesized to  m ediate 
the  development o f TD. Consequently, more freq u en t trea tm en t w ith 
an tip a rk in so n  agents could m ediate the  development o f TD.
Simpson e t  a l .  (1978) s tu d ied  four asp ec ts  o f an tip ark in son  
treatm ent h is to ry  in  th e i r  TD and No-TD groups matched on age, sex, 
d iag n o sis , and length  o f h o s p ita l iz a t io n :  d u ra tio n  o f ad m in is tra tio n ,
mean to ta l  amount, mean d a ily  dose, and v a r ie ty  o f an tip a rk in so n  ag en ts . 
None of the  d iffe ren c es  found between the two groups were s t a t i s t i c a l l y  
s ig n if ic a n t .  However, th e  TD su b jec ts  did tend to  have a h ig h er mean 
d a ily  dose (TD = 2 .8  mg; No-TD = 2 .5  mg) and a g re a te r  v a r ie ty  of
an tip a rk in so n  agents p rescrib ed  (TD mean = 1 .9 ; No-TD mean = 1 .6) than
d id  the  No-TD group. Simpson e t  a l .  d id  no t cease g a th erin g  da ta  upon
the  emergence o f TD, however. Thus an tip a rk in so n  drugs used to  t r e a t
TD may have confounded th e  d a ta . A lso, i t  i s  n o t uncommon fo r  p a rk in ­
sonism and TD to  co ex is t (Crane, 1972; Fann & Lake, 1974). In  such 
in s tances an tip a rk in so n  agents would have been adm inistered  to  t r e a t  
the  parkinsonism .
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Mallya e t  a l .  (1979) conducted the  only o th e r study found th a t 
used matched TD and No-TD groups matched on age, sex , and d iag n o sis . 
They found a s t a t i s t i c a l l y  s ig n if ic a n t  re la tio n s h ip  between a n tip a r ­
k inson agent p re sc r ip tio n  and TD. The TD su b jec ts  had a s ig n if ic a n t ly  
g re a te r  amount o f an tipark in sons adm inistered (TD = 4.51 g . ;  No-TD = 
1 .65g .) fo r  a s ig n if ic a n t ly  g re a te r  length  o f time (TD = 33.7 mo.; 
No-TD = 17.9 m o.). However, they only examined the average to ta l  
amount adm inistered and the  average treatm ent d u ra tio n  o f two a n t i ­
parkinson agen ts .
Jus e t  a l .  (1976) found no d iffe ren c es  between the unmatched 
TD and No-TD groups on h is to ry  o f an tip a rk in so n  ag en ts . They cau tio n , 
however, th a t  they were no t ab le  to  g a th er d a ta  so le ly  p r io r  to  the  
development o f TD as records d id  n o t document the  o n -se t o f  the  
syndrome. In  l ig h t  o f the  c o n f lic tin g  fin d ings of the  two s tu d ie s  
using  matched con tro l groups and the f a i lu r e  o f a l l  th ree  s tu d ie s  to 
c u t-o f f  d a ta  c o lle c tio n  a t  the  emergence o f TD, the  re la tio n s h ip  
between TD and an tip a rk in so n  m edication h is to ry  m erits  fu r th e r  exami­
n a tio n .
C. Polypharmacy
In  a  survey on polypharmacy, Sheppard e t  a l .  (1974) concluded 
th a t  the  main cause o f using  more than one an tip sy ch o tic  was a 
p a t ie n t 's  responding poorly  to  h is  o r h e r a n tip sy ch o tic  regim e. The 
physician  then adds a concom itant a n tip sy c h o tic . Chouinard e t  a l .  
(1979) found th a t  l i t t l e  th e ra p eu tic  improvement was a v a ria b le
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s ig n if ic a n tly  re la te d  to  the presence of TD. When these  two find ings 
a re  combined, i t  could be expected th a t  p a t ie n ts  w ith TD w i l l  have a 
g re a te r  incidence o f polypharmacy than  p a tie n ts  no t having TD.
Jus e t  a l .  (1976) in v e s tig a te d  th e  ro le  polypharmacy may play 
in  th e  development of TD. They o p e ra tio n a lized  polypharmacy as 
in stances in  which p a tie n ts  "were tre a te d  w ith a sim ultaneous combi­
n a tio n  (c o c k ta il)  of two or more n e u ro le p tic s  during a t  le a s t  one month 
and the  monthly amount exceeded 3g o f chlorprom azine equ iv alen t"
(p . 258). Such o p e ra tio n a liz a tio n  i s  necessary  "because w ithout 
r e s t r ic t io n s  to  some time and q u a n tity  l im i t s ,  th e  sporad ic  adm inis­
t r a t io n  of only one a d d itio n a l n eu ro lep tic  during the  whole course o f 
treatm ent would be a lread y  labeled  as c o c k ta il  and most i f  no t a l l  
p a tie n ts  would have been evaluated as tre a te d  by c o c k ta ils "  (Jus e t  
a l . ,  1979, p. 260). They found no s ig n if ic a n t  d iffe ren c es  between the 
unmatched TD and No-TD groups on the  number o f c o c k ta ils  rece iv ed . 
U nfortunate ly , drug d a ta  a f te r  the  o n -se t o f TD was included  in  th e i r  
a n a ly s is . Furtherm ore, the  c r i t e r i a  o f  3g o f chlorprom azine equiva­
le n ts  per month equals only 100 mg. p e r day which i s  much lower than 
the  average amount of chlorpromazine equ iv alen ts  adm in istered  to  the  
m ajo rity  o f p a t ie n ts  (Davis & G arver, 1978). I f  TD su b jec ts  do rece iv e  
h igher a n tip sy ch o tic  dosages, which may be adm in istered  in  the  form of 
polypharmacy—although p o ssib ly  fo r s h o r te r  periods of tim e—then th is  
may no t be ev iden t when studying  such a broadly  defined  drug fa c to r .
Borison (1979) a s s e r ts  th a t combining an an tip a rk in so n  agent 
and an a n tip sy ch o tic  w i l l  promote dopamine re c ep to r h y p e rs e n s i t iv i ty .
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I t  may be expected th a t increased  incidence o f polypharmacy involv ing  
an a n tip sy ch o tic  and an an tip a rk in so n  would be found in  the  drug 
h is to r ie s  o f p a tie n ts  w ith  TD. Jus e t  a l .  (1976) found no d iffe ren c es  
between the  unmatched TD and No-TD groups on the  mean to ta l  amount 
and mean d u ra tio n  of treatm ent w ith  an tipark in son  agents in  ad d itio n  
to  o th e r a n tip sy ch o tic  trea tm en t. However, i t  i s  un c lea r i f  they 
examined a l l  in s tances o f an tip a rk in so n  ad m in is tra tio n , o r only those 
in s tances where both a n tip sy ch o tic  and an tip ark inson  drugs were sim ul­
taneously  adm in istered . In  co n sid era tio n  o f B o rison 's  (1979) a s s e r tio n , 
the  fin d ings reviewed e a r l i e r  concerning an tip a rk in so n  agents in  
g en era l, and the  m ethodological g e n e ro s itie s  and u n c e r ta in t ie s  o f 
Jus e t  a l .  (1976), i t  is  necessary  to  examine fu r th e r  the  re la tio n s h ip  
of an tip a rk in so n  and concomitant a n tip sy ch o tic  drug ad m in is tra tio n  to  
the  development o f TD.
Nothing about two o th e r c a teg o rie s  o f polypharmacy, a n t i ­
p s y c h o tic ^ )  p lus lith iu m  and a n tip sy c h o tic (s )  plus t r i c y c l i c  
a n tid e p re ssan ts , has been rep o rted  in  the  l i t e r a tu r e  on th e  r e la t io n ­
sh ip  o f drug h is to ry  v a ria b le s  and the development o f  TD. Lithium 
has been re p o rte d , in  some case s , to  improve TD (Simpson, 1973) and, 
in  o th e r cases , to  aggravate TD (Rosenbaum e t  a l . ,  1977). T r ic y c lic  
an tid ep ressan ts  have a n tic h o lin e rg ic  p ro p e r tie s , l ik e  an tip a rk in so n  
agents (B a ld essa r in i, 1977), and a re  th e re fo re  im plicated  in  the  
development o f TD fo r  the same reasons an tip a rk in so n  agents a re  
(Borison, 1979). In  f a c t ,  Rosenbaum e t  a l .  (1977) rep o rted  cases 
of TD th a t  developed in  p a t ie n ts  w ith  drug h is to r ie s  co n s is tin g
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p rim arily  of an tid ep ressan ts  o r a n tia n x ie ty  ag en ts . Fann e t  a l .
(1976) a lso  repo rted  the  development o f TD among some o f th e i r  
su b jec ts  as being asso c ia ted  w ith t r i c y c l i c  an tid ep ressan t usage.
These v a r ia b le s , i f  included in  drug h is to ry  s tu d ie s , could p o ssib ly  
exp lain  some of the in c o n s is te n t f in d in g s . They have been overlooked 
to  d a te , although they a re  im plicated  on a neurochemical b a s is .
Simpson e t  a l .  (1978) s tud ied  the  v a ria b le  o f polypharmacy but 
i t s  o p e ra tio n a l d e f in i t io n  was no t s im ila r  to  th a t  of Jus e t  a l .
(1976). They defined  polypharmacy as "two psychotropic drugs admin­
is te re d  concurren tly" (p . 120). "Psychotropic" re fe rs  to  any drugs 
a ffe c t in g  mental a c t iv i ty  and they analyzed a l l  in s tan ces  where 
n e u ro le p tic s , an tip a rk in so n  agen ts , a n tid e p re s sa n ts , and m iscellaneous 
drugs were adm inistered to  the  matched TD and No-TD groups. They d id  
examine ano ther type of polypharmacy; namely, the  v a r ie ty  o f a n tip sy ­
ch o tics  adm inistered to  each group. The TD group received  a mean o f 
5 .4  d if f e r e n t  an tip sy ch o tic s  and the No-TD group received  a mean of 
5 .0  d i f f e r e n t  an tip sy ch o tic s  although no s t a t i s t i c a l  t e s t  was reported  
on these  d iffe re n c e s .
D. Drug-Free Periods
As a p rev en ta tiv e  measure a g a in s t TD, d ru g -free  periods 
la s t in g  from two days to  two months have been advocated. These time 
periods would allow  TD being masked by an tip sy ch o tic s  to  be d e tec ted ; 
they would a lso  cu t down on the  cum ulative doses and leng th  o f 
ad m in is tra tio n  o f an tip sy ch o tic s  (Ayd, 1970). R ecently , J e s te  e t  a l .
(1979) found th a t the  b e s t d isc rim in a to r between TD p a tie n ts  whose
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symptoms reversed  a f t e r  th re e  months f re e  o f drugs and TD p a tie n ts  
whose symptoms p e rs is te d  was the  number of in te rv a ls  f r e e  o f 
an tip sy ch o tic  d rugs. P arad o x ica lly , the  p e r s is te n t  group had a 
g re a te r  number o f d ru g -free  in te rv a ls  o f a t  le a s t  two months. This 
v a r ia b le  c o rre c t ly  c la s s i f ie d  76% o f the  cases o f dysk inesia  in to  
re v e rs ib le  and p e r s is te n t  groups. They only used d a ta  p r io r  to  the  
development o f TD and s e t  d u ra tio n  c r i t e r i a  o f a two month period 
d ru g -fre e . T heir fin d in g  i s  very d is tu rb in g  as i t  in d ic a ted  th a t  a 
preven tive  measure p rev iously  advocated may in s tead  a c tu a lly  be 
in c reasin g  the s e v e r ity  and /or i r r e v e r s ib i l i t y  o f TD.
Simpson e t  a l .  (1978) d id  g a th er d a ta  on the  d u ra tio n  o f 
documented time f re e  o f m edication , b u t did no t t e s t  fo r  s ig n if ic a n t  
d iffe ren c es  between the  matched TD and No-TD groups as they used the  
inform ation to  determ ine polypharmacy d u ra tio n . Although they d id  not 
address th e  is su e  o f d ru g -free  periods in  th e i r  study , they did 
provide th e  fin d in g s  in  a ta b le .  The TD group had a mean o f 3.7 years 
per su b jec t o f no m edication, out o f a mean o f 15 years per su b jec t 
when psychotropic  m edications could have been adm in istered . The No-TD 
group had a mean o f 2 .5  years per su b jec t o f no m edication , out o f a 
mean of 14.3 years per su b jec t when psychotrop ic  m edications could 
have been adm in istered . This appears to  be a s iz a b le  d iffe re n c e  w ith 
th e  TD group having a g re a te r  period o f time d ru g -fre e . However, data  
p r io r  to  and subsequent to  th e  development o f TD was used in  th is  
s tudy . Also the  d ru g -free  periods re fe rre d  to  times when no psycho­
tro p ic s  were adm in istered  ra th e r  than only  time f r e e  o f an tip sy ch o tic s .
Given the  d is tu rb in g  fin d in g s  o f J e s te  e t  a l .  (1979), c lo se r  
exam ination of two d ru g -free  v a r ia b le s  is  needed. Any d iffe ren c es  
between p a tie n ts  w ith  TD and p a tie n ts  w ithout TD on the  number o f 
incidences o f d ru g -free  p e rio d s—i . e . ,  two. months f re e  of antipsycho­
t i c s —m erits  a d d itio n a l a t te n t io n . A lso, d iffe ren c es  between groups 
on th e  number o f  d ru g -free  days needs fu r th e r  study.
Other D esc rip tiv e  C h a ra c te r is tic s
A. H is to ry  o f Extrapyram idal Symptoms (EPS)
There a re  c o n f lic tin g  fin d in g s  concerning the re la tio n s h ip  
between EPS h is to ry  and the  subsequent development o f TD (Sovner 
& DiMascio, 1978). This lack  o f  consistency  r e s u l t s ,  in  p a r t ,  from 
the  lack  o f w ell-developed assessm ent methods fo r  EPS (Mindham, 1976). 
In  a d d itio n , the  s id e  e f fe c ts  a re  o f te n  no t mentioned o r s p e c if ic a l ly  
named in  p a t ie n ts ' reco rd s . D espite  the  c o n f lic t in g  f in d in g s , Crane 
(1972, 1978) has co n tin u a lly  found a p red isposing  re la t io n s h ip . He 
has had e x c e lle n t d esigns, c o n tro llin g  fo r  in te rv en in g  v a ria b le s  and 
r ig o ro u sly  assess in g  EPS, which a re  o f te n  lack ing  in  o th e r s tu d ie s  
(McClelland, 1976). Crane, however, d id  not d is tin g u ish  among the 
various types o f EPS studying only  the  re la tio n s h ip  between p a rk in ­
sonism, which i s  a combination o f r ig id i ty ,  trem or, and a k in e s ia , and 
the development of TD. Chouinard e t  a l .  (1979) a re  the  f i r s t  
re sea rch ers  to  make such a d is t in c t io n .  They found an in v erse  
re la tio n s h ip  between park inson ian  symptoms and TD. They then excluded 
from the  to t a l  park insonian  sco re  those fo r  trem or and a k a th is ia ,  the
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h y p erk in e tic  types of EPS, and found th a t the  in v erse  re la tio n s h ip  
became more pronounced. Chouinard e t  a l .  (1979) p o s tu la te  th a t  the  
h y p e rk in e tic  types o f EPS may be p red isposing  to  the development of 
TD w hile the hypokinetic  types o f  EPS may reduce the  development of 
TD. However, th e i r  study examined only the  c u rre n t EPS o f the  
s u b je c ts . F urther ex p lo ra tio n  o f  s u b je c ts ' EPS h is to ry  is  needed in  
o rder to  t e s t  fo r  a p o ss ib le  h i s to r i c a l  r e la t io n s h ip  s im ila r  to  the 
find ings o f Chouinard e t  a l .  (1979).
B. P sy c h ia tr ic  Behavior P a tte rn
I t  i s  necessary  to  research  both EPS h is to ry  and p sy c h ia tr ic  
behavior p a tte rn s , ra th e r  than so le ly  EPS h is to r y ,  due to  the  v a l id i ty  
problem in h eren t in  try in g  to  in v e s t ig a te  the  re la tio n s h ip  between EPS 
and the  subsequent development o f TD. Medical personnel and re sea rch ers  
o f te n  have d i f f i c u l ty  d i f f e r e n t ia l ly  diagnosing EPS from p sy c h ia tr ic  
symptomology. A kath isia  has been confused w ith  psychotic  a g ita t io n  
(Davis & Cole, 1975), tremor w ith anx iety  (Donlon & Stenson, 1976), 
r ig id i ty  w ith anx iety  accompanied by ten sio n  (Donlon & Stenson, 1976), 
dyston ic  reac tio n s  w ith h y s te r ia  (Lesser & Fahn, 1978), and ak in es ia  
w ith  depression  and apathy (R ifk in  e t  a l . ,  1975). The lack  of a 
c o n s is te n t re la tio n s h ip  between EPS and TD may thus r e s u l t  from 
confusion between p s y c h ia tr ic  symptoms and n eu ro lo g ica l s id e  e f f e c t s .
To avoid th is  confusion the  re la tio n s h ip  between p sy c h ia tr ic  behavior 
p a tte rn  and the  development o f TD should a lso  be examined.
C. I n i t i a l  P sy c h ia tr ic  Behavior P a tte rn
F riedho ff e t  a l .  (1960) determ ined th a t  an tip sy ch o tic s  reduced 
motor a c t iv i ty  in  p a tie n ts  whose a c t iv i ty  was p rev io u sly  qu icker than 
average, b u t sped up p a tie n ts  whose motor a c t iv i ty  had been re ta rd e d . 
Van P u tten  (1978) found th a t  a hypok inetic  type of EPS, a k in e s ia , 
occurred more o f te n  in  p a tie n ts  e x h ib itin g  h igh  le v e ls  o f e x c ita tio n  
in  th e i r  i n i t i a l  p sy c h ia tr ic  behav io r. These s tu d ie s  in d ic a te  th a t  
p a t ie n ts ' i n i t i a l  p sy c h ia tr ic  behavior p a tte rn s  could p o ssib ly  suggest 
the type o f EPS, i f  any, they may develop in  response to trea tm en t w ith  
an tip sy ch o tic s . Furtherm ore, in  l ig h t  o f th e  fin d in g s  of Crane (1972,
1978) and Chouinard e t  a l .  (1979), knowing the  type o f EPS a p a t ie n t  
may be su scep tib le  to  may a lso  in d ic a te  h is  o r  h e r  r i s k  o f developing 
TD.
D. M iscellaneous C h a ra c te r is tic s
Crane (1978) a s s e r ts  th a t  no d a ta  a re  a v a ila b le  on g en e tic  
v a riab le s  which could account fo r  d iffe ren c es  in  in d iv id u a l s u sc e p ti­
b i l i t y  to  TD. Brandon e t  a l .  (1971) rep o rted  an unexpected find ing  
they f e l t  in d ica ted  a ro le  fo r  g en e tics  in  the  development o f TD. In  
th e i r  study of dysk in esia  among in p a t ie n ts ,  they found a marked excess 
of blue-eyed males w ith  dysk inesia  th a t  was no t found among the female 
su b je c ts . Gardos e t  a l .  (1978), however, were unable to  r e p l ic a te  th is  
find ing  and found no support fo r  an a sso c ia tio n  between eye co lo r and 
d y sk in esia . Furtherm ore, th e  f in d in g  o f Brandon e t  a l .  p e r ip h e ra lly  
addresses the q u estio n  o f what r e la t io n s h ip , i f  any, e x is ts  between 
race  and the  inc idence  o f TD as blue-eyed males would be Caucasian.
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I t  has been known fo r some time th a t  edentulous e ld e r ly  
p a tie n ts  may appear to  have TD in  the b u cca l-lin g u a l-m astic a to ry  
t r i a d  due to  the  gumming movements th is  s ta te  o fte n  p re c ip i ta te s .  
S im ila r ly , p a tie n ts  w ith  i l l - f i t t i n g  dentures may move th e i r  mouth, 
tongue, and jaws in  a manner found in  TD p a t ie n ts .  Consequently, a 
physician  i s  warned to  always check on the  d en ta l s ta tu s  of a p a t ie n t  
when considering  a d iagnosis o f TD (Sutcher e t  a l . ,  1971). O ccasion­
a l ly ,  d en ta l s ta te  has been found to  be a sso c ia ted  w ith the  presence 
o f TD. Asnis e t  a l .  (1977) found a s ig n if ic a n t  a sso c ia tio n  between 
the  presence o f dentures and dysk inesia  in  th e i r  TD group. Brandon 
e t  a l .  (1971) rep o rted  th a t  edentulous p a tie n ts  were a h igh r is k  
group fo r  f a c ia l  dysk inesia  in  th e i r  study . Consequently, the  TD 
group in  th is  study may p o te n tia l ly  have more in s tan ces  o f m issing 
te e th , w ith o r  w ithout den tu res .
Summary
Research on the re la tio n s h ip  o f various fa c to rs  to  th e  develop­
ment o f TD i s  in c re a s in g . Many o f the  fin d ings a re  unc lear and/or 
in c o n s is te n t. The prim ary reasons fo r  th is  a re  m ethodological flaws 
such as the  lack  o f matched co n tro l groups, f a i lu r e  to  cut o f f  
g a th erin g  da ta  w ith the  emergence o f TD, and th e  lack  o f c le a r ly  
d e lin ea ted  c r i t e r i a  conducive to  re p l ic a t io n .  H is to r ic a l  fa c to rs  a lso  
confound r e s u l ts  of s tu d ie s  in v e s tig a tin g  s im ila r  v a ria b le s  a t  
d i f f e r e n t  p o in ts  in  time s in ce  the  trea tm ent o f TD has changed sev e ra l 
tim es over the  p a s t two decades. Record-keeping procedures have a lso  
changed, thus making i t  p o ss ib le  to  in v e s t ig a te  v a ria b le s  on which
P
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l i t t l e  inform ation  was form erly a v a ila b le . This study in v e s tig a te d  
th e  re la tio n sh ip s  d iscussed  in  the  l i t e r a tu r e  review w hile improving 
th e  major design  flaws in d ic a ted .
I I I .  METHODOLOGY
Population and S e lec tio n  of the  Samples
In  June, 1979 the  m edical s t a f f  a t  E astern  S ta te  H o sp ita l were 
asked to  id e n tify  a l l  p a tie n ts  they b e liev ed  had ta rd iv e  dysk inesia  
(TD). The to t a l  number of id e n t i f ie d  p a tie n ts  was 51. This o r ig in a l  
number was reduced, however, s in ce  sev e ra l p a tie n ts  d ied o r were 
d ischarged , re s u lt in g  in  a sample s iz e  of 47. Each p a tie n t  was 
matched on age, sex , and d iagnosis  w ith  ano ther p a t ie n t  chosen from 
the  h o s p ita l  census (see  Appendix B fo r  matching procedure). A 
p s y c h ia tr is t  a t  E astern  S ta te  H o sp ita l, b lin d  to  the  group membership 
o f th e  su b je c ts , screened 37 p a tie n ts  from the  TD group and 28 o f the 
co n tro ls  fo r  the  presence o r absence o f TD. The presence o f  TD was 
diagnosed in  17 of th e  screened TD su b je c ts ; the  absence o f TD was 
confirmed in  15 of th e  matched co n tro ls  screened . The rem aining 
co n tro ls  were diagnosed as having TD. To in c rease  the TD sample s iz e ,
9 o f the co n tro ls  diagnosed as having a t  l e a s t  m oderately severe  TD 
were reassigned  to  th e  TD group. Of th e  TD su b jec ts  diagnosed as f re e  
o f TD, 11 were reassigned  to  th e  co n tro l group on the b a s is  o f  appro­
p r ia te  co n tro l v a r ia b le s  and c le a r  reasons fo r  th e  s t a f f  m is id en tify in g  
them as having TD. For in s ta n c e , a p a tie n t  id e n tif ie d  by the  s t a f f  as 
having TD was diagnosed by th e  p s y c h ia tr i s t  as having abnormal move­
ments secondary to  a s tro k e . The TD and co n tro l groups each had a 
f in a l  sample s iz e  o f 26.
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Matching the  groups on age, sex, and d iagnosis was done as these  
v a ria b le s  a re  " th e  most l ik e ly  sources o f in te rn a l in v a l id i ty  due to  
se le c tio n "  (Tuckman, 1978, p . 105). The i n i t i a l  prevalence s tu d ie s  
c o n s is te n tly  found TD to  occur more freq u en tly  among e ld e r ly , female, 
chronic schizophrenic in p a tie n ts  (Crane, 1978). As TD became more 
c le a r ly  d e fined , assessm ent procedures more so p h is tic a te d , and samples 
la rg e r , the  find ings became more d isc r im in an t. The 2:1 female to  male 
r a t io  c u rre n tly  "appears to  be tru e  only fo r  the  more severe  forms o f 
ta rd iv e  dysk inesia" (Smith e t  a l . ,  1979, p . 921), which i s  a find ing  
a lso  supported by Jus e t  a l .  (1976). This r a t io  i s  a lso  most evident 
in  groups aged 59 and over (Smith e t  a l . ,  1978; B ell & Smith, 1978). 
Tardive dysk inesia  continues to  be found more freq u en tly  among e ld e rly  
su b jec ts  (B ell & Smith, 1978; Chouinard e t  a l . ,  1979; Jus e t  a l . ,
1976). The TD group id e n t i f ie d  a t  E astern  S ta te  H o sp ita l was composed 
o f severe TD cases, a 3:1 female to  male r a t i o ,  and had an average 
age o f about 70. Matching on age and sex thus assu res th a t  the  No-TD 
su b jec ts  have the  same r i s k  fa c to rs  e t io lo g ic a l ly  as th e  TD su b je c ts , 
y e t had n o t developed TD. The No-TD su b jec ts  were a lso  matched on the  
TD s u b je c ts ' d iagnosis due to  fin d ings in d ic a tin g  a re la tio n s h ip  between 
o rg a n ic ity  and TD (Brandon e t  a l . ,  1971; Edwards, 1970). D iagnosis was 
a lso  chosen as a co n tro l v a r ia b le  due to  i t s  im p lica tions concerning 
psychotropic t r e a tm e n t- - ! .e . , m anic-depressives rece iv e  p rim arily  
lith iu m .
P r io r  to  the  p s y c h ia t r i s t 's  screen ing , the  samples were 
matched on sex and d iag n o sis; matching on age was w ith in  th re e  years
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and achieved according to  y ear o f b i r t h .  Following the p s y c h ia t r i s t 's  
d iagnoses, su b jec ts  were reassigned  so th a t  each was matched on sex 
and on the broad d ia g n o s tic  ca tego ries  o f organic b ra in  syndrome, 
sch izophren ia , and o th e r psychoses. A ll p a irs  were matched w ith in  
eleven years on age. This was deemed accep tab le  as the  r a t io n a le  
fo r  matching on age was based on the  c o n s is te n t fin d in g  o f a r e la t io n ­
sh ip  between age over 55 and the occurrence o f TD (Chouinard e t  a l . ,
1979). I t  i s  most im portan t, th e re fo re , th a t  TD su b jec ts  55 years o f 
age and o lder be matched w ith  co n tro l su b jec ts  of the  same age 
b ra c k e t. A ll b u t 4 su b jec ts  in  th is  study were over 55 years  o f  age; 
th e  o th e r 4 were matched ex ac tly  on age. The co n tro l v a ria b le s  a re  
dep ic ted  in  Table 1.
Table 1
C ontrol V ariables o f Samples
CONTROL
VARIABLE
TD SUBJECTS 
(N .  26)
CONTROL SUBJECTS 
(N = 26)
TOTAL
Sex:
Males 7 7 14 (27%)
Females 19 19 38 (73%)
Age (years):
Mean 71.4 71.5 71.5
Range 49 - 87 47 - 86 49 - 87
D iagnosis:
Organic 13 13 26 (50%)
Schizophrenia 9 9 18 (35%)
O ther psychoses 4 4 8 (15%)
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Procedures
Under Chapter 13, Human Research, o f the  Code o f  V irg in ia , 
p a t ie n t  perm ission i s  no t necessary as th i s  study i s  considered 
epidem iological and does not involve an experim ental tre a tm en t. A ll 
d a ta  co lle c ted  was kep t c o n fid e n tia l as code numbers were used . Data 
was gathered from th e  h o sp ita l records and ward ch a rts  o f  a l l  p a tie n ts  
included in  the s tudy . The co n tro l v a ria b le s  of b i r th  d a te , sex, and 
d iagnosis were f i r s t  gathered fo r  th e  TD su b jec ts  to  a llow  fo r  subse­
quent matches to  be found.
The da te  o f th e  f i r s t  TD symptom or d iagnosis  mentioned in  the 
records was obtained  so th a t da ta  c o lle c tio n  would be lim ite d  to  the 
tim e preceding TD development. A ll TD s u b je c ts ' c u t-o f f  d a tes  were 
app lied  to  th e i r  matched contro ls’ d a ta  as w e ll. This procedure 
prevented h i s to r i c a l  d iffe ren ces  from a f fe c t in g  th e  d a ta . For in s tan ce , 
i f  a TD s u b je c t 's  c u t-o f f  date was 1976 and th e  matched c o n tro l 's  data  
had been c o lle c te d  through December 1979, the  l a t t e r  could have had 
more EPS incidences only  because problem -oriented record-keep ing  
procedures were in troduced  in  the mid-1970s. C u t-o ff d a te s  were 
determined fo r  a l l  b u t 5 of the  TD su b je c ts . For th ese  f iv e ,  and 
th e i r  matched c o n tro ls , data was c o lle c te d  through December, 1979.
Data on the  behav ioral v a ria b le s  of i n i t i a l  and subsequent 
p sy c h ia tr ic  behavior p a tte rn  was c o lle c te d  by a s s i s ta n t s  b lin d  to  
group membership and hypotheses in  o rder to  guard a g a in s t experim enter 
b ia s .  Drug h is to ry  d a ta  was co lle c te d  s ta r t in g  in  1953, th e  year 
an tip sy ch o tic s  were f i r s t  widely a v a ila b le . As recommended by Smith
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e t  a l .  (1978), d isc rep an c ies  between p h y s ic ian s ' m edication o rders and 
n u rse s ' records were reso lved  in  favo r o f the  n u rse s ' records as they 
re f le c te d  the  m edications g iven . Data a f te r  th e  f i r s t  mention o f a 
TD diagnosis o r one o f the TD symptoms (Appendix C) was ignored as i t  
i s  ir r e le v a n t to  the  d e sc r ip tiv e  c h a ra c te r is t ic s  p r io r  to  the develop­
ment of TD.
"H istory  of extrapyram idal s id e  e f fe c ts  (EPS)" re fe rs  to  
recorded behavior tre a te d  w ith an tip a rk in so n  ag en ts . A p re-study  
check o f the  h o s p ita l  records in d ica ted  th a t  extrapyram idal symptoms 
a re  not so-named—i . e . ,  they a re  no t recorded by form such as a k a th i-  
s ia .  The m edical s t a f f  record  d a ily  behavior w ith problem numbers 
assigned and physicians then  code p re sc r ip tio n s  to  th ese  numbers.
For example, i f  a behavior d e sc r ip tio n  of " r e s t l e s s ,  paces con stan tly "  
i s  coded as problem #3 and the  phy sic ian  p re sc rib es  an tip a rk in so n  
m edication coded to  problem #3, then the  behavior was recorded under 
'H is to ry  o f EPS." Symptom d u ra tio n  was determ ined by the  length of 
an tipark inson  m edication a d m in is tra tio n . P rophy lac tic  p re sc r ip tio n  of 
an tipark in son  agents involves p re s c r ip tio n  p r io r  to  the  emergence o f 
extrapyram idal s id e  e f fe c ts  (EPS) in  an e f f o r t  to  p reven t th e i r  
occurrence. Consequently, such ad m in is tra tio n s  o f an tipark in son  
agents were n o t considered in d ic a tiv e  o f extrapyram idal s id e  e f f e c ts .
Ins trum entation
The d a ta  gathered  fo r  a l l  o f th e  su b jec ts  a re  dep icted  on 
th e  P a tie n t Inform ation Sheet in  Appendix D. The codes fo r  the  
'^General In form ation , S ection  I , "  a re  given in  Appendix E. For
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"P sy ch ia tr ic  D iagnosis" th e  cu rre n t d iagnosis  of the  su b jec t was 
recorded in  terms o f  DSM-II coding. The " F ir s t  TD Symptom" i s  the  
f i r s t  recorded symptom o f TD found which corresponds w ith  those l i s te d  
in  Appendix C. Unis was deemed necessary  as i n i t i a l  symptoms a re  o ften  
recorded , b u t the  d iagnosis i s  w ithheld  u n t i l  the  c l in ic a l  p ic tu re  
becomes more ev id en t. Hie symptoms l i s t e d  in  Appendix C were derived  
from th e  l i t e r a tu r e  as w ell as an exam ination o f about 50 h o s p ita l  
re co rd s . F o r 'b e n ta l S ta tu s"  i f  code 2 i s  used (m issing te e th ) ,  the 
number m issing i s  recorded in  p a ren th eses. F lu c tu a tin g  d a ta  was 
determ ined as o f December 31, 1979—i . e . ,  age, d iag n o sis , d en ta l 
s ta tu s .
The behav io ral d e sc rip tio n s  o f EPS (Appendix F) were derived  
from th e  work of Donlon & Stenson (1976) and Sovner & DiMascio (1978). 
There a re  two h y p erk in e tic  forms—aka th is  ia  and trem or—and th re e  
hypokinetic  forms—a k in es ia , r ig i d i ty ,  and dyston ic  re a c tio n s . A ll 
behavior tre a te d  w ith  an tip a rk in so n  agents was c la s s i f ie d  in to  one 
o f  f iv e  EPS forms, and coded in  one o f th re e  types, hy p o k in e tic , 
h y p e rk in e tic , o r mixed. The form o f  EPS was determ ined by reviewing 
the  b ehav io ra l n o ta tio n s  in  th e  records fo r  periods o f tim e immediately 
preceding and immediately follow ing the  a d m in is tra tio n  o f  an tipark inson  
ag en ts . I n i t i a l  a d m in is tra tio n  and d isco n tin u a tio n  o f th e  a n tip a r ­
kinson agents determ ined o n -se t and o f f - s e t  da tes  o f th e  EPS 
occurrences. The d e sc r ip tio n s  and codes fo r  the  EPS h i s to r ie s  a re  
provided in  Appendix F.
The "P sy ch ia tr ic  Behavior P a tte rn "  was c la s s i f ie d  as hypo­
k in e t ic ,  h y p e rk in e tic , mixed, o r  none based on d e sc r ip to rs  derived
from the  work o f Donlon & Stenson (1976) and Sovner and DlMasclo 
(1978). In  cases o f  Inadequate Inform ation an "unknown" c la s s i f i c a ­
t io n  was used . O rig in a lly , an instrum ent measuring fa c to rs  of 
psychopathology which included excitem ent and withdrawal sca le s  was 
considered (Lorr e t  a l . ,  1963). This instrum ent involved q u ite  a 
b i t  o f ad ap ta tio n  as i t  was designed to  be used during  an in te rv iew . 
A fte r  an ex tensive  search an instrum ent s p e c if ic a l ly  designed to  
a ssess  p sy c h ia tr ic  v a r ia b le s  on the b a s is  o f sources such as n u rse s ' 
no tes was found (S p itz e r  e t  a l . ,  1967). Once reviewed, however, i t  
was re a liz e d  th a t  th i s  instrum ent was designed to measure fa c to rs  
r a th e r  than behav io rs, involved in  psychopathology and th e re fo re  d id  
no t s u i t  the  needs o f  th is  study . S ince d i f f e r e n t i a l  d iagnosis between 
psychopathology and extrapyram idal s id e  e f fe c ts  i s  o f te n  d i f f i c u l t  
(Davis & Cole, 1975; Donlon & Stenson, 1976; L esser & Fahn, 1978; 
R ifk in  e t  a l . ,  1975), i t  was deemed necessary  to  r a te  behav io ral 
h is to r ie s  as h y p e rk in e tic , hypok ine tic , mixed, or none in  case some 
in stances o f EPS were overlooked o r misdiagnosed as psychopathology. 
Consequently, using  an instrum ent designed to  a ssess  psychopathology 
was no t found to  be s u i ta b le .  I t  was decided th a t r a t in g  the 
b ehav io ra l h is to r ie s  in  terms o f EPS d e sc rip to rs  would more d ir e c t ly  
s a t i s f y  the  purpose o f examining the b eh av io ra l v a r ia b le s .  The 
d e sc r ip to rs  and ra t in g  sca le  a re  presen ted  in  Appendix 6 .
The b eh av io ra l h i s to r ie s  were b lin d ly  ra te d  by a s s i s ta n t s .
Data c o lle c tio n  begem e i th e r  from January 1953, when an tip sy ch o tic s  
became w idely a v a ila b le , o r subsequent to  th e  adm ission n o ta tio n s  fo r
p a tie n ts  adm itted  a f te r  1953. Data g a th erin g  fo r  the  c o n tro l and TD 
su b jec t p a irs  ended w ith the  TD s u b je c t 's  f i r s t  recorded TD symptom 
o r d iag n o sis . For each s ix  month p erio d , beginning w ith  January 1953 
or subsequent to  adm ission n o ta tio n s , the  r a te r  read  th e  ward notes 
and semi-annual a p p ra is a l  summaries in  o rder to  r a te  th e  p a t ie n ts ' 
behav ior. The f iv e  ca teg o rie s  a re  defined  on the  Bating Form 
(Appendix G). The s ix  month period  was chosen as a p re -s tu d y  check 
in d ica ted  th a t  i t  was long enough to  encompass th e  two sources o f 
inform ation  and, th u s , provides adequate in form ation  fo r  a r a t in g ,  
y e t was sh o rt enough to  ensure s e n s i t iv i ty  to  changes in  behavior 
p a tte rn s . An in t e r  judge agreement r a t io  o f  767. was achieved between 
the  ra te r s  and i s  deemed accep tab le  as  only one d ire c t  c o n tra d ic tio n  
of ra tin g ?  was found. Appendix H d e p ic ts  t ra in in g  procedures and in te r ­
judge agreement r a t io  f in d in g s .
I n i t i a l  p s y c h ia tr ic  behav io r p a tte rn  re fe r s  to  a l l  no tes  made 
upon the s u b je c ts ' f i r s t  adm ission to  a p sy c h ia tr ic  f a c i l i t y .  These 
no tes may cover two to  th i r ty  days. The same ra t in g  procedure 
described  above was used fo r  th i s  v a r ia b le .
"Drug H is to ry "  d a ta  was c o lle c te d  on four main v a r ia b le s ;  
an ti-p sy ch o tic  m edications, an tip a rk in so n  ag en ts , polypharmacy, and 
d ru g -free  p e rio d s .
Appendix A d ep ic ts  the  various names of m edications, d i f f e r e n t  
m edication abb rev ia tio n s  found in  th e  h o s p ita l  re co rd s , and ch lo rp ro - 
mazine eq u iv a len ts  fo r th e  a n tip sy c h o tic s . These equ iv alen ts  a re  
p rim arily  from th e  work o f Davis and Garver (1978) and a re  necessary
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fo r  conversion of the  various an tip sy ch o tic s  in to  equ ivalen t dosages 
so comparisons can be made. A ntipark inson agents were converted in to  
benzotropine m esylate equ ivalen ts  ob tained  from Simpson e t  a l .  (1978) 
fo r  th e  same purpose. A ll o f the p a t ie n t s ' dosages and leng ths o f 
ad m in is tra tio n s  w ith in  th ese  ca teg o rie s  as w ell as a l l  periods of 
time the  p a tie n ts  d id  n o t rece iv e  m ed ications, were recorded on the  
form dep icted  in  Appendix I .  Computer c a lc u la tio n s  then determ ined 
amounts fo r  each o f the  follow ing v a r ia b le s : cumulative dose o f
a n tip sy ch o tic s , cum ulative length  o f  ad m in is tra tio n  of a n tip sy c h o tic s , 
average d a ily  dose o f a n tip sy c h o tic s , maximum an tip sy ch o tic  dosage 
per y ear, cum ulative dose o f an tip a rk in so n  ag en ts , cum ulative leng th  
o f ad m in is tra tio n  o f an tip a rk in so n  ag en ts , average d a ily  dose o f 
an tipark in son  ag en ts , number o f an tip a rk in so n  agents adm in istered , 
number o f  incidences o f polypharmacy, number o f  incidences per 
category o f polypharmacy, number o f  an tip sy ch o tic s  adm in istered , 
number o f  d ru g -free  p e rio d s , and number o f  d ru g -free  days.
The fou r types o f  polypharmacy in v e s tig a te d  includes concurrent 
ad m in is tra tio n  o f an a n tip sy ch o tic  plus e i th e r  another a n tip sy ch o tic , 
an a n tid e p re ssan t, lith iu m , o r an an tip a rk in so n  agent (see  Appendix A). 
The d u ra tio n  c r i t e r i a  fo r  the  f i r s t  th re e  types was 2 months to  ensure 
th a t  a c tu a l polypharmacy was occurring  r a th e r  than only a drug change­
over. D uration c r i t e r i a  fo r  an a n tip sy ch o tic  plus an an tip a rk in so n  
agent was s e t  a t  3 months as 2 months i s  considered r a t io n a l  trea tm en t 
w hile  treatm ent beyond 3 months i s  considered in ap p ro p ria te  (B aldessa- 
r i n i ,  1977). The fou r types o f polypharmacy were computed u sing  two
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d if f e re n t  chlorprom azine equivalence c r i t e r i a :  a le n ie n t d a ily
c r i te r io n  of any amount o f a n tip sy ch o tic  in  combination w ith ano ther 
drug and a  d a ily  c r i te r io n  of a t  le a s t  1,100  mg. o f an tip sy ch o tic  
in  combination w ith  ano ther drug. Such a broad coverage was n e c e s s i­
ta te d  by o th er in v e s tig a to rs  de fin in g  polypharmacy in  a v a r ie ty  o f 
ways (Jus e t  a l . ,  1976; Simpson e t  a l . ,  1978). Another kind of 
polypharmacy, the  number of d if f e r e n t  an tip sy ch o tic s  and an tip a rk in so n  
agents adm inistered  to  each su b je c t, was a lso  examined. A d ru g -free  
period  was defined  as a 2 month o r longer period  o f time during which 
the  su b jec t received  no a n tip sy ch o tic  m edications. This c r i t e r i a  is  
based on the  J e s te  e t  a l .  (1979) fin d in g  th a t  a n tip sy c h o tic -f re e  
in te rv a ls  of a t  le a s t  2 months was the  b e s t d isc r im in a to r between 
p e r s is te n t  and re v e rs ib le  TD groups.
The p s y c h ia tr i s t  examining the  p a tie n ts  used a sc a le  developed 
by Van P u tten  (1974) which is  in tended fo r  use in  a ssess in g  the  ex ten t 
of extrapyram idal involvement in  response to  pharmacotherapy. I t  was 
adapted fo r use in  th is  study to  ra te  th e  ex ten t o f the  presence o r 
absence o f TD (Appendix J ) . Van P u tten  (1974) does no t re p o rt r e l i a ­
b i l i t y  ra tin g s  fo r  assessm ent devices on d iso rd e rs  of th e  extrapyram idal 
t r a c t ,  inc lud ing  EPS and TD, as th e  syndromes f lu c tu a te  over tim e and 
in  response to  m edications (Gardos e t  a l . ,  1977). This sca le  allowed 
the  p s y c h ia t r i s t 's  c l in ic a l  judgment to  be sca le d . A ra t in g  of 1 or 
above on TD was th e  c r i t e r i a  fo r  th e  TD s u b je c ts ' in c lu s io n ; the  no-TD 
su b jec ts  must have received  a ra t in g  o f 0 to  remain in  th e  study .
Design
This design  is  ex post fa c to  as the  phenomena to  be examined 
have a lready  occurred n a tu r a l i s t i c a l ly —i . e . ,  th e re  i s  no m anipulation 
o f v a r ia b le s . This is  a d e sc r ip tiv e , re tro sp e c tiv e  study wherein the  
ex is ten ce  o f re la tio n sh ip s  among v a ria b le s  was explored . Such a design 
is  mandated by hum anitarian reasons as the  a l te rn a t iv e  method, a 
p ro sp ec tiv e  study, would encompass observation  of su b jec ts  u n t i l  
development o f TD occurs w ith no attem pt being made to  prevent the 
occurrence o f th is  d e b i l i ta t in g  syndrome. Such an approach would be 
h igh ly  u n e th ic a l.
The c rite r io n -g ro u p  approach i s  th e  type of ex post fa c to  
design  proposed. This involves "co n tra s tin g  the  c h a ra c te r is t ic s  of 
a s ta t e  [TD] w ith th e  c h a ra c te r is t ic s  o f i t s  opposite  s ta te  [No-TD]" 
in  an attem pt to  "determ ine what c h a ra c te r is t ic s  a re  a sso c ia ted  w ith 
th e  c r i te r io n  and have presumably preceded the  c r i te r io n "  (Tuckman, 
1972, pp. 149, 151). The c r i te r io n  fo r  group membership i s  the  
presence or absence o f TD which is  th e re fo re  the  independent v a r ia b le . 
The occurrence of the  various d e sc r ip tiv e  c h a ra c te r is t ic s  w il l  depend 
upon th e  s u b je c ts ' group membership and a re , th e re fo re , the  dependent 
v a r ia b le s .
This study has a m ethodological fe a tu re  no o th e r research  on 
th e  ro le  drug v a ria b le s  p lay  in  th e  development o f TD has had: the
c u ttin g -o f f  o f drug da ta  w ith  the  f i r s t  recorded TD symptom or 
d iagnosis  mention. This was p o ss ib le  s in ce  the records a t  ESH a re  
b eh av io r-o rien ted , thus a l l  e n tr ie s  a re  sym ptom -descriptive o f the
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p a t ie n ts ' behav io rs. A lso, the records include a "Problem L is t"  
where s id e  e f fe c ts  o f drug regimes a re  o f te n  no ted . H opefully , th is  
added m ethodological fe a tu re  avoided obscuring d iffe re n c e s  in  dosage 
in gestions between the two groups th a t  may have ex is ted  p r io r  to  the 
development o f TD. A lso, u n lik e  o th e rs  (Asnis e t  a l . ,  1977; Chouinard 
e t  a l . ,  1976), e n t i r e  drug h is to r ie s  beginning January 1953 were taken 
inc lud ing  any and a l l  an tip sy ch o tic s  and an tip ark inson  agents adm inis­
te re d . The length  of an tip sy ch o tic  a d m in is tra tio n  does not inc lude  
any days the  su b jec ts  were o f f  m edications, which has no t been taken 
in to  account by o th e r in v e s t ig a to r s . These aspec ts  of th is  study 
should have guarded ag a in s t the confounding p o s s ib i l i ty  o f TD su b jec ts  
having lower cum ulative an tip sy ch o tic  dosages o r h ig h er cum ulative 
an tip a rk in so n  agent dosages due to  a n tip sy ch o tic  dosage reductions or 
an tip a rk in so n  agent ad m in is tra tio n  occurring  in  response to  the  
development of TD.
Crane (1972, 1978) i s  the only in v e s t ig a to r  to  examine the 
GPS h is to r ie s  o f TD su b je c ts . However, he did no t d is tin g u ish  between 
the 5 forms or 3 types o f EPS as th is  study h as. Chouinard e t  a l .
(1979) d id  make such d is t in c t io n s  y e t only  in v e s tig a te d  concurrent 
EPS in  th e i r  TD su b je c ts . The cu rren t study makes the two d is t in c t io n s  
and examines h is to r ie s  o f , as w ell as concu rren t, EPS. Furtherm ore, 
the  safeguard taken ag a in s t EPS being  misdiagnosed or overlooked by 
in v e s tig a tin g  p sy c h ia tr ic  behavior p a t te rn s ,  as w ell as EPS p a tte rn s  
has never been done in  previous in v e s t ig a tio n s . The c o n f lic t in g  
find ings repo rted  in  previous research  r e la t in g  various drug and
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d ia g n o stic  v a ria b le s  to  TD occurrences may have come, in  p a r t ,  from 
th e i r  lack  o f th ese  procedures.
S t a t i s t i c a l  A nalysis
The hypotheses about a n tip sy ch o tic  and an tip a rk in so n  drug 
dosages and ad m in is tra tio n  d u ra tio n  (#1 - # 7 ), polypharmacy (#8 - # 11) ,  
d ru g -free  periods (#12 - #13), EPS h is to ry  (#17 - #18), and p sy c h ia tr ic  
behavior p a t te rn  (#20) ,  involve in te rv a l  measures o f the  dependent 
v a r ia b le s  and nominal independent v a r ia b le s  in  a comparison o f the  
means o f each su b jec t in  a p a i r  to  determ ine i f  any mean d iffe ren c es  
found over a l l  the  p a irs  a re  s t a t i s t i c a l l y  s ig n if ic a n t .  Consequently, 
the  t - t e s t  fo r  dependent o r  p a ired  samples was used to  c a lc u la te  the 
p ro b a b il i ty  a sso c ia ted  w ith th e  hypotheses ( a l l  a re  l i s t e d  below ).
The p a ir-w ise  matching c a rrie d  ou t between the  TD sample and co n tro l 
sample was done to  co n tro l fo r  extraneous in flu en ces  in  the  v a ria b le s  
being measured. Such experim ental co n tro l reduces th e  e f f e c t  of 
su b je c t- to -su b je c t v a r ia b i l i ty  and, u su a lly , the  v a riance  and standard  
e r ro r  o f d iffe re n c e  as w e ll. Consequently, the  sampling e r ro r  is  
lowered, which allows more degrees o f freedom in  the  answer (n -1) than 
an independent t - t e s t  (n-2) a llo w s. Although p a ir in g  fo r  t - t e s t s  most 
o f te n  occurs w ith p re - and p o s t - te s t  d esig n s , i t  i s  a lso  ap p ro p ria te  
fo r  th is  s tu d y 's  design  wherein the  p a irs  a re  c o rre la te d  on the  co n tro l 
v a r ia b le s  and a re  consequently dependent r a th e r  than independent (Hays, 
1963). A tw o -ta iled  t e s t  o f s t a t i s t i c a l  s ig n if ic a n c e  was app lied  as 
d iffe ren c es  could occur in  e i th e r  d ire c t io n .
A s e r ie s  o f t - t e s t s  were chosen over an a n a ly s is  o f variance  
due to  group membership being the  only independent v a r ia b le . J e s te  
e t  a l .  (1979) u t i l iz e d  d isc rim in an t an a ly s is  to  determ ine which of 
the drug v a ria b le s  b e s t d is tin g u ish ed  between th e i r  two groups. This 
s t a t i s t i c a l  technique i s  in ap p ro p ria te  fo r  th is  study as th e re  a re  
too many v a r ia b le s  involved according to  th e  1:10 v a r ia b le s - to -su b je c ts  
g u id e lin e  fo r  use o f d isc rim in an t a n a ly s is . Perhaps a t  a l a t e r  d a te  
P earson 's  c o rre la tio n  can be u t i l i z e d  to  determ ine redundant v a ria b le s  
and thus d is tin g u ish  which f iv e  o r s ix  v a ria b le s  would be most in f o r ­
m ative in  a d iscrim in an t a n a ly s is .
For the  remaining hypotheses, ch i-sq u are  was used to  determ ine 
i f  system atic  re la tio n sh ip s  e x is t  among the v a r ia b le s .  This s t a t i s t i c  
was chosen as i t  i s  used "w ith d a ta  in  the  form of frequencies"  
(G uilfo rd , 1965, p . 227) " to  determ ine whether o r no t the  v a ria b le s  
a re  s t a t i s t i c a l l y  independent" (Nie e t  a l . ,  1975, p. 218). The 
samples being compared can thus be judged as being e s s e n t ia l ly  th e  same 
or d i f f e r e n t .
S p e c if ic  Hypotheses
In  an e f f o r t  to  answer the  question  "What a re  the d e sc r ip tiv e  
c h a r a c te r is t ic s  o f  p a tie n ts  w ith  ta rd iv e  dysk inesia  th a t  d is tin g u ish  
them from p a tie n ts  w ithout ta rd iv e  dysk inesia  (T D )"the follow ing 
hypotheses were te s te d .
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Drug H is to r ie s
A. A ntipsychotics
1. Hq : No d iffe re n c e  w i l l  be found in  mean cum ulative dose fo r
an tip sy ch o tic  m edications between TD and No-TD groups.
2 . Hq : No d iffe re n c e  w i l l  be found in  the  mean cum ulative length
of a n tip sy ch o tic  m edication a d m in is tra tio n  between the  TD and No-TD 
groups.
3. Hq: No d iffe re n c e  w i l l  be found in  mean d a ily  dose o f a n t i ­
psycho tic  m edications between the  TD and No-TD groups.
4 . Hq: No d iffe re n c e  w i l l  be found in  th e  maximum an tip sy ch o tic
d a ily  dosage fo r  any year between the  TD and No-TD groups.
B. A ntiparkinson Agents
5. Hq : No d iffe re n c e  w il l  be found in  the  mean cum ulative dose
o f an tip a rk in so n  agents between the  TD and No-TD groups.
6 . Hq: No d iffe re n c e  w i l l  be found in  the  mean cum ulative length
of an tip a rk in so n  agent ad m in is tra tio n  between the  TD and No-TD groups.
7. Hq : No d iffe re n c e  w i l l  be found in  the  mean d a ily  dose of
an tip ark in son  agents between the  TD and No-TD groups.
C. Polypharmacy
8 . Hq : No d iffe re n c e  w i l l  be found in  the  mean number o f to ta l  
incidences o f polypharmacy a t  th e  CFZE c r i te r io n  dosage le v e ls  of 0 o r 
100 mg., between th e  TD and No-TD groups.
9. Hq : No d iffe re n c e  w i l l  be found in  the  mean number o f 
incidences in  any o f the  fo u r ca teg o rie s  o f polypharmacy—a n tip sy ch o tic
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plus an a n tip sy ch o tic , an tip sy ch o tic  p lus an an tip a rk in so n  agen t, 
an tip sy ch o tic  plus an a n tid e p re ssa n t, a n tip sy ch o tic  p lus lith iu m —a t  
the  CPZE c r i te r io n  dosage le v e ls  o f 0 o r 100 mg. between the  TD 
and No-TD groups.
10. H^: No d iffe re n c e  w i l l  be found in  the  mean number o f
an tip sy ch o tic s  adm inistered  between th e  TD and No-TD groups.
11. Hq! No d iffe re n c e  w il l  be found in  th e  mean number of
an tipark in son  agents adm inistered between th e  TD and No-TD groups.
D. Drug-Free Periods
12. HqI No  d iffe re n c e  w i l l  be found in  the  mean number of 
incidences of d ru g -fre e  p e rio d s , la s t in g  a t  le a s t  2 months, between 
th e  TD and No-TD groups.
13. H^: No d iffe re n c e  w i l l  be found in  the  mean number o f drug- 
f r e e  days between th e  TD and No-TD groups.
O ther D escrip tiv e  C h a ra c te r is tic s
A. Extrapyram idal Symptom(s) H is to ry
14. Hq : No d iffe re n c e  w i l l  be found in  the  number o f su b jec ts
experiencing extrapyram idal symptoms between the  TD and No-TD groups.
15. HqI No  d iffe re n c e  w i l l  be found in  the  number o f ex trap y ra ­
m idal symptom incidences between the  TD and No-TD groups.
16. Hq! No d iffe re n c e  w i l l  be found in  the  number o f ex trap y ra ­
m idal symptom incidences ra te d  as h y p o k in e tic , h y p e rk in e tic , mixed, 
and more between the  TD and No-TD groups.
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17. Hq: No d iffe ren c e  w i l l  be found In  th e  mean number of days
extrapyram idal symptoms ra te d  as hy p o k in e tic , h y p e rk in e tic , o r mixed 
occurred between the  TD and No-TD groups.
18. Hq : No d iffe re n c e  w i l l  be found in  th e  mean cum ulative
days extrapyram idal symptoms occurred between the  TD and No-TD groups.
B. I n i t i a l  and P sy c h ia tr ic  Behavior P a tte rn s
19. Hq: No  d iffe ren c e  w i l l  be found in  the  number of p sych ia­
t r i c  behavior p a tte rn s  ra te d  h y p o k in e tic , h y p e rk in e tic , mixed, or 
more between the  TD and No-TD groups.
20. I f  subsequent to  having a hypok inetic  i n i t i a l  p sy c h ia tr ic  
behavior p a tte rn  a p a t ie n t  has a h y p erk in e tic  h is to ry  or e x tra ­
pyramidal symptoms, then h e /she  w i l l  be more l ik e ly  to  have TD than
a p a tie n t  who subsequent to  having a  h y p erk in e tic  i n i t i a l  p sy c h ia tr ic  
behavior p a tte rn  has a hypokinetic  h is to ry  o f extrapyram idal symptoms.
21. I f  subsequent to  having a hypokinetic  i n i t i a l  p sy c h ia tr ic  
behavior p a tte rn  a  p a t ie n t  has a h y p erk in e tic  p sy c h ia tr ic  behavior 
p a tte rn , then he /sh e  w i l l  be more l ik e ly  to  have TD than a  p a tie n t 
who subsequent to  having a h y p e rk in e tic  i n i t i a l  p sy c h ia tr ic  behavior 
p a tte rn  has a hypokinetic  p sy c h ia tr ic  behavior p a tte rn .
C. M iscellaneous C h a ra c te r is tic s
22. H^: No d iffe ren c e  w i l l  be found in  eye co lo r between the  TD
and No-TD groups.
23. H^: No d iffe ren c e  w i l l  be found in  d e n ta l s ta tu s  between the
TD and No-TD groups.
24. H g i N o d iffe ren c e  w i l l  be found in  race  between the  TD and
No-TD groups.
Summary of Methodology
Two samples, each w ith  N=26, were se le c ted  from cu rren t 
in p a tie n ts  a t  Eastern  S ta te  H o sp ita l. The TD group included p a tie n ts  
diagnosed by a p s y c h ia tr i s t  as having TD. The No-TD group were 
randomly-chosen p a t ie n ts ,  based on th e i r  matching the  TD su b jec ts  on 
age, sex , and d iag n o sis , and examined by the  p s y c h ia tr i s t  to  ensure 
the absence o f TD. The p s y c h ia tr i s t  was b lin d  to  s t a f f  d iagnosis o r 
r e f e r r a l  and used a ra tin g  s c a le  adapted from Van P u tten  (1974) which 
is  dep ic ted  in  Appendix J .
The follow ing d a ta  was gathered  from the  h o s p ita l  records and 
ward c h a rts  o f a l l  su b je c ts : h is to ry  of a n tip sy ch o tic  m edications,
h is to ry  c f  an tip ark in son  ag en ts , h is to ry  o f polypharmacy, h is to ry  of 
d ru g -free  p e rio d s , h is to ry  o f  extrapyram idal (EPS) symptoms, i n i t i a l  
and subsequent p sy c h ia tr ic  behav ior p a t te rn s , ra c e , eye c o lo r , d e n ta l 
s ta tu s ,  d iag n o sis , b i r th  d a te , sex , and d a te  o f f i r s t  TD symptom o r 
d iagnosis m ention. The Data G athering Instrum ent and i t s  codes a re  
dep ic ted  in  Appendices D - G. A ll s u b je c ts ' names and d a ta  were kept 
c o n f id e n tia l .
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An I n i t i a l  and P sy c h ia tr ic  Behavior P a tte rn s  R ating Form, 
using  the  extrapyram idal d e sc rip to rs  o f Donlon & Stenson (1976) and 
Sovner & DiMascio (1978), was designed to  r a te  the b ehav io ra l 
v a r ia b le s  of " I n i t i a l  p sy c h ia tr ic  behavior p a tte rn "  and "P sy ch ia tr ic  
behavior p a t te rn ."  Two a s s is ta n ts ,  b lin d  to the  s tu d y 's  hypotheses 
and the  group membership o f the su b je c ts , ra te d  the b eh av io ra l 
v a r ia b le s . The in te r  judge agreement r a t io  of 767. (see  Appendix H) 
was deemed accep tab le . The extrapyram idal d e sc rip to rs  of Donlon & 
Stenson (1976) and Sovner & DiMascio (1978) were a lso  used to  determ ine 
the  type and form of EPS incidences (Appendix F ).
This study i s  an ex post fa c to  design  as the  phenomena stud ied
have a lready  occurred n a tu r a l i s t i c a l ly ,  thus th e  independent v a ria b le  
was n o t co n tro lled  o r m anipulated. The c r ite rio n -g ro u p  approach is  
the type of design . The independent v a r ia b le  i s  the  presence or
absence of TD and the  dependent v a ria b le s  a re  the  d e s c r ip t iv e  charac­
t e r i s t i c s  being in v e s tig a te d . D esc rip tiv e  c h a ra c te r is t ic s  of a TD 
group were co n trasted  w ith those of a No-TD group in  an e f f o r t  to  
determ ine which c h a ra c te r is t ic s  presumably preceded th e  c r i t e r io n .
The hypotheses about a n tip sy ch o tic  and an tip ark in son  drug 
dosages and ad m in is tra tio n  du ra tio n  (#1 - # 7 ), polypharmacy (#8 - #11), 
d ru g -free  periods (#12 - #13), EPS h is to ry  (#17 - #18), and p sy ch ia tr ic  
behavior p a tte rn  (#20) involve in te rv a l  measures of the  dependent v a r i­
ab les  and nominal independent v a r ia b le s . Consequently, t - t e s t  fo r  
dependent, o r p a ire d , samples was used to  determ ine i f  any mean 
d iffe ren c es  found, over a l l  the  p a ir s ,  were s t a t i s t i c a l l y  s ig n if ic a n t .
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Chi-square was used to  determ ine the  s t a t i s t i c a l  s ig n ific a n ce  
o f any system atic  re la tio n sh ip s  among th e  v a ria b le s  te s te d  in  the  
rem aining hypotheses.
IV. RESULTS
In  th is  ch ap te r, th e  r e s u l t s  of the  p resen t study a re  l i s te d  
by hypotheses.
Drug H is to r ie s
A. A ntipsychotics
Hypothesis 1 . No d iffe re n c e  w i l l  be found in  mean cum ulative 
dose of a n tip sy ch o tic  m edications between the  TD and No-TD groups.
The TD g roup 's  mean cum ulative dose of a n tip sy ch o tic  medi­
ca tio n s  was 1348.27 grams o f chlorprom azine eq u iv a len ts ; the No-TD 
g roup 's  mean cum ulative dose o f a n tip sy ch o tic  m edications was 2565.68 
grams o f chlorprom azine equ iv alen ts  (see  Table 2 ) . The t  value was 
-2.12 and s ig n if ic a n t  a t  the  .05 le v e l fo r a tw o -ta ile d  t e s t  (with 
25 degrees o f freedom ). The n u l l  hypothesis i s  re je c te d  as the  No-TD 
group had a s ig n if ic a n t ly  g re a te r  mean cum ulative dose o f a n tip sy ­
ch o tic  m edications than the  TD group.
Hypothesis 2 . No d iffe re n c e  w i l l  be found in  th e  mean cumu­
la t iv e  length  o f a n tip sy ch o tic  m edication a d m in is tra tio n  between the  
TD and No-TD groups.
The TD g roup 's  mean cum ulative leng th  o f a n tip sy ch o tic  
m edication a d m in is tra tio n  was 2890.19 days (7.92 y e a rs ) ;  the  No-TD 
g roup 's  mean cum ulative leng th  o f a n tip sy ch o tic  m edication admin­
i s t r a t io n  was 3200.23 days (8.77 years) (see  Table 2 ) . The t  value
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Table 2
Means and t  Values of A ntipsychotic  (AP) 
and A ntiparkinson (ap) M edication V ariables 
________ (dependent t  w ith 25 DF)___________
DRUG
VARIABLE
MEAN
TD NO-TD t P
R eject
Null?
Mean cum. 
dose o f APs 
( in  CPZE)
1348.27 g 2565.68 g -2.12 .044 Yes
Mean cum. 
length  of 
AP admin­
i s t r a t io n
2890.19 days 
(7.92 years)
3200.23 days 
(8.77 years)
-.53 .597 No
Mean d a ily  
dose o f APs 
( in  CPZE)
323.58 mg 493.81 mg -2.12 .044 Yes
Mean max. 
AP d a ily  
dose fo r 
any year 
( in  CPZE)
1514.18 mg 2306.17 mg -1 .54 .14 No
Mean cum. 
dose of aps 
( in  BME)
4g 10.23 g -1 .90 .07 No
Mean cum. 
length  of 
ap admin­
is t r a t io n
393.96 days 
(1 .08  years)
950.73 days 
(2.61 years)
- 2 .12 .04 Yes
Mean d a ily  
dose of aps
7.42 mg 12.79 mg -1.71 .10 No
Legend: cum = cum ulative
max 9 maximum
CPZE = Chlorpromazine equ ivalen ts
BME = Benztropine m esylate equ ivalen ts
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was -.5 3  and n o t s ig n if ic a n t  a t  the  .05 le v e l fo r  tw o -ta ile d  te s t s  
(w ith 25 degrees of freedom). The n u ll  hypothesis i s  accep ted .
Hypothesis 3 . No d iffe ren c e  w i l l  be found in  mean d a ily  dose 
o f an tip sy ch o tic  m edications between the  TD and No-TD groups.
The TD g roup 's  mean d a ily  dose o f an tip sy ch o tic  m edications 
was 323.58 mg of chlorprom azine eq u iv a len ts ; the  No-TD g ro u p 's  mean 
d a ily  dose of an tip sy ch o tic  m edications was 493.81 mg of chlorprom a­
zine  equ ivalen ts (see Table 2 ) . The t  va lue  was -2 .20  and s ig n if ic a n t  
a t  the  .05 le v e l fo r a tw o -ta iled  t e s t  (w ith 25 degrees o f freedom ). 
The n u ll  hypothesis i s  re je c te d  as th e  No-TD group had a s ig n if ic a n t ly  
g re a te r  mean d a ily  dose of a n tip sy ch o tic  m edications than th e  TD group.
Hypothesis 4 . No d iffe ren c e  w i l l  be found in  the  maximum 
an tip sy ch o tic  d a ily  dosage fo r  any year between the  TD and No-TD 
groups.
The TD g roup 's  mean maximum a n tip sy ch o tic  d a ily  dosage per 
year was 1514.18 mg o f chlorprom azine eq u iv a len ts ; the  No-TD g ro u p 's  
mean maximum a n tip sy ch o tic  d a ily  dosage per year was 2306.17 mg of 
chlorpromazine equ ivalen ts  (see  Table 2 ) . The t  value was -1 .54  and 
not s ig n if ic a n t  a t  the  .05 le v e l fo r a  tw o -ta iled  t e s t  (w ith 25 
degrees o f freedom). The n u ll  hypothesis can no t be re je c te d .
B. A ntiparkinson Agents
Hypothesis 5 . No d iffe ren c e  w i l l  be found in  the  mean cumu­
la t iv e  dose of an tip a rk in so n  agents between the  TD and No-TD groups.
The TD g roup 's  mean cum ulative dose of an tip a rk in so n  agen ts 
was 4.00 grams o f benztrop ine m esylate eq u iv a len ts ; the  No-TD g ro u p 's
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mean cum ulative dose o f an tip a rk in so n  agents was 10.23 grams of 
benztropine m esylate equ ivalen ts  (see Table 2 ) . The t  value was 
-1 .90  and no t s ig n if ic a n t  a t  the  .05 le v e l fo r  a  tw o -ta iled  t e s t  
(w ith 25 degrees o f freedom). The n u ll  hypothesis  c a n 't  be re je c te d .
Hypothesis 6 . No d iffe ren c e  w i l l  be found in  the  mean 
cum ulative leng th  o f an tip a rk in so n  agent a d m in is tra tio n  between the 
TD and No-TD groups.
The TD g roup 's  mean cum ulative leng th  o f an tip a rk in so n  agent 
ad m in is tra tio n  was 393.96 days (1.08 y e a rs ) ;  th e  No-TD group 's mean 
cum ulative length  o f an tip a rk in so n  agent a d m in is tra tio n  was 950.73 
days (2.61 years) (see Table 2 ). The t  value was -2.12 and s i g n i f i ­
cant a t  the .05 le v e l fo r  a tw o -ta iled  t e s t  (w ith 25 degrees of 
freedom). The n u l l  hypothesis i s  re je c te d  as th e  No-TD group had 
a  s ig n if ic a n tly  g re a te r  mean cum ulative leng th  o f an tip a rk in so n  agent 
ad m in is tra tio n  than th e  TD group.
Hypothesis 7 . No d iffe ren ce  w i l l  be found in  the  mean d a ily  
dose of an tip a rk in so n  agents between th e  TD and No-TD groups.
The TD g ro u p 's  mean d a ily  dose of an tip a rk in so n  agents was
7.42 mg of benztrop ine m esylate eq u iv a len ts ; the  No-TD group 's  mean 
d a ily  dose of an tip a rk in so n  agents was 12.79 mg o f benztropine 
m esylate equ ivalen ts  (see  Table 2 ). The t  v a lue  was -1 .71 and not 
s ig n if ic a n t  a t  the  .05 le v e l fo r  a tw o -ta ile d  t e s t  (w ith 25 degrees 
of freedom). The n u ll  hypothesis can no t be r e je c te d .
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C. Polypharmacy
Hypothesis 8 . No d iffe re n c e  w il l  be found in  the  mean number 
of to ta l  incidences o f  polypharmacy, a t  e i th e r  o f the two chlorproma­
zine  equ ivalen ts  c r i te r io n  dosage lev e ls  (0 & 100), between the  TD 
and No-TD groups.
The TD g roup 's  mean number of t o t a l  incidences o f polypharmacy 
was 1.77 a t  the  0 mg chlorprom azine equ ivalen ts  (CPZE) c r i te r io n  le v e l 
and 1.77 a t  the  100 mg CPZE le v e l .  The No-TD g ro u p 's  mean number of 
to ta l  incidences of polypharmacy was 3 .0 a t  the  0 mg CPZE c r i te r io n  
dosage le v e l and 2.77 a t  the  100 mg CPZE c r i t e r io n  le v e l (see  Table 
3 ). The t  values were -1 .72 a t  0 mg and -1 .42 a t  100 mg and not 
s ig n if ic a n t  a t  the  .05 le v e l fo r  a tw o -ta iled  t e s t  (w ith 25 degrees 
of freedom). The n u ll  hypothesis can n o t be re je c te d .
Hypothesis 9 . No d iffe re n c e  w il l  be found in  th e  mean number 
of incidences in  any o f the  fou r ca teg o rie s  of polypharmacy—a n tip sy ­
ch o tic  plus an an tip sy ch o tic , a n tip sy ch o tic  plus an an tip a rk in so n  
ag en t, an tip sy ch o tic  p lus an a n tid e p re s sa n t, and a n tip sy ch o tic  plus 
lith iu m —a t  th e  CPZE c r i te r io n  dosage le v e ls  of 0 o r 100 mg, between 
the  TD and No-TD groups.
As dep icted  in  Table 3 , no s ig n if ic a n t  d iffe ren c es  were found 
in  th e  mean number of incidences in  any o f the fou r ca teg o rie s  of 
polypharmacy, a t  the  CPZE c r i te r io n  dosage le v e ls  of 0 o r 100 mg, 
between the  TD and No-TD groups. The n u l l  hypothesis can n o t be re je c te d .
Hypothesis 10. No d iffe re n c e  w i l l  be found in  the mean number 
o f an tip a rk in so n  agents adm in istered  between the  TD and No-TD groups.
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Table 3
Means and t  Values o f Polypharmacy Incidences 
(dependent t  w ith  25 DF)
DOSAGE 
LEVEL OF 
CPZE
TYPE OF 
POLY­
PHARMACY
MEAN 
TD No-TD t P
R eject
Null?
0 AP/AP 1.38 2.30 -1.62 .12 No
0 AP/ap .38 .61 - .97 .34 No
0 AP/ad .0 .08 -1 .44 .16 No
0 AP/L 0 0 0 1.00 No
0 T otal 1.77 3 .0 -1.72 .09 No
100 AP/AP 1.38 2.19 -1.43 .16 No
100 AP/ap .38 .54 -  .66 .52 No
100 AP/ad .0 .03 - 1.00 .33 No
100 AP/L 0 0 0 1.00 No
100 T otal 1.77 2.77 -1.42 .17 No
Legend: AP = an tip sy ch o tic
ap = an tip a rk in so n  agent 
ad = an tid ep ressan t 
L = lith ium
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The TD group received  a mean o f 1.08 (SD=.80) d if f e r e n t  a n t i ­
parkinson ag en ts . The No-TD group received  a mean o f 1.81 (SD=1.17) 
d if f e r e n t  an tip a rk in so n  agents (see Table 4 ) . The t  value was -2 .56  
and s ig n if ic a n t  a t  th e  .05 le v e l  fo r  a tw o -ta ile d  t e s t  (w ith 25 de­
grees of freedom). The n u l l  hypothesis  i s  re je c te d .
Hypothesis 11. No d iffe re n c e  w i l l  be found in  the  mean number 
o f a n tip sy ch o tic s  adm in istered  between the  TD and No-TD groups.
The TD group received  a mean of 4.23 d if f e r e n t  a n tip sy c h o tic s . 
The No-TD group received  a mean of 5.65 d if f e r e n t  a n tip sy c h o tic s . The 
t  value was -1 .67  and no t s ig n if ic a n t  a t  the  .05 le v e l fo r  a tw o -ta ile d  
t e s t  (w ith 25 degrees of freedom) (see Table 4 ) . The n u l l  hypothesis 
can n o t be re je c te d .
D. Drug-Free V ariab les
Hypothesis 12. No d iffe re n c e  w i l l  be found in  the mean 
number of incidences o f d ru g -free  p e rio d s , la s t in g  a t  le a s t  two 
months, between the  TD and No-TD groups.
Both the  TD and th e  No-TD groups had a  mean o f 3.04 d ru g -free  
periods la s t in g  a t  l e a s t  two months. The t  value was .00 and no t 
s ig n if ic a n t  a t  th e  .05 le v e l  fo r  a tw o -ta ile d  t e s t  (w ith 25 degrees o f 
freedom) (see  Table 5 ) . The n u l l  h y p o thesis  can n o t be re je c te d .
Hypothesis 13. No d iffe re n c e  w i l l  be found in  the  mean 
number of d ru g -free  days between the  TD and No-TD groups.
The TD g roup 's  mean number o f d ru g -free  days was 1780.42 days 
(4 .88  y e a r s ) ; the  No-TD group' s mean number o f d ru g -free  days was
1855.42 days (5.08 y ears) (see  Table 5 ) . The t  value was - .1 7  and
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Table 4
Means and t  Values o f Number o f A ntipsychotic  (AP) and 
A ntiparkinson (ap) M edications Adm inistered
(dependent t  w ith  25 DF)
MEAN (SD)
TD No-TD t P
R eject
N ull?
Number of 
APs admin­
is te re d
4.23 5.65 -1.67 .11 No
Number of 
aps admin­
is te re d
1.08
(.80)
1.81
(1.17)
-2.56 .02 Yes
Table 5
Means and t  Values o f Drug-Free V ariables 
(dependent t  w ith  25 DF)
MEAN
TD No-TD t P
R eject
Null?
2 mo.
d ru g -free
periods
3.04 3.04 .0 1.0 No
Number of 
d ru g -free  
days
1780.42
(4.88
years)
1855.42
(5.08
y ears)
-.17 .87 No
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n o t s ig n if ic a n t  a t  th e  .05 le v e l fo r  a tw o -ta ile d  t e s t  (w ith 25 degrees 
of freedom). The n u l l  hypothesis i s  accepted .
Other D esc rip tiv e  C h a ra c te r is t ic s
A. H isto ry  o f Extrapyram idal Symptoms
Hypothesis 14. No d iffe ren c e  w i l l  be found in  the  number of 
su b jec ts  experiencing extrapyram idal symptoms between the  TD and 
No-TD groups.
In  the  TD group, 14 su b jec ts  had a  h is to ry  of extrapyram idal
symptoms as compared to  18 su b jec ts  in  the  No-TD group (see  Table 6) .
2 2 The r e s u l ts  of the  X t e s t  were no t s ig n if ic a n t  (X = 1 .3 , df = 1,
p = NS), thus the  n u ll  hypothesis can no t be rte jected .
Hypothesis 15. No d iffe re n c e  w i l l  be found in  th e  number
of extrapyram idal symptom incidences between th e  TD and No-TD groups.
There were 23 incidences o f extrapyram idal symptoms in  the
TD group as compared to  46 incidences of extrapyram idal symptoms in
2the  No-TD group (see Table 7 ) . The r e s u l t s  o f the  X t e s t  were
2
s ig n if ic a n t  (X = 4 .6 2 , d f = 1, p < .05) in d ic a tin g  th a t a g re a te r  
number o f extrapyram idal symptom incidences were found in  the  No-TD 
group. The n u l l  hypothesis is  re je c te d .
Hypothesis 16. No d if fe re n c e  w i l l  be found in  th e  number 
of extrapyram idal symptom incidences ra te d  as hypok ine tic , hyper­
k in e t ic ,  o r mixed between the  TD and No-TD groups.
Of th e  23 extrapyram idal symptom incidences found in  th e  TD 
group, 8 were ra te d  as hypo k in e tic , 11 were ra te d  as h y p e rk in e tic , and
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Table 6
Summary o f D escrip tiv e  C h a ra c te r is tic s  R esults
VARIABLE TD No-TD ANALYSIS
REJECT
NULL?
# of Ss 14 18 X2=1.3 , d f-1 , No
developing p=NS
EPS
# o f EPS 23 46 X2=4.62, d f-1 , Yes
Incidences P  < .05
# of EPS X2=.2766, df=2, No
Incidences p=NS Nora te d :
hypo 8 (19.92) 19 (57.88) t = - l .7 9 ;TD, SD=52; TD^ SD=117
hyper 11 (88) 20 (181.92)t = - l .0 5 ;TD,SD=222;TDi, SD=395
mixed 4 (8.69 7 (25.50) t=-1.07;TD,SD=35;TD, SD=70
(w/mean (df=25, p=NS)
# days)
Mean cum. 116.62 265 .31 t= -1 .5 2 , No
days EPS d f=25, p=NS
occurred
# of PBPs
ra te d : O
hypo 60 54 X =1.97, No
hyper 55 i 62 df=3,
mixed 46 52 p=NS
none 121 149
Hypo IPBP 2
w/Hyper EPS 1 1 x=o No
(Hyper PBP) (2) (0) (X =2.52, No
df=2, p=NS)
Hyper IPBP
w/Hypo EPS 1 1 X A|t 0 No
(Hypo PBP) (2) (1) (X =2.52, No
df=2, p=NS)
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Table 7
Comparison o f Extrapyram ldal 
Symptom (EPS) Incidences
EPS NO EPS
ro 23
(27)
12
(8)
>10-TD 46
(42)
8
(12)
2
(Expected c e l l  frequency) X =4.62, d f= l, p ^ .05
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4 were ra te d  as mixed. Of the  46 extrapyram ldal symptom Incidences 
found In the  No-TD group, 19 were ra te d  as hypo k in e tic , 20 were ra ted
as h y p e rk in e tic , and 7 were ra te d  as mixed (see Table 6) .  The
2 2 r e s u l ts  o f th e  X t e s t  were n o t s ig n if ic a n t  (X s  .2766, df = 2,
p = NS). The n u l l  hypo thesis  can n o t be re je c te d .
Hypothesis 17. No d iffe ren c e  w i l l  be found in  the  mean 
number of days extrapyram ldal symptoms ra te d  as hypo k in e tic , hyper­
k in e t ic ,  o r  mixed occurred between the TD and No-TD groups.
A comparison o f the  means of the  two groups on number o f  days 
the  d if f e r e n t  ra tin g s  o f extrapyram ldal symptoms occurred fo llow s: 
ra te d  hypokinetic(TD: X = 19.92, SD = 52; No-TD: X = 57.88, SD = 117), 
ra te d  h y p erk in e tic  (TD: X = 57.88, SD = 222; No-TD: X = 181.92,
SD = 395), and mixed (TD: X = 8 .69 , SD = 35; No-TD: X = 25.50,
SD = 70). The t  values were -1 .7 9 , -1 .0 5 , and -1 .0 7 , re sp e c tiv e ly . 
They a re  no t s ig n if ic a n t  a t  the  .05 le v e l  fo r  tw o -ta ile d  te s t s  (w ith  
25 degrees o f freedom ), thus th e  n u ll  hypo thesis  can no t be re je c te d .
Hypothesis 18. No d iffe re n c e  w i l l  be found in  the  mean 
cum ulative days ex trapyram ldal symptoms occurred between th e  TD and 
No-TD groups.
The TD g roup 's  mean cum ulative days on which extrapyram ldal 
symptoms occurred was 116.62; th e  No-TD g ro u p 's  mean was 265.31 days 
(see Table 6) .  The t  value was -1 .5 2  and not s ig n if ic a n t  a t  th e  .05 
le v e l  fo r  a tw o -ta ile d  t e s t  (w ith  25 degrees o f freedom ). The n u ll  
hypothesis  can no t be re je c te d .
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B. P sy c h ia tr ic  Behavior P a tte rn s
Hypothesis 19. No d iffe re n c e  w i l l  be found In the  number of 
p sy c h ia tr ic  behavior p a tte rn s  ra te d  h ypok ine tic , h y p e rk in e tic , mixed, 
o r none between the  TD and No-TD groups.
Of the  282 known p sy c h ia tr ic  behavior p a tte rn s  fo r  the  TD 
group, 60 were ra te d  hypo k in e tic , 55 were ra te d  h y p e rk in e tic , 46 were 
ra te d  mixed, and 121 were ra te d  as having no predominant p a tte rn . Of 
th e  317 p sy c h ia tr ic  behavior p a tte rn s  fo r  the  No-TD group, 54 were 
ra te d  hypo k in e tic , 62 were ra te d  h y p e rk in e tic , 52 were ra te d  mixed,
and 149 were ra te d  as having no predominant p a tte rn  (see Table 6) .
2 2 The r e s u l ts  of the  X t e s t  were no t s ig n if ic a n t  (X -  1 .97 , d f = 3,
p « NS). The n u ll  hypothesis can no t be re je c te d .
C. I n i t i a l  P sy c h ia tr ic  Behavior P a tte rn s
Hypothesis 20. I f  subsequent to  having a hypokinetic  i n i t i a l  
p sy c h ia tr ic  behavior p a tte rn  a  p a t ie n t  has a h y p e rk in e tic  h is to ry  of 
extrapyram ldal symptoms, then h e /sh e  w i l l  be more l ik e ly  to  have TD 
than a p a t ie n t  who subsequent to  having a h y p e rk in e tic  i n i t i a l  
p sy c h ia tr ic  behavior p a tte rn  has a hypokinetic  h is to ry  o f ex trapy ra- 
midal symptoms.
Of th e  26 TD s u b je c ts , 1 d isp layed  a hypok inetic  i n i t i a l  
p s y c h ia tr ic  behavior p a tte rn  follow ed by a h y p erk in e tic  h is to ry  of 
extrapyram ldal symptoms and 1 d isp layed  a h y p erk in e tic  i n i t i a l  
p sy c h ia tr ic  behavior p a tte rn  follow ed by a  hypok inetic  h is to ry  of 
extrapyram ldal symptoms. This was a lso  th e  case fo r  the  No-TD group. 
There were no t enough cases fo r s t a t i s t i c a l  a n a ly s is .
Hypothesis 21. If subsequent to having a hypoki%;,|, If subsequent to having a hypokinetic initial 
psychiatric behavior pattern a patient has a hyperkinetic^ pattern a patient has a hyperkinetic psychiatric 
behavior pattern, then he/she will be more likely to haveiMiigo be/she will be more likely to have TD than a 
patient who subsequent to having a hyperkinetic initial It^ jlot to having a hyperkinetic initial psychiatric 
behavior pattern has a hypokinetic psychiatric behavior 3 h y p o k i n e t i c  psychiatric behavior pattern.
A hypokinetic initial psychiatric behavior p a t te r s  initial psychiatric behavior pattern followed 
by a hyperkinetic psychiatric behavior pattern was displ^lvcbUtcic behavior pattern was displayed by 
2 TD subjects and none of the No-TD subjects. A hyperkimfftiiioe of the No-TD subjects. A hyperkinetic initial 
psychiatric behavior pattern followed by a hypokinetic pgg$ pattern followed by a hypokinetic psychiatric 
behavior pattern was displayed by 2 TD subjects and 1 of i | | j | I  displayed by 2 TD subjects and 1 of the No-TD 
subjects. There were not enough cases for statistical aw)^ y@ trot enough cases for statistical analysis.
D. Miscellaneous Characteristics tomteristics
Hypothesis 22. No difference will be found in e$i||,8. No difference will be found in eye color 
between the TD and No-TD groups. Hl'd-OD groups.
In both the TD and No-TD groups, there were 12 silfyhflft tad No-TD groups, there were 12 subjects with
blue eyes and 14 subjects with brown eyes (see Table 8). rejects with brown eyes (see Table 8). The
2 2 2 results of the X were not significant (X = 0). The nu%iide net significant (X = 0). The null hypo­
thesis can not be rejected. Jnfjected-
Hypothesis 23. No difference will be found in d d |||. No difference will be found in dental status 
between the ID and No-TD groups. Hld-H) 5rouP8 •
In the TD group, 5 subjects had teeth or denturestyijonp, 5 subjects had teeth or dentures; 21 of 
the subjects had no teeth and no dentures. In the No-TD |||ldeethand no dentures. In the No-TD group,
12 subjects had teeth or dentures; 14 had no teeth and nc*J|ji s »r dentures; 14 had no teeth and no dentures
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Table 8
Summary of M iscellaneous C h a ra c te r is tic s ' R esults
VARIABLE TD NO-TD x2
R eject
Null?
Eye Color: 
Blue 12 12 0 No
Brown 14 14 d f-1 , p=NS
Race:
Black 10 8 .34 No
White 16 18 d f-1 , p=NS
D ental S ta tu s : 
Teeth 5 21 4.28 Yes
(includ ing
den tu res)
No Teeth 
(no dentures)
12 14
df= l 
p < .05
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2 2 (see Table 9 ). The r e s u l ts  o f the  X were s ig n if ic a n t  (X = 4 .2 8 ,
d f = 1, p <  .0 5 ). The n u ll  hypothesis i s  re je c te d .
Hypothesis 24. No d iffe ren c e  w i l l  be found in  race  between
the  TD and No-TD groups.
There were 10 b lack  su b jec ts  and 16 w hite su b jec ts  in  the
TD group. In  the  No-TD group th e re  were 8 b lack  su b jec ts  and 18 w hite
2su b jec ts  (see Table 8 ) . The r e s u l ts  o f the  X were no t s ig n if ic a n t  
2
(X = .34, d f = 1, p = NS). The n u ll  hypothesis g a n 't  be re je c te d .
Summary
Four an tip sy ch o tic  v a ria b le s  were te s te d : mean cum ulative
dose, mean cum ulative leng th  o f a d m in is tra tio n , mean d a ily  dose, and 
maximum dose in  any y ear. S ig n if ic a n t d if fe re n c e s , w ith the  co n tro l 
group having g re a te r  means, were found on the v a ria b le s  o f  mean 
d a ily  and cum ulative dose o f an tip sy ch o tic s  (see Table 2 ) . As a 
fu r th e r  measure of p o ss ib le  d iffe ren c es  between the  groups on concen­
t r a t io n  and schedule o f a n tip sy ch o tic  ad m in is tra tio n , th e  number of 
incurred  changes in  a n tip sy ch o tic  dosage lev e ls  and frequencies o f 
ad m in is tra tio n  was te s te d .  No s ig n if ic a n t  d iffe ren c e  was found on 
th is  v a ria b le  e i th e r .  Three an tip a rk in so n  agent v a ria b le s  were 
te s te d : mean cum ulative dose, mean cum ulative leng th  of adm inis­
t r a t io n ,  and mean d a ily  dose. A s ig n if ic a n t  d if fe re n c e , w ith the 
co n tro l group having a  g re a te r  mean, was found on the  mean cum ulative 
leng th  of an tip ark in son  agent ad m in is tra tio n  (see  Table 2 ) .
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Table 9 
Comparison o f D ental S ta tus
Teeth 
(inc lud ing  den tures)
No Teeth 
(no den tu res)
TD 5 21
(8.5) (17.5)
NO-TD 12 14
(8.5) (17.5)
2
(Expected c e l l  frequences) X = 4 .2 8 , d f= l, p < .0 5
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No s ig n if ic a n t  d iffe ren c es  were found on any of the  poly­
pharmacy v a r ia b le s . A tren d  was noted fo r th e  No-TD group having a 
g re a te r  number o f incidences of polypharmacy. No s ig n if ic a n t  d i f f e r ­
ences were found between the  TD and No-TD groups on th e  v a ria b le s  of 
of 2 month periods or mean number o f days f r e e  o f a n tip sy ch o tic  
m edications (see Table 5 ) .
A s ig n if ic a n t  d iffe ren c e  was found between th e  TD and No-TD 
groups on the  number of extrapyram idal symptom in c id en ces; the No-TD 
group had a g re a te r  number of incidences (see  Table 7 ) . No s i g n i f i ­
can t d iffe ren ces  were found on th e  rem aining extrapyram idal symptom 
v a ria b le s  (see Table 6 ). On the  v a ria b le  o f  number o f  p sy c h ia tr ic  
behavior p a tte rn s  ra ted  as hypok ine tic , h y p e rk in e tic , mixed, o r none, 
no s ig n if ic a n t  d iffe ren ce  was found between the  groups (see  Table 6 ). 
L ikew ise, no s ig n if ic a n t  d iffe ren c es  were found on th e  i n i t i a l  psych i­
a t r i c  behavior p a tte rn  and the  subsequent p sy c h ia tr ic  behavior p a tte rn  
o r subsequent extrapyram idal symptom p a tte rn  (see Table 6 ) .
No s ig n if ic a n t  d iffe ren c es  were found on th e  v a ria b le s  o f eye 
co lo r o r race  between th e  TD and No-TD groups (see Table 8 ) . The TD 
group had a s ig n if ic a n t ly  g re a te r  number of su b jec ts  w ithout te e th  
than  th e  No-TD group (see Table 9 ).
V. SUMMARY AND CONCLUSIONS
This chap ter i s  designed to  summarize and in te r p r e t  the 
p re sen t study and i t s  r e s u l t s .  C onclusions, l im ita t io n s , and 
im p lica tions fo r  fu r th e r  re sea rch  a re  a lso  included.
Summary
Tardive dysk inesia  (TD) i s  a d e b i l i ta t in g  s id e  e f f e c t  of 
a n tip sy ch o tic  m edications th a t  i s  l a t e  in  o n -se t and o fte n  i r r e v e r ­
s ib le  ( J e s te  e t  a l . ,  1979). The e tio lo g y  o f TD, as w ell as the  
trea tm en t fo r  TD remain e lu s iv e , although h eav ily  researched  
(J e s te  & W yatt, 1979). Before comprehensive and conclusive research  
on the  e tio lo g y  and, th e re fo re , trea tm ent o f TD can be accom plished, 
c o n s is te n t find ings about d is tin g u ish in g  c h a ra c te r is t ic s  o f TD 
p a tie n ts  a re  needed in  o rd er fo r  i t s  p recu rso rs  to  be id e n t i f ie d .
I t  was th e  purpose o f th is  study to  in v e s t ig a te  some of th e  charac­
t e r i s t i c s  which d esc rib e  p a tie n ts  w ith  TD. An attem pt was made to  
answer the  question  "Are th e re  asp ec ts  o f TD p a t ie n ts ' drug and 
beh av io ra l h is to r ie s  which d is tin g u ish  them from p a tie n ts  w ithout 
TD?"
The general hypothesis o f th is  study i s  th a t  th e re  a re  no 
d iffe ren c es  between a  group o f in p a tie n ts  w ith  TD and a  group of 
in p a tie n ts  w ithout TD on the  d e sc r ip tiv e  c h a r a c te r is t ic s  o f h is to ry  
o f a n tip sy ch o tic  m edications, h is to ry  o f an tip a rk in so n  a g en ts ,
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h is to ry  of polypharmacy, h is to ry  of d ru g -free  p e rio d s , h is to ry  of 
extrapyram idal symptoms (EPS), i n i t i a l  p sy c h ia tr ic  behavior p a tte rn , 
p sy c h ia tr ic  behavior p a t te rn , ra c e , eye c o lo r , and race .
Due to  the  p o ss ib le  i r r e v e r s ib i l i t y  o f TD, i t s  growing 
incidence among in p a tie n ts  (Jus e t  a l . ,  1976) and o u tp a tie n ts  (Asnis 
e t  a l . ,  1977), and the  community adjustm ent problems i t  o ften  causes 
(Ayd, 1970), i t  i s  im perative th a t  th e  d e sc r ip tiv e  c h a ra c te r is t ic s  
o f  TD p a tie n ts  a re  c o n s is te n tly  d e lin e a te d . Although th e re  have been 
sev e ra l epidem iological s tu d ie s  o f TD, th e re  have been few c o n s is te n t 
find ings due to  sev e ra l m ethodological problems. Ananth (1978), 
in  reviewing e t io lo g ic a l  s tu d ie s ,  p o in ts  out th a t  co n tro l groups 
a re  seldom used and suggests th a t  "a more f r u i t f u l  approach would 
be to  understand th e  d iffe ren c es  between those who develop dysk inesia  
and those  who do n o t"  (p. 34 ). Simpson e t  a l .  (1978) a s s e r t  th a t  
m erely using a  co n tro l group i s  inadequate and th a t  matching on age, 
sex , d iag n o sis , and length  o f h o s p i ta l iz a t io n  i s  necessa ry , although 
seldom done, fo r adequate ep idem iological s tu d ie s  of TD as " d ire c t  
comparison . . . w ith in  matched p a tie n ts  should y ie ld  more d e f in i t iv e  
r e s u l t s "  (p. 119). The p re sen t study met th ese  two m ethodological 
needs as a  matched co n tro l group was used.
Em pirical j u s t i f i c a t io n  fo r  p re d ic tin g  and resea rch in g  the  
s p e c if ic  d e sc r ip tiv e  c h a r a c te r is t ic s  p rev io u sly  d e lin ea ted  was gained 
from a review of ep idem iological re sea rch  on TD. R ep lica tio n  of the 
fin d ings on a l l  th e  v a ria b le s  s tu d ied  was needed s in ce  matched co n tro l 
groups were used in  only th re e  previous s tu d ie s  (Mallya e t  a l . ,  1979;
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Simpson e t  a l . ,  1978; Pryce & Edwards, 1966). The m ajo rity  of
epidem iological research  i s  d e sc r ip tiv e , o ften  re p o rtin g  find ings in
percentages (Fann e t  a l . ,  1972) and no t te s t in g  fo r  s t a t i s t i c a l  s ig n i­
f ic a n ce . Recent find ings have a lso  ra is e d  some questions as to  the 
accuracy of some of th e  previous find ings and in d ic a te  a l te rn a t iv e  
da ta  c o lle c tio n  methods, such as c u tt in g -o f f  da ta  c o lle c tio n  w ith  the
emergence of TD symptoms (Jus e t  a l . ,  1976).
The occurrence of TD is  a t t r ib u te d  to  an tip sy ch o tic  medica­
tio n s  due to  prevalence s tu d ie s  fin d in g  the  syndrome to  be re la t iv e ly  
common in  d ru g -trea ted  populations and r e la t iv e ly  r a re  in  un trea ted  
populations (Crane, 1973). What remains u n c lea r, however, i s  how TD 
develops as w e ll as how the  m edications cause th e  syndrome. I t  i s  
u n lik e ly  th a t th is  w i l l  be known u n t i l  the mechanisms by which a n t i -  
psychotics operate  a re  more c le a r ly  understood. C u rren tly , 
an tip sy ch o tic  m edications a re  thought to  fu n c tio n a lly  d ep le te  dopamine 
by blocking th is  n e u ro - tra n sm itte r 's  recep to rs  a t  sev e ra l s i t e s  in  the  
b ra in  (B a ld essa rin i, 1977). This framework derives from th e  dopamine- 
surp lus theory of sch izophren ia , which i s  only one theory  of the  
e tio lo g y  fo r th is  p sychosis, wherein th e  psychosis i s  understood as 
a neurochem ical d iso rd e r (Lehman, 1975). However, th is  theory a lso  
provides a b a s is  fo r  understanding th e  development o f TD. I f  
sch izophrenia  i s  a s ta t e  o f  dopamine su rp lus and a n tip sy ch o tic s  a c t 
by reducing dopamine, then TD can be understood as a  dopamine le v e l 
d is tu rb an ce . This i s  hypothesized as re s u lt in g  from a " s ta te  o f 
denervation  su p e rse n s i t iv ity  o f . . . dopamine re c ep to rs"  (J e s te  &
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W yatt, 1979, p . 252) due to  a "prolonged blockage o f dopaminergic 
mechanisms by the  a n tip sy ch o tic  drugs" (B a ld essa r in i, 1977, p. 47). 
Consequently, sev e ra l epidem iological s tu d ie s  have focused on the  
drug h is to r ie s  o f p a tie n ts  w ith  TD expecting to  fin d  th a t  they had 
received  increased  amounts of a n tip sy c h o tic s , e i th e r  in  dosages or 
length  of a d m in is tra tio n s , to  account fo r  the  hypothesized dopamine 
supers ens i t i v i t y .
Even i f  TD is  proven to  be a r e s u l t  o f neurochemical imbalance 
caused by the in g es tio n  of a n tip sy c h o tic s , no exp lanation  would be 
given as to  why some in d iv id u a ls  develop TD w hile  o thers  do n o t. 
Consequently, in d iv id u a l d iffe ren c es  in  s u s c e p t ib i l i ty  a re  hypo­
th esized  (B a ld essa rin i & Tarsy, 1978; Crane, 1978). Epidem iological 
s tu d ie s  have in v e s tig a te d  c h a ra c te r is t ic s  o f in d iv id u a ls  w ith  TD, in  
an e f f o r t  to  d e lin e a te  p recu rso rs  o f the  syndrome.
Four a n tip sy ch o tic  dosage and a d m in is tra tio n  v a ria b le s  were 
o f resea rch  in te r e s t :  cum ulative dose, cum ulative leng th  of adm inis­
t r a t io n ,  d a ily  dose, and maximum dose received  per y ear. On the  b a s is  
o f the  dopamine-blockage hypothesis one could expect TD p a tie n ts  to  
have had h igher cum ulative dosages of an tip sy ch o tic s  than co n tro l 
p a t ie n ts .  This has no t been c o n s is te n tly  found. Three s tu d ie s  
(Mallya e t  a l . ,  1979; Pryce & Edwards, 1966; Simpson e t  a l . ,  1978) 
examined the  d iffe ren c es  in  cum ulative a n tip sy ch o tic  dose le v e l ,  
comparing matched TD and No-TD sam ples. Only one study (Pryce & 
Edwards, 1966) found a s ig n if ic a n t  d iffe re n c e  w ith  the  TD sample 
rece iv in g  h igher cum ulative dosages than th e  No-TD sample. S ince TD
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i s  la te  in  o n -se t compared to  o ther n eu ro lo g ica l s id e  e f fe c ts  (ACN-FDA, 
1973), i t  seems th a t  sev e ra l years of trea tm en t w ith an tip sy ch o tic s  may 
be necessary  before  the  syndrome emerges. I t  can thus be expected th a t 
p a tie n ts  who develop TD w il l  have a longer h is to ry  of a n tip sy ch o tic  
m edication treatm ent than p a tie n ts  who d o n 't  develop TD (Crane, 1973). 
The l i t e r a tu r e  has fa i le d  to  support such an expec ta tion  (Mallya e t  
a l . ,  1979; Pryce & Edwards, 1966; Simpson e t  a l . ,  1978).
In  an e f f o r t  to  avoid in te rv en in g  in te ra c t io n s  between length 
of an tip sy ch o tic  a d m in is tra tio n  and cum ulative an tip sy ch o tic  dose, 
the  mean d a ily  dose is  a v a r ia b le  th a t  may provide more s p e c if ic  
in form ation . However, fin d ings on th is  v a r ia b le  have been in c o n s is ­
te n t (Crane, 1974; Simpson e t  a l . ,  1978). The maximum a n tip sy ch o tic  
dosage per year i s  another measure of th e  re la tio n sh ip  between drug 
h is to ry  v a ria b le s  and the  development o f TD. Two s tu d ie s  have examined 
th is  v a r ia b le  and th e  outcomes a re  p o s it iv e  and c o n s is te n t (Crane,
1974; Smith e t  a l . ,  1978). Although th ese  s tu d ie s  were c o r re la tio n a l 
and w ithout matched c o n tro ls , they do in d ic a te  a need to  examine th is  
v a r ia b le  more in te n se ly .
P reviously  an tip a rk in so n  ag en ts , which a re  used to  t r e a t  
extrapyram idal symptoms (EPS), were t r i e d  as a form of trea tm en t fo r  
TD sin ce  both d iso rd e rs  involve the  extrapyram idal system. However, 
i t  was soon re a liz e d  th a t these  drugs d id  n o t improve TD (Turek e t  
a l . ,  1972) and a c tu a lly  aggravated the  syndrome in  some cases (Je s te  
& W yatt, 1979). Borison (1979) a s s e r ts  th a t  an tip ark inson  agents may 
promote the  development o f TD by in c reas in g  dopamine re cep to r hyper-
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s e n s i t iv i ty ,  cu rre n tly  hypothesized to  m ediate the development of TD. 
Consequently, frequent trea tm ent w ith an tip a rk in so n  agents could 
mediate the  development of TD. The two s tu d ie s  using matched co n tro l 
groups in  examining th is  v a r ia b le  had c o n f lic tin g  find ings (Mallya 
e t  a l . ,  1979; Simpson e t  a l . ,  1978).
In  a survey on polypharmacy, Sheppard e t  a l .  (1974) concluded 
th a t  the  main cause of using more than one an tip sy ch o tic  was a 
p a t ie n t 's  responding poorly to  h is  or her an tip sy ch o tic  regimen. The 
physician  then adds a concomitant an tip sy ch o tic . Chouinard e t  a l .  
(1979) found th a t  l i t t l e  th e ra p eu tic  improvement was a v a r ia b le  
s ig n if ic a n tly  re la te d  to  the  presence of TD. When these  two find ings 
a re  combined, i t  could be expected th a t p a tie n ts  w ith TD w il l  have a 
g re a te r  incidence of polypharmacy than p a tie n ts  not having TD. Four 
psychotropic combinations were in v e s tig a te d  in  th is  study: an
an tip sy ch o tic  plus an a n tip sy c h o tic , an a n tip sy ch o tic  p lus an a n t i ­
parkinson ag en t, an a n tip sy ch o tic  plus lith iu m , and an a n tip sy ch o tic  
plus a t r i c y c l ic  a n tid e p re s sa n t. When th e  re la tio n s h ip  o f th e  f i r s t  
two types o f polypharmacy to  the  development o f TD has been s tu d ie d , 
o p e ra tio n a l d e f in it io n s  d if fe re d  between s tu d ie s  (Jus e t  a l . ,  1976; 
Simpson e t  a l . ,  1978); no s ig n if ic a n t  d iffe ren ces  were found between 
the experim ental and co n tro l groups in  e i th e r  study . Nothing has 
been rep o rted  in  the  l i t e r a tu r e  on the  re la tio n sh ip s  of the  o th e r 
two ca teg o rie s  of polypharmacy to  the  development of TD.
As a p rev en ta tiv e  measure ag a in s t TD, d ru g -free  periods la s t in g  
from two days to  two months have been advocated. These time periods
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would allow  TD being masked by an tip sy ch o tic s  to  be d e tec te d ; they 
would a lso  cu t down on the  cum ulative doses and leng th  of adm inis­
t r a t io n  of an tip sy ch o tic s  (Ayd, 1970). R ecently , J e s te  e t  a l .  (1979) 
found th a t  the  b e st d isc rim in a to r between TD p a tie n ts  whose symptoms 
reversed  a f te r  th re e  months f re e  o f drugs and TD p a tie n ts  whose 
symptoms p e rs is te d  was the number of in te rv a ls  f re e  o f a n tip sy ch o tic  
d rugs. P aradox ically , the  p e r s is te n t  group had a g re a t number of 
d ru g -free  in te rv a ls  o f a t  le a s t  two months. Given th is  d is tu rb in g  
f in d in g , c lo se r  exam ination of two d ru g -free  v a r ia b le s  was m erited ; 
namely, number of d ru g -free  periods of a t  le a s t  two months du ra tio n  
and to t a l  number o f d ru g -free  days.
There a re  c o n f lic tin g  find ings concerning the  re la tio n s h ip  
between extrapyram idal symptom (EPS) h is to r ie s  and the  subsequent 
development o f TD (Sovner & DiMascio, 1978). This lack  of consistency  
r e s u l t s ,  in  p a r t ,  from the lack  of w ell-developed assessm ent methods 
fo r  EPS (Mindham, 1976). D esp ite  the  c o n f lic tin g  f in d in g s , Crane 
(1972, 1978) has co n tin u a lly  found a p red isposing  re la t io n s h ip . He 
has had ex ce llen t d esigns, c o n tro llin g  fo r  in te rv en in g  v a ria b le s  and 
rig o ro u sly  a sse ss in g  EPS; however, d is t in c t io n  among the  various types 
of EPS was no t made. Chouinard e t  a l .  (1979) a re  the f i r s t  re sea rch ers  
to  make such a d is t in c t io n  and concluded th a t  the  h y p e rk in e tic  types 
of EPS (a k a th is ia  and trem or) may be p red isposing  to  th e  development 
o f TD w hile the  hypokinetic  types o f EPS (a k in e s ia , r ig i d i ty ,  dyston ic  
re a c tio n s )  may reduce th e  development o f TD. However, th e i r  study 
examined only the cu rren t EPS of the  s u b je c ts . F u rth er ex p lo ra tio n
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of s u b je c ts ' EPS h is to r ie s  i s  needed in  order to  t e s t  fo r  a p o ssib le  
h i s to r ic a l  re la tio n s h ip  s im ila r  to  th e i r  fin d in g s.
I t  is  necessary  to research  both EPS h is to ry  and p sy ch ia tr ic  
behavior p a tte rn s  ra th e r  than so le ly  EPS h is to ry  as medical personnel 
and resea rch ers  o ften  have d i f f i c u l ty  d i f f e r e n t ia l ly  diagnosing EPS 
from p sy c h ia tr ic  symptomology (Davis & Cole, 1975; Donlon & Stenson, 
1976; Lesser & Fahn, 1978; R ifk in  e t  a l . ,  1975). The lack  of a 
c o n s is te n t re la tio n s h ip  between EPS and TD may thus r e s u l t  from 
confusion between p sy ch ia tr ic  symptoms and n eu ro lo g ica l s id e  e f f e c ts .
F riedho ff e t  a l .  (1960) determ ined th a t  an tip sy ch o tic s  reduced 
motor a c t iv i ty  in  p a tie n ts  whose a c t iv i ty  was p rev iously  qu icker than 
average, bu t sped up p a tie n ts  whose motor a c t iv i ty  had been re ta rd e d . 
Van P u tten  (1978) found th a t  a hypokinetic  type o f EPS, a k in e s ia , 
occurred more o ften  in  p a tie n ts  ex h ib itin g  high le v e ls  o f e x c ita tio n  
in  th e i r  i n i t i a l  p sy c h ia tr ic  behavior. These s tu d ie s  in d ic a te  th a t  
p a t ie n ts ' i n i t i a l  p sy c h ia tr ic  behavior p a tte rn s  could p o ssib ly  suggest 
th e  type of EPS, i f  any, they may develop in  response to  treatm ent 
w ith  a n tip sy c h o tic s . Furtherm ore, in  l ig h t  of the find ings o f Crane 
(1972, 1978) and Chouinard e t  a l .  (1979), knowing the type o f EPS a 
p a tie n t may be su sc e p tib le  to  may a lso  in d ic a te  h is  o r her r i s k  of 
developing TD.
Crane (1978) a s s e r ts  th a t  no da ta  a re  a v a ila b le  on g en e tic  
v a ria b le s  which could account fo r  d iffe ren c es  in  in d iv id u a l s u sc e p ti­
b i l i t y  to  TD. Brandon e t a l .  (1971), however, rep o rted  an excess o f 
b lue-eyed males w ith  dysk inesia  which they f e l t  in d ica ted  a ro le  fo r
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genetics  in  the development o f TD. Gardos e t  a l .  (1978), however, 
were unable to  r e p l ic a te  th is  f in d in g . The fin d in g  of Brandon e t  a l .  
p e rip h e ra lly  addresses the  u n tested  question  o f what re la t io n s h ip , I f  
any, e x is ts  between race  and Incidence of TD.
I t  has been known fo r  some time th a t  edentulous e ld e r ly  
p a tie n ts  may appear to  have TD In the  b u cca l-lin g u a l-m astic a to ry  t r i a d  
due to  the  gumming movements th is  s ta t e  o ften  p re c ip i ta te s .  S im ila r ly , 
p a tie n ts  w ith 1 1 1 -f lt t ln g  dentures may move th e i r  mouth, tongue, and 
jaws in  a manner found in  TD p a tie n ts  (Sutcher e t  a l . ,  1971). Occas- 
s io n a l ly , d en ta l s t a t e  has been found to  be a sso c ia ted  w ith the 
presence of TD (Asnis e t  a l . ,  1977; Brandon e t a l . ,  1971).
Many of the research  find ings on the  re la tio n s h ip  of the  
fa c to rs  reviewed to  the  development o f TD a re  u nc lear and /or in c o n sis ­
te n t .  The primary reasons fo r  th is  a re  m ethodological flaws such as 
the lack  of matched co n tro l groups, f a i lu r e  to  c u t-o f f  da ta  g a th erin g  
w ith the emergence o f TD, and the  lack  of c le a r ly  d e lin ea ted  c r i t e r i a  
conducive to  r e p lic a t io n . H is to r ic a l  fa c to rs  a lso  confound re s u l ts  
of s tu d ie s  in v e s tig a tin g  s im ila r  v a ria b le s  a t  d if f e r e n t  po in ts  in  time 
s in ce  the treatm ent of TD has changed sev e ra l times over the  p ast two 
decades. Record-keeping procedures have a lso  changed, thus making i t  
p o ssib le  to  in v e s t ig a te  v a ria b le s  on which l i t t l e  in form ation  was 
form erly a v a ila b le . This study in v e s tig a te d  the  re la tio n sh ip s  
d iscussed  w hile improving as much as p o ssib le  the major design flaws 
in d ic a ted .
Two samples, each w ith N=26, were se le c ted  from c u rren t
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In p a tie n ts  a t  E astern  S ta te  H o sp ita l. The TD group included p a tie n ts  
diagnosed by a p s y c h ia tr is t  as having TD. The No-TD group were 
randomly chosen p a t ie n ts ,  based on th e i r  matching th e  TD su b jec ts  on 
age, sex , and d iag n o sis , and examined by the  p s y c h ia tr is t  to  ensure 
the absence of TD. The p s y c h ia tr is t  was b lin d  to  s t a f f  r e f e r r a ls  
and used a ra t in g  sca le  adapted from Van P utten  (1974) which is  
dep icted  in  Appendix H.
An I n i t i a l  and P sy c h ia tr ic  Behavior P a tte rn s  Rating Form, 
using the  extrapyram idal d e sc rip to rs  of Donlon & Stenson (1976) and 
Sovner & DiMascio (1978), was designed to  r a te  the  behav io ral 
v a ria b le s  o f " I n i t i a l  p sy c h ia tr ic  behavior p a tte rn "  and "P sy ch ia tr ic  
behavior p a t te rn ."  Two a s s is ta n t s ,  b lin d  to  the  s tu d y 's  hypotheses 
and the  group membership of the  su b je c ts , ra te d  the  behav io ral 
v a r ia b le s . The in te rju d g e  agreement r a t io  o f 76% (see Appendix E) 
was deemed accep tab le . The extrapyram idal d e sc r ip to rs  of Donlon & 
Stenson (1976) and Sovner & DiMascio (1978) were a lso  used to  determ ine 
the  type and form of EPS incidences (Appendix D ).
This study is  an ex post fa c to  design  as the  phenomena s tu d ied
had a lready  occurred n a tu r a l i s t i c a l ly ,  thus th e  independent v a r ia b le  
was n o t co n tro lle d  or m anipulated. The c rite rio n -g ro u p  approach is  
the type of design . The independent v a r ia b le  is  th e  presence or
absence o f TD and the  dependent v a ria b le s  a re  the d e sc r ip tiv e  charac­
t e r i s t i c s  in v e s tig a te d . D esc rip tiv e  c h a ra c te r is t ic s  of a TD group 
were co n tra sted  w ith those  o f a No-TD group in  an e f f o r t  to  determ ine 
which c h a ra c te r is t ic s  presumably preceded th e  c r i te r io n .
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The hypotheses about a n tip sy ch o tic  and an tip a rk in so n  drug 
dosages and ad m in is tra tio n  d u ra tion  (1 -7 ), polypharmacy (8 -11), drug- 
f re e  periods (12, 13), EPS h is to ry  (17, 18), and p sy ch ia tr ic  behavior 
p a tte rn  (20) involve in te rv a l  measures o f the  dependent v a ria b le s  
and nominal independent v a r ia b le s . Consequently, t - t e s t  fo r  dependent, 
or p a ired , samples was used to  determ ine i f  any mean d iffe ren ces  found, 
over a l l  the  p a ir s ,  were s t a t i s t i c a l l y  s ig n if ic a n t .  C hi-square was 
used to  determ ine the  s ig n if ic a n c e  o f any system atic  a sso c ia tio n  
among the  v a ria b le s  te s te d  in  the  rem aining hypotheses.
Conclusions
The v a ria b le s  o f length  of drug and p sy ch ia tr ic  h i s to r ie s  were 
te s te d  to  determ ine i f  they may be in te rv en in g  v a ria b le s  a f fe c t in g  the  
p resen t s tu d y 's  r e s u l t s .  The mean leng th  of the TD g roup 's  drug h is to ry  
was 15.93 y ears ; the  No-TD g roup 's  drug h is to ry  was 15.62 y e a rs . The 
TD group 's  mean length  of h o s p i ta l iz a t io n ,  rep resen tin g  p sy c h ia tr ic  
h is to ry , was 12.79; the  No-TD group 's  leng th  of h o s p ita l iz a t io n  was 
13.84. No s ig n if ic a n t  d iffe ren ces  were found between th e  TD and No-TD 
groups on th ese  two v a r ia b le s , thus they a re  not considered in te rv en in g  
v a ria b le s  capable of confounding th is  s tu d y 's  r e s u l t s .
Due to  the  n e ce ss ity  o f group reassignm ents, the independence 
of the  samples was examined in  terms o f th e  17 in te rv a l ly  measured drug 
v a r ia b le s . The 5 s ig n if ic a n t  c o rre la tio n s  generated  by a  dependent 
t - t e s t  a re  dep icted  in  Table 10. The f i r s t  two a re  d e s ira b le  c o r re la ­
tio n s  as very d is s im ila r  lengths o f h o s p i ta l iz a t io n  and drug h is to ry
94
Table 10
S ig n if ic a n t C o rre la tio n s  Generated By Dependent T-Test
VARIABLE CORRELATION
(2 - ta i le d  p ro b a b ility )
Length o f p sy c h ia tr ic  h is to ry .67 (.000)
Length o f drug h is to ry .61 (.001)
Number of days received  an tip sy ch o tic s .49 (.01)
D aily dose o f an tip sy ch o tic s .60 (.001)
T o tal cum ulative dose of an tip sy ch o tic s .62 (.001)
may have in troduced a r t i f i c i a l  d iffe ren ces  in to  the s t a t i s t i c a l  
a n a ly s is  of the  drug v a r ia b le s . The remaining 3 c o rre la tio n s  a re  
a lso  d e s ira b le  as they in d ic a te  th a t  the two samples received  s im ila r  
trea tm en t w ith  a n tip sy c h o tic s , which was p a r t  of the r a t io n a le  fo r  
matching on d iag n o sis . The two groups were not s ig n if ic a n tly  
c o rre la te d  on the rem aining 12 v a r ia b le s , in d ic a tin g  th e i r  indepen­
dence. W ithin group homogeneity was examined by an independent 
t - t e s t  on th e  17 drug v a ria b le s  of the  subgroups of each sample. No 
s ig n if ic a n t  d iffe ren c es  were found w ith in  th e  TD sample between the  
o r ig in a l TD su b jec ts  (n=17) and the reassigned  co n tro ls  (n=9). One 
s ig n if ic a n t  d iffe re n c e  was found w ith in  the  co n tro l group between 
th e  o r ig in a l co n tro ls  (n=15) and the  reassigned  TD su b jec ts  ( n = l l ) .
The number of d ru g -free  periods was s ig n if ic a n t ly  g re a te r  fo r  the  
reassigned  TD su b je c ts . This p a r t ic u la r  v a r ia b le  never proved 
s ig n if ic a n t  in  l a te r  analyses and is  th e re fo re  n o t considered in d ic a ­
t iv e  of lacking  homogeneity in  the co n tro l sample.
A l i s t in g  of th is  s tu d y 's  f in d in g s , by hypothesis number, is  
provided below in  o rd er to  he lp  the  reader see unquestionably what was 
found h e re in .
Drug H is to rie s
A. A ntipsychotics
1. S ig n if ic a n t d iffe ren ces  were found in  mean cum ulative dose 
of a n tip sy ch o tic  m edications; the No-TD g ro u p 's  mean was g re a te r  than 
th e  TD g ro u p 's  mean.
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2. No s ig n if ic a n t  d iffe ren c es  were found in  the  mean cumula­
t iv e  length  o f a n tip sy ch o tic  m edication a d m in is tra tio n  between the
TD and No-TD groups.
3. S ig n if ic a n t d iffe ren c es  were found in  mean d a ily  dose 
of an tip sy ch o tic  m edications; th e  No-TD g roup 's  mean was g re a te r  
than the  TD g roup 's  mean.
4 . No s ig n if ic a n t  d iffe ren c es  were found in  the  maximum 
an tip sy ch o tic  d a ily  dose fo r  any year between the  TD and No-TD groups.
B. A ntiparkinson Agents
5 . No s ig n if ic a n t  d iffe ren c es  were found in  the  mean 
cum ulative dose of an tip a rk in so n  agents between the  TD and No-TD groups.
6 . S ig n if ic a n t d iffe ren c es  were found in  the mean cum ulative 
length  of an tip ark inson  agent a d m in is tra tio n ; the No-TD g ro u p 's  mean 
was g re a te r  than the  TD g ro u p 's  mean.
7. No s ig n if ic a n t  d iffe ren c es  were found in  the  mean d a ily  
dose of an tip a rk in so n  agents between the  TD and No-TD groups.
C. Polypharmacy
8 . No s ig n if ic a n t  d iffe ren c es  were found in  the  mean number 
of to t a l  incidences o f polypharmacy, a t  e i th e r  of the  two chlorproma- 
z in e  equ ivalen ts c r i te r io n  dosage le v e ls  of 0 mg. and 100 mg., between 
the  TD and No-TD groups.
9. No s ig n if ic a n t  d iffe ren c es  were found in  the  mean number 
of incidences in  any of the  four ca teg o rie s  o f polypharmacy—a n t i ­
psychotic  plus an a n tip sy c h o tic , a n tip sy ch o tic  plus an an tip a rk in so n  
ag en t, a n tip sy ch o tic  p lus an a n tid e p re s sa n t, and a n tip sy ch o tic  plus
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lith iu m —a t  e i th e r  o f the  chlorpromazine equ iv alen ts  c r i te r io n  dosage 
le v e ls  of 0 mg. or 100 mg., between the  TD and No-TD groups.
10. S ig n if ic a n t d iffe ren c es  were found in  th e  mean number
of an tip a rk in so n  agents adm inistered  between groups; th e  No-TD group 
received  a g re a te r  v a r ie ty  o f an tip a rk in so n  ag en ts .
11. No s ig n if ic a n t  d iffe ren ces  were found in  th e  mean number
of an tip sy ch o tic s  adm inistered  between the  TD and No-TD groups.
D. Drug-Free V ariab les
12. No s ig n if ic a n t  d iffe ren c es  were found in  th e  mean number
of incidences o f  d ru g -free  p e rio d s , la s t in g  a t  l e a s t  two months,
between the  TD and No-TD groups.
13. No s ig n if ic a n t  d iffe ren c es  were found in  the  mean number 
of d ru g -free  days between the  TD and No-TD groups.
Other D esc rip tiv e  C h a ra c te r is tic s
A. Extrapyram idal Symptoms
14. No s ig n if ic a n t  d iffe ren c es  were found in  th e  number of 
su b jec ts  experiencing extrapyram idal symptoms between the  TD and 
No-TD groups.
15. S ig n if ic a n t d iffe ren c es  were found in  the  number of 
extrapyram idal symptom incidences between th e  TD and No-TD groups; 
a g re a te r  number of extrapyram idal symptom incidences were found in  
the  No-TD group.
16. No s ig n if ic a n t  d iffe ren c es  were found in  the  number of 
extrapyram idal symptom incidences ra te d  as hy p o k in e tic , h y p e rk in e tic ,
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or mixed.
17. No s ig n if ic a n t  d iffe ren c es  were found in  the  mean number of 
days extrapyram idal symptoms ra te d  as hypo k in e tic , h y p e rk in e tic , or 
mixed occurred between the TD and No-TD groups.
18. No s ig n if ic a n t  d iffe ren c es  were found in  th e  mean cumula­
t iv e  days extrapyram idal symptoms occurred between th e  TD and No-TD 
groups.
B. I n i t i a l  and P sy c h ia tr ic  Behavior Problems
19. No s ig n if ic a n t  d iffe ren c es  were found in  th e  number of 
p sy ch ia tr ic  behavior p a tte rn s  ra te d  hypo k in e tic , h y p e rk in e tic , mixed, 
or none between the  TD and No-TD groups.
20. No s ig n if ic a n t  d iffe ren c es  were found in  i n i t i a l  psychia­
t r i c  behavior p a tte rn  ra tin g s  and subsequent extrapyram idal symptom 
ra tin g s  between th e  TD and No-TD groups.
21. No s ig n if ic a n t  d iffe ren c es  were found in  i n i t i a l  psychia­
t r i c  behavior p a tte rn  ra tin g s  and subsequent p sy c h ia tr ic  behavior 
p a tte rn  ra tin g s  between the  TD and No-TD groups.
C. M iscellaenous C h a ra c te r is tic s
22. No s ig n if ic a n t  d iffe ren c es  were found in  eye co lo r between 
the  TD and No-TD groups.
23. S ig n if ic a n t d iffe ren c es  were found in  d en ta l s ta tu s ;  the 
TD group had s ig n if ic a n t ly  more edentulous su b je c ts .
24. No s ig n if ic a n t  d iffe ren c es  were found in  race  between the  
TD and No-TD groups.
D iscussion
This s ec tio n  addresses th e  fin d in g s  o f th is  study as re la te d  
to  the  em pirical ju s t i f i c a t io n s  provided In  Chapter I I .
Drug H is to rie s
A. A ntipsvchotics
The No-TD group had s ig n if ic a n t ly  g re a te r  grams and m illig ram s, 
re sp e c tiv e ly , of chlorprom azine equ iv alen ts  on the v a ria b le s  of mean 
cum ulative dose and mean d a ily  dose o f an tip sy ch o tic  m edications. No 
s ig n if ic a n t  d iffe ren c es  were found between the  groups fo r  the  v a ria b le s  
o f mean length  o f a n tip sy ch o tic  m edication a d m in is tra tio n  and mean 
maximum a n tip sy ch o tic  d a ily  dose fo r any year (see Table 2 ) .
Pryce & Edwards (1966) a re  the  only re sea rch ers  who used a 
matched co n tro l group and found a s ig n if ic a n t ly  h igher in tak e  of 
an tip sy ch o tic s  fo r  the  TD group, which i s  in  d ire c t  c o n tra s t  to  th is  
s tu d y 's  r e s u l t s .  In  1966 chlorprom azine equ ivalen ts  were n o t a v a i l ­
a b le , causing Pryce & Edwards to  u t i l i z e  th e  standard  weekly dose of 
each an tip sy ch o tic  s tu d ied  as a common u n i t .  Length o f an tip sy ch o tic  
in tak e  ranges were determ ined and ch i-sq u are  was used to  t e s t  fo r  
s ig n if ic a n t  d if fe re n c e s . A p o ss ib le  exp lanation  of the d if f e r in g  
r e s u l ts  i s  th e i r  method o f quan tify in g  cum ulative a n tip sy ch o tic  dose.
I t  d i f f e r s  from th e  one used by the  p re sen t s tudy , as w ell as the  
o th e r two s tu d ie s  using  matched c o n tro l groups to  in v e s t ig a te  th is  
v a r ia b le  (Mallya e t  a l . ,  1979; Simpson e t  a l . ,  1978). N ailya e t  a l .  
and Simpson e t  a l .  found no s ig n if ic a n t  d iffe ren c es  between the  matched
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TD and No-TD groups on the  v a ria b le  o f cum ulative a n tip sy ch o tic  dosage; 
however, both s tu d ie s  found s l ig h t ly  h ig h e r cum ulative dosages fo r 
the  co n tro l groups. Simpson e t  a l .  a s s e r t  th a t  " th e  sim plest 
exp lanation  fo r  th e se  fin d ings i s  in d iv id u a l v u ln e ra b ili ty "  (1978, 
p. 123). They a lso  p o in t ou t th a t  d iffe re n c e s  in  cum ulative dosages 
may have ex is ted  p r io r  to  the  development o f TD as they were unable 
to  d iscon tinue  da ta  c o lle c tio n  w ith  the  emergence of TD. The cu rren t 
study d id  u t i l i z e  da ta  c u t-o f f  and found a s ig n if ic a n t ly  h igher 
cum ulative a n tip sy ch o tic  dosage fo r the  No-TD su b je c ts . Consequently, 
g re a te r  support i s  provided fo r  the a s s e r t io n  o f Simpson e t  a l .  
Furtherm ore, Brandon e t  a l .  (1971) and Jus e t  a l .  (1976), using 
unmatched co n tro l groups, d id  not fin d  s ig n if ic a n t  d iffe ren c es  between 
the  TD and No-TD groups on cum ulative an tip sy ch o tic  dosages.
The only study to  in v e s t ig a te  d iffe ren c es  between matched TD 
and No-TD groups on the  v a r ia b le  of mean d a ily  dose i s  Simpson e t  a l .  
(1978). No d iffe re n c e  was found between the  groups, although the  TD 
group had a s l ig h t ly  h ig h er mean d a ily  dose. The p resen t study found 
a s ig n if ic a n t ly  g re a te r  mean d a ily  an tip sy ch o tic  dose fo r  the  co n tro l 
group. The in c lu s io n  by Simpson e t  a l .  o f post-TD drug d a ta  may 
r e f l e c t  the  p r io r  method o f t r e a t in g  TD w ith  an in c rease  in  a n tip sy ­
ch o tic  dose. Consequently, th e  presen t s tu d y 's  r e s u lts  c la r i f y  as 
s ig n if ic a n t  th e  tren d  o f h ig h er a n tip sy ch o tic  mean d a ily  dose among TD 
su b jec ts  noted by Simpson e t  a l .
The fin d in g s  of g re a te r  mean cum ulative a n tip sy ch o tic  dose and 
g re a te r  mean d a ily  a n tip sy ch o tic  dose fo r  th is  s tu d y 's  co n tro l group
p a ra l le l  each o th e r , in d ic a tin g  th a t  th e  t o t a l  gram in tak e  o f c h lo r- 
promazine equ ivalen ts  was g re a te r  fo r  the  co n tro l group. This is  
fu r th e r  in d ica ted  by the la ck  of s ig n if ic a n t  d iffe ren c e  between th is  
s tu d y 's  TD and No-TD groups on mean leng th  o f an tip sy ch o tic  adm inis­
t r a t io n .  This find ing  i s  in  concurrence w ith the l i t e r a tu r e  as a l l  
s tu d ie s  u t i l iz in g  co n tro l groups in  th e i r  in v e s t ig a tio n  o f th is  
v a r ia b le  f a i le d  to  show a s ig n if ic a n t  a sso c ia tio n  between treatm ent 
d u ra tio n  and th e  development of TD (Asnis e t  a l . ,  1977; Brandon e t 
a l . ,  1971; Chouinard e t  a l . ,  1979; Jus e t  a l . ,  1976; Mallya e t  a l . ,  
1979; Fryce & Edwards, 1966; Simpson e t  a l . ,  1978). Furtherm ore, a 
tren d  was noted wherein th i s  s tu d y 's  c o n tro l group had a g re a te r  mean 
leng th  o f an tip sy ch o tic  a d m in is tra tio n , which was a lso  noted by Asnis 
e t  a l .  (1977) and Simpson e t  a l .  (1978). The p resen t study in v e s t i ­
gated  th is  v a ria b le  as p r io r  s tu d ie s  included  post-TD drug d a ta .
Such methodologies consequently f a i le d  to  guard a g a in s t the  p o ssib le  
in te rv en in g  v a r ia b le  of a n tip sy ch o tic  d isco n tin u a tio n  or in c reases  fo r 
p a tie n ts  developing TD. The r e p lic a t io n  o f the  fin d in g  w ith  th is  
s tu d y 's  improved methodology in d ica ted  th a t  such confounding apparen tly  
d id  no t occur and confirms the accuracy of previous f in d in g s .
The v a ria b le  o f maximum a n tip sy ch o tic  dosage per year was 
in v e s tig a te d  to  determ ine i f  th e  co n cen tra tio n  and schedule o f a n t i ­
psychotic  ad m in is tra tio n  provided inform ation not a v a ila b le  from 
exam ination o f the  more gross drug v a ria b le s  d iscussed  above (Smith 
e t  a l . ,  1978). Smith e t a l .  and Crane (1974) found a sm all p o s itiv e  
c o rre la tio n  between maximum amount of an a n tip sy ch o tic  a su b jec t
102
*
received  in  any year and the  s e v e rity  o f TD. T heir find ings m erited  
r e p lic a t io n  in  r e la t io n  to  the  occurrence o f TD due to  th e i r  s p e c i­
f i c i t y  and consistency . This study found no s ig n if ic a n t  d iffe ren c es  
between the  TD and No-TD groups; in  f a c t ,  th e  No-TD group had a 
h ig h e r mean. As a fu r th e r  measure of p o ss ib le  d iffe ren ces  between 
the  experim ental and co n tro l groups on co n cen tra tio n  and schedule of 
a n tip sy ch o tic  a d m in is tra tio n , the  number o f incu rred  changes in  a n t i ­
psychotic  dosage lev e ls  and frequencies o f ad m in is tra tio n  was te s te d . 
The TD g roup 's  mean number o f such changes was 25.19; the No-TD g roup 's  
mean was 42.42. The t  value was -1 .60 and no t s ig n if ic a n t  a t  th e  .05 
le v e l fo r  tw o -ta iled  t e s t  (w ith 25 degrees o f freedom ). A pparently , 
what may e x is t  in  regard  to  TD s e v e r ity  does not e x is t  in  regard  to  
TD occurrence. The two s p e c if ic  v a ria b le s  in v e s tig a te d  appear to  
only provide a d d itio n a l inform ation  on the  c o n tro l group 's a n tip s y ­
ch o tic  ad m in is tra tio n s  as a tren d  fo r  th is  group to  receive  g re a te r  
maximum a n tip sy ch o tic  dosages p e r year and more co n cen tra tio n  and 
schedule changes i s  no ted . This trend  is  c o n s is te n t w ith th e  trends 
and s ig n if ic a n t  find ings o f th e  an tip sy ch o tic  v a r ia b le s  a lready  
d iscussed .
I t  i s  im portant to  no te  th a t  th e  p resen t study found g re a te r  
means fo r  th e  No-TD group on a l l  a n tip sy ch o tic  v a r ia b le s  in v e s tig a te d  
h e re in . Such trends were a lso  found by Simpson e t  a l .  (1978) and 
N ailya e t  a l .  (1979) fo r  the  v a r ia b le  o f cum ulative a n tip sy ch o tic  dose. 
Likew ise, Simpson e t  a l .  and Asnis e t  a l .  (1977) noted s im ila r  trends 
fo r th e  v a r ia b le  of cum ulative length  o f an tip sy ch o tic  a d m in is tra tio n .
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These tren d s , in  conjunction  w ith  the  r e s u l ts  d iscussed  above, a re  
considered s tro n g ly  supportive  of th e  ro le  in d iv id u a l d iffe ren ces  play 
in  the development of TD. The conclusion i s  drawn th a t  in d iv id u a l 
s e n s i t iv i ty  in te ra c t in g  w ith a c r i t i c a l  in g es tio n  o f an tip sy ch o tic  
m edications is  more re la te d  to  the development o f TD than the s p e c if ic  
q u a n tit ie s  o f the  drug v a ria b le s  te s te d . Confirm ation i s  provided fo r 
the  a s s e r t io n  o f Simpson e t  a l .  (1978) th a t  in d iv id u a ls  d i f f e r  g re a tly  
in  the  ab so rp tion  of m edications in to  th e i r  c e n tra l  nervous and blood 
system s, thus "the  m illigram s in g ested  may not g ive a to ta l ly  accu ra te  
in d ic a tio n  of what is  a c tu a lly  occurring  in  the  b ra in "  (p. 123).
The conclusion drawn by both Brandon e t  a l .  (1971) and Jus e t 
a l .  (1976), who in v e s tig a te d  the  re la tio n s h ip  of drug v a ria b le s  to  the  
occurrence of TD, th a t  age was the most s ig n if ic a n t  fa c to r  in  d e te r ­
mining th e  r i s k  of developing TD is  i l l u s t r a t i v e  of such in d iv id u a l 
v u ln e ra b ili ty  p o s tu la ted  by Simpson e t  a l .  (1978). The re la tio n s h ip  
between in d iv id u a l s u s c e p t ib i l i ty  and the  development of TD is  
supported by the neurochemical b asis  hypothesized fo r  TD. Neurochem- 
i c a l ly ,  TD is  understood as a primary dopamine d e fic ien c y , due to  the  
an tip sy ch o tic s  b locking some of th is  n e u ro tra n sm itte r 's  receptor- 
s i t e s  in  the  b ra in , and a secondary dopaminergic h y p e rs e n s it iv ity .
Such a d ec lin e  in  the  dopamine system occurs o rg a n ic a lly  w ith 
in c reaa in g  age as w ell and th e  in g estio n  o f a n tip sy ch o tic s  a re  be lieved  
to  a c c e le ra te  th is  a g e -re la te d  change in  th e  b ra in  (G erlach, 1977). 
Consequently, th e  o ld e r p a t ie n ts  a re  a t  the  i n i t i a t i o n  o f an tip sy ch o tic  
trea tm ent o r as p a tie n ts  rece iv in g  long-term  trea tm en t w ith an tipsycho­
t i c s  age, the  h igher the  r i s k  o f  developing TD.
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Streng th  fo r  concluding th a t  in d iv id u a l s u s c e p t ib i l i ty  i s  of 
g re a te r  importance in  the  development of TD than sp e c if ic  an tipsycho­
t i c  drug v a ria b le s  i s  drawn from the  main m ethodological improvement 
of th e  p resen t study . Namely, ceasing  d a ta  c o lle c tio n  on the  TD 
su b jec ts  w ith the  emergence o f TD. This method i s  c re d ite d  fo r  the 
c o n s is te n t trend  o f g re a te r  a n tip sy ch o tic  v a r ia b le  means fo r  the  No-TD 
group as the  two groups d id  n o t d i f f e r  s ig n if ic a n t ly  on the  leng th  of 
drug and p sy ch ia tr ic  h i s to r ie s .
B. A ntiparkinson Agents
Like the a n tip sy ch o tic  v a r ia b le s ,  the  th ree  an tip a rk in so n  
agent v a ria b le s  te s te d  in  th is  study—mean cum ulative dose, mean 
d a ily  dose, and mean length  o f a d m in is tra tio n —evidenced a trend  
of g re a te r  means fo r  the  No-TD group (see Table 2 ) . The co n tro l 
g roup 's  mean length  o f an tip a rk in so n  a d m in is tra tio n  was s ig n if ic a n t ly  
g re a te r  than th a t  of the  TD group. These fin d ings p a r a l le l  those of 
Simpson e t  a l .  (1978) as they a lso  noted th e  tren d  of g re a te r  mean 
cum ulative dose and mean leng th  o f ad m in is tra tio n  fo r  th e i r  matched 
c o n tro l group. They noted a very  s l ig h t ,  and in s ig n if ic a n t ,  h igher 
mean d a ily  dose fo r  the  TD group. Conversely, Mallya e t  a l .  (1979) 
found mean cum ulative dose and mean leng th  o f an tip a rk in so n  adm inis­
t r a t io n  to  be s ig n if ic a n t ly  g re a te r  fo r  the  TD group than fo r  the  
matched co n tro l group. This d iscrepancy more than  l ik e ly  r e f le c ts  
m ethodological d iffe ren c es  as th e  in v e s t ig a tio n  o f Mallya e t  a l .  
was lim ited  to  only two an tip a rk in so n  agents over about e ig h t years
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of trea tm ent w hile Simpson e t  a l .  (1978) and the  p resen t study were 
more comprehensive, examining a l l  an tip a rk in so n  agents adm inistered  
throughout the s u b je c ts ' e n t i r e  trea tm en t h is to r ie s  (about 15 years 
fo r  both s tu d ie s ) .
The p re sen t study found g re a te r  mean d iffe ren ces  between the  
TD and No-TD groups' an tip a rk in so n  v a r ia b le s , w ith h ig h e r means fo r 
the  co n tro l group. These find ings a re  more d e f in i t iv e  than the  
s im ila r  trend  noted by Simpson e t  a l .  (1978); th is  d iffe ren c e  in  
s p e c i f ic i ty  is  a t t r ib u te d  to  the  d isco n tin u a tio n  o f da ta  c o lle c tio n  
fo r  the TD su b jec ts  in  th is  study w ith  th e  emergence o f TD. The 
in v e s t ig a tio n  o f Simpson e t  a l .  was completed in  1977 when the  
treatm ent o f TD w ith  an tip a rk in so n  agen ts was s t i l l  w idely p ra c tic e d  
(J e s te  & W yatt, 1979). T heir in c lu s io n  o f post-TD an tip a rk in so n  
agent h is to r ie s  more than  l ik e ly  accounts fo r  th e i r  fin d in g  a s l ig h t ly  
h igher an tip a rk in so n  mean d a ily  dose fo r  the  TD group. I t ' s  in te re s t in g  
to  no te  th a t  even w ith the  in c lu s io n  o f post-TD d a ta , Simpson e t  a l .  
d id  no t f in d  s ig n if ic a n t ly  more an tip a rk in so n  agent usage fo r the  TD 
group. In  f a c t ,  they noted trends fo r the  co n tro l group to  have 
g re a te r  means on th e  an tip a rk in so n  agent v a r ia b le s .
There a re  sev e ra l reasons re sea rch ers  could expect to  fin d  
s ig n if ic a n t  re la tio n s h ip s  between the occurrence o f TD and a n tip a rk in ­
son agent usage. C urren tly  the  s tro n g e s t r a t io n a le  i s  psychopharma- 
co lo g ica l as an tip a rk in so n  agents a re  a n tic h o lin e rg ic s  which could 
exaggerate an imbalance between th e  c h o lin e rg ic  and dopaminergic 
systems r e s u lt in g  in  fu r th e r  increased  dopamine r e la t iv e  to  th e
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decreased ace tycho line  (B orison, 1979). Another r a t io n a le  is  the 
c o rre la tio n  repo rted  between parkinsonism  and TD (Crane, 1972) in d i­
ca tin g  th a t  p a tie n ts  developing TD have had a g re a te r  h is to ry  of EPS, 
which i s  tre a te d  w ith  an tip a rk in so n  ag en ts , than p a tie n ts  not 
developing TD.
The p resen t study provides no support fo r ,  and consequently 
r a is e s  questions about, such r a t io n a le s .  This s tu d y 's  find ings of 
an tip a rk in so n  agent usage to  be more re la te d  to  th e  absence o f TD 
than to  the  presence o f TD has some psychopharmacological im p lica tio n s . 
Mallya e t  a l .  (1979) viewed th e i r  find ing  a s trong  re la tio n s h ip  between 
an tip a rk in so n  agent usage and the  development o f TD as c l in ic a l  c o n f ir ­
mation of th e  work of Klawans & Rubovits (1974). Klawans & Rubovits 
hypothesize th a t  an tip a rk in so n  treatm ent may in c rease  th e  occurrence 
o f TD by reducing the  th resh o ld  fo r  the  development o f TD. The 
p resen t s tu d y 's  r e s u l ts  do no t support such a causal re la tio n s h ip  
between an tip a rk in so n  agent usage and the  incidence of TD. I t  appears 
th a t  Mallya e t  a l .  (1979) were overly  conclusive given th e i r  f a i lu re  
to  d isco n tin u e  da ta  c o lle c tio n  fo r the  TD su b jec ts  w ith  th e  emergence 
o f TD. This is  of g re a t im portance given th a t  ad m in is tra tio n  of 
an tip a rk in so n  agents was p rev iously  a standard  treatm ent fo r  TD.
This s tu d y 's  r e s u l ts  provide fu r th e r  evidence th a t  TD most 
probably r e s u l ts  from a fu n c tio n a l prim ary dopamine d e fic ien cy , w ith 
a secondary dopamine h y p e rs e n s it iv ity  (G erlach, 1977), due to  in d iv id u a l 
v u ln e ra b il i ty  to  th e  dopam ine-depleting mechanisms of an tip sy ch o tic s  
ra th e r  than a dopamine excess in  r e la t io n  to  an an tip a rk in so n  agen t-
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Induced ch o lin e rg ic  red u c tio n . Such an in te rp re ta t io n  does no t negate 
the  hypothesis o f Klawans and Rubovits (1974) th a t an tip a rk in so n  
agents may in c rease  the s e v e r ity  of TD as th is  was not examined h e re in . 
This hypothesis o f increased  se v e rity  i s  in  concurrence w ith  th e  
in d iv id u a l s u s c e p t ib i l i ty  in te rp re ta t io n  provided as Klawans and 
Rubovitz sp ec ify  th a t  increased  se v e rity  is  most l ik e ly  to  occur w ith 
" a n tic h o lin e rg ic  therapy in  p a tie n ts  prone to  developing TD" (p . 941).
I f  an tip a rk in so n  agents do m ediate the development of TD, th is  r e l a ­
tio n sh ip  would be, as is  tru e  fo r  a n tip sy ch o tic s , a m atter of in d iv id u a l 
v u ln e ra b il i ty  ra th e r  than q u a n tita tiv e  amounts o f an tip a rk in so n  agent 
v a r ia b le s .
This s tu d y 's  fin d in g  o f g re a te r  an tip a rk in so n  usage fo r  the 
co n tro l group i s  understood as a r e s u l t  of the  co n tro l group a lso  
having a s ig n if ic a n t ly  g re a te r  number o f EPS incidences as  w ell as 
a trend  towards g re a te r  amount of days on which extrapyram idal 
symptoms were experienced. Such find ings in d ic a te  th a t an tip a rk in so n  
m edications a re  probably more re la te d  to  the  incidence o f  EPS than 
to  the  presence o r absence of TD. This in te rp re ta t io n  i s  fu r th e r  
supported by the  trend  fo r  a l l  an tip sy ch o tic  v a ria b le s  te s te d  to  be 
g re a te r  fo r  the  co n tro l group. This is  in d ic a tiv e  of th e  r e la t io n ­
sh ip  o ften  evidenced between g re a te r  usage of an tip sy ch o tic s  and 
increased  EPS occurrences r e s u lt in g  in  g re a te r  an tip a rk in so n  agent 
usage (Simpson e t  a l . ,  1978).
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C. Drug-Free Periods
No d iffe ren c e  was found between the TD and No-TD groups on 
e i th e r  th e  mean incidences o f  two month periods f r e e  o f an tip sy ch o tic s  
o r on th e  mean days fre e  o f an tip sy ch o tic s ; a tren d  was noted fo r the 
No-TD group to  have more d ru g -free  days. I t  is  concluded, th e re fo re , 
th a t  the  number of d ru g -free  two month periods and cum ulative number 
o f d ru g -free  days a re  not r e la te d  to  the  presence o r absence of TD.
J e s te  e t  a l .  (1979) found the  cum ulative number of d ru g -free  
two month periods to  be th e  b e s t d isc r im in a to r between re v e rs ib le  and 
p e r s is te n t  TD groups. To d a te , no epidem iological study has determined 
i f  th is  fin d in g  is  a p p licab le  in  d i f f e r e n t ia t in g  between TD and No-TD 
groups. The p resen t s tu d y 's  r e s u l ts  in d ic a te  th a t  i t  i s  not a p p lic a ­
b le  as both th e  TD and No-TD groups incu rred  a mean of 3.04 d ru g -free  
two month periods. This s tu d y 's  find ings a lso  in d ic a te  th a t  d ru g -free  
periods o r d ru g -free  days a re  no t an e f fe c t iv e  p rev en ta tiv e  measure 
a g a in s t TD as the  co n tro l and experim ental groups did no t d i f f e r  
s ig n if ic a n t ly  on these  v a r ia b le s .
J e s te  e t  a l .  (1979) p o in t out th a t  in c reases  in  th ese  d ru g -free  
v a r ia b le s  may indeed in c rease  th e  r i s k  of developing p e r s is te n t  TD fo r 
p a tie n ts  a lread y  predisposed to  developing th e  d iso rd e r . They postu­
la te  a "k in d lin g "  e f f e c t—i . e . , increased  s e n s i t iz a t io n —th a t occurs 
in  response to  in te rm itte n t ad m in is tra tio n  o f  an tip sy ch o tic s  as an 
exp lanation  of th e i r  f in d in g s . The conclusions o f J e s te  e t  a l .  and 
o f  the  p re sen t study in d ic a te  th a t  lengthy a n tip sy ch o tic  treatm ent 
in te rru p tio n s  should be avoided in  favor o f c o n s is te n t, maintenance
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treatm ent w ith  only sh o rt In te r ru p tio n s , when necessary , c u r ta i le d  to  
a span o f sev e ra l days o r more.
D. Polypharmacy
Four types o f polypharmacy were In v es tig a ted : an an tipsycho­
t i c  plus an a n tip sy c h o tic , an a n tip sy ch o tic  p lus an an tip ark in son  
ag en t, an an tip sy ch o tic  p lus an a n tid e p re s sa n t, and an a n tip sy ch o tic  
plus lith iu m  (see Appendix A ). Another kind of polypharmacy, the  
number of d if f e r e n t  an tip sy ch o tic s  and d if f e r e n t  an tip a rk in so n  
agents adm inistered  to  each subject^ was a lso  examined.
No s ig n if ic a n t  d iffe ren c es  were found between the  TD and No-TD
groups in  the  mean number o f in c id en ces, in  any o f the  four c a te g o rie s , 
o f polypharmacy a t  e i th e r  o f the  two d a ily  chlorpromazine equ ivalen ts  
(CFZE) c r i te r io n  dosage le v e ls  o f 0 mg. and 100 mg. This was a lso  the  
case fo r  the  mean number o f  to ta l  incidences o f polypharmacy a t  each 
of the  d a ily  CFZE c r i te r io n  le v e ls  (see Table 3 ) . A very c o n s is te n t
tren d  was noted wherein th e  No-TD group had h ig h er incidences of
polypharmacy in  every category , and to ta l ly ,  fo r  each dosage le v e l . 
F u rther analyses in d ica ted  th is  trend  is  tru e  fo r  CFZE c r i te r io n  dosage 
le v e ls  o f 500 mg. and 1000 mg. as w e ll. The mean d u ra tio n  of po ly­
pharmacy on any of the  fou r c a te g o rie s , a t  a l l  four d a ily  CFZE dosage 
le v e ls ,  was a lso  examined. No s ig n if ic a n t  d iffe ren c es  were found 
between th e  TD and No-TD groups. Also th e re  was no t a s ig n if ic a n t  
d iffe re n c e  between the  two groups in  the  number o f su b jec ts  rece iv in g  
polypharmacy o f any category  a t  any dosage le v e l .  Consequently, 
support i s  provided fo r  th e  fin d in g  of Jus e t  a l .  (1976) o f no
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s ig n if ic a n t  d iffe re n c e  between th e i r  unmatched TD and No-TD groups on 
the  number o f  " c o c k ta ils "  received  (concomitant a d m in is tra tio n  of two 
or more a n tip sy c h o tic s ) . Their fin d in g  was questioned  as the  opera­
t io n a l iz a t io n  o f " c o c k ta il"  was q u ite  le n ie n t n e c e s s ita tin g  only a 
one month a d m in is tra tio n  o f polypharmacy w ith  d a ily  CPZE of a t  le a s t  
100 mg. The p resen t study used a more rigorous o p e ra tio n a liz a tio n  as 
a two month ad m in is tra tio n  of polypharmacy was necessary . Furtherm ore 
h ig h e r(500 & 1000 mg.) d a ily  CFZEs and mean d u ra tio n  o f polypharmacy 
of a l l  CPZE le v e ls  were a lso  in v e s tig a te d . This study was more 
in c lu s iv e  as the  four d i f f e r e n t  c a teg o rie s  o f polypharmacy were 
in v e s tig a te d  and a l l  were included in  the  t o t a l  incidences v a r ia b le . 
Examining polypharmacy a t  a d a ily  CPZE of 0 mg.—i . e . ,  no c r i te r io n  
dosage le v e l—a lso  expanded th is  s tu d y 's  in v e s t ig a tio n  of polyphar­
macy as compared to  th a t  o f Jus e t  a l .  (1976). F in a lly ,  post-TD drug 
da ta  was no t included fo r e i th e r  the  TD or No-TD groups, thus providing 
g re a te r  c e r ta in ty  th a t  th e  s tu d y 's  r e s u l ts  a re  not confounded by 
trea tm ent changes made. In  l ig h t  o f th e  p resen t s tu d y 's  a d d itio n a l 
m ethodological fe a tu re s , expanded in v e s t ig a tiv e  focus, and the  
find ings being supportive  o f Jus e t  a l . ,  i t  i s  very probable th a t  the  
a d m in is tra tio n  of polypharmacy as defined  h e re in  is  not re la te d  to  
the  occurrence o f TD.
The ra t io n a le  fo r  examining polypharmacy was p rim arily  based 
on th e  ex p ec ta tion  th a t  g re a te r  a n tip sy ch o tic  usage would be found 
among p a tie n ts  w ith  TD to  account fo r  the  dopamine s u p e rse n s i t iv ity  
hypothesized as the  neurochem ical b a s is  o f TD ( J e s te  & W yatt, 1979).
The above find ings on polypharmacy do not negate such a  neurochemical 
b a s is . They do, however, provide cause to  question  a pred isposing  
re la tio n s h ip  between g re a te r  an tip sy ch o tic  usage and th e  occurrence 
o f TD. This p a ra l le l s  a l l  the drug v a ria b le  find ings d iscussed  in  
the  previous s e c tio n s . This study has c o n s is te n tly  found le ss  a n t i ­
psychotic and an tip a rk in so n  agent usage—whether in  the  form o f 
dosage le v e ls ,  leng ths of a d m in is tra tio n , or polypharmacy—among the  
TD su b je c ts . The r e s u l ts  o f the  polypharmacy analyses a re  th e re fo re  
in te rp re te d  as fu r th e r  support fo r  th e  re la tio n sh ip  of TD to  in d iv id u a l 
v u ln e ra b ili ty  ra th e r  than sp e c if ic  drug q u a n titie s  or com binations.
The fa c t  th a t  a trend  was noted fo r  g re a te r  polypharmacy among the  . 
No-TD su b jec ts  i s  in te rp re te d  as p a ra l le l in g  the  fin d in g s  of g re a te r  
an tip sy ch o tic  and an tip a rk in so n  agent usage in  general fo r  the No-TD 
group (see Table 2 ).
No s ig n if ic a n t  d iffe ren c e  was found in  the  mean number o f 
d if f e r e n t  an tip sy ch o tic s  adm inistered  between the  TD and No-TD groups 
(see Table 4 ) . In  f a c t ,  a trend  was noted fo r  the  co n tro ls  to  rece iv e  
a g re a te r  number. Again, th is  i s  r e f le c t iv e  of the  g re a te r  a n t i ­
psychotic usage found in  g en era l fo r  th e  No-TD group. The co n tro l 
group d id  rece iv e  a s ig n if ic a n tly  g re a te r  number o f an tip a rk in so n  
agents than the  TD group (see Table 4 ) . This i s  considered  r e f le c t iv e  
of the  s ig n if ic a n t ly  g re a te r  number o f incidences o f extrapyram idal 
symptoms (EPS) and the  s ig n if ic a n t ly  g re a te r  leng th  o f an tip a rk in so n  
agent a d m in is tra tio n  found fo r  the  No-TD groups. I t ' s  q u ite  p o ss ib le  
th a t ,  g iven more EPS and an tip a rk in so n  agent trea tm en t, the No-TD
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su b jec ts  were tre a te d  by a v a r ie ty  o f physicians who p re fe rre d  p re ­
s c r ib in g  d if f e r e n t  ag en ts . A lso, s in ce  the  No-TD su b jec ts  were 
tre a te d  over a longer period o f tim e, i t  i s  p o ssib le  th a t  new agents 
became a v a ila b le  to  p re sc rib in g  p h y sic ians.
Other D escrip tiv e  C h a ra c te r is tic s
A. H isto ry  of Extrapyram idal Symptoms (EPS)
C rane's (1974, 1978) p red isposing  re la tio n s h ip  between EPS 
and the development of TD was no t supported by the  p resen t study.
The No-TD group evidenced a trend  of more su b jec ts  developing EPS 
fo r  longer periods of time than the  TD group (see Table 8 ) . In  f a c t ,  
the co n tro l group had a s ig n if ic a n t ly  g re a te r  number o f EPS incidences 
than th e  TD group. One exp lanation  of th is  r e s u l t  may l i e  in  the 
find ing  o f mean number o f d ru g -free  days. A "reverse  to le ran ce"  
phenomenon is  hypothesized by Sovner & DiMascio (1978) wherein 
in te rru p ted  a n tip sy ch o tic  trea tm ent regimens may in c rease  th e  occur­
rence o f  EPS. A lso , the  mean d a ily  a n tip sy ch o tic  dose of th e  co n tro l 
group was s ig n if ic a n t ly  g re a te r  than th a t  o f the  experim ental group. 
Consequently, i f  th e  incidence o f EPS is  d o se - re la te d , as o ften  
hypothesized (Simpson e t  a l . ,  1978), i t  follows th a t  the  No-TD group 
would have a g re a te r  number o f su b jec ts  developing more incidences o f 
EPS which la s te d  fo r  longer periods than  i s  tru e  fo r the  TD group.
Another p o ss ib le  exp lanation  of th is  r e s u l t  may be due to  
record-keeping procedure changes. About 2 years ago, E astern  S ta te  
H o sp ita l adopted a problem -oriented system of reco rd ing  p a tie n t in fo r -
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mation. This procedure involves an in c rease  in  symptom d e sc rip tio n s  
which r e s u l ts  in  a g re a te r  amount of in fo rm ation . Data c o lle c tio n  
ceased fo r  the  m ajo rity  of TD su b jec ts  (n=17) p r io r  to  1978; the 
co n tro l s u b je c ts ' da ta  c o lle c tio n  a lso  ceased according to  th e i r  
m atches' c u t-o f f  d a te s . Such e q u a liza tio n  of c u t-o f f  dates makes 
th is  exp lanation  u n lik e ly .
A f in a l  exp lanation  of th e  co n tro l g roup 's  g re a te r  EPS in c i ­
dence l i e s  in  the  p o s s ib i l i ty  th a t  in d iv id u a l 's  prone to  the  develop­
ment o f TD may develop a very  b r ie f  form o f EPS th a t  i s  le ss  l ik e ly  to  
be mentioned in  the  h o s p ita l  c h a r ts . Dystonic re a c tio n s  occur w ith in  
1 to  3 days o f trea tm ent i n i t i a t i o n  o r changes. They can be e f fe c t iv e ly  
tre a te d  immediately w ith an in je c t io n  o f an an tip a rk in so n  agent (Sw ett, 
1975). Only one in s tan ce  o f th is  form of EPS was d e tec ted  in  the  
record ing  of EPS h is to r ie s  fo r th is  study ; i t  was incurred  by a TD 
s u b je c t. This i s  an extrem ely low incidence o f 17. when compared to  
S w ett's  (1975) find ing  the  incidence o f dyston ic  reac tio n s  among 
in p a tie n ts  to  be 10.17.. Consequently, i t  i s  very probable th a t  
unrecorded dyston ic  re a c tio n s  occurred among the  p resen t s tu d y 's  
s u b je c ts . Furtherm ore, i t  i s  p o s tu la ted  th a t  dyston ic  re a c tio n s  may 
be more common among p a tie n ts  prone to  developing TD (Simpson e t  a l . ,  
1978). This form of EPS, l ik e  TD, is  ag e-, sex -, and in d iv id u a l 
s e n s itiv ity - re la te d (S o v n e r  & DiMascio, 1978). Unlike the o th e r forms 
of EPS, dyston ic  reac tio n s  d i f f e r  in  e tio lo g y  from the  dopaminergic- 
ch o lin e rg ic  balance hypothesis which a s s e r ts  th a t  a s h i f t  to  ch o lin e rg ic  
excess r e s u l ts  in  EPS. Conversely, d y ston ic  re a c tio n s  a re  c u rre n tly
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understood as a r e s u l t  o f the  "h y p e rac tiv ity  o f dopaminergic neurons 
caused by the  i n i t i a l  in c rease  in  the  tu rnover and sy n th esis  of 
dopamine" (Sovner & DiMascio, 1978, p. 1025). This i s  a lso  the  
hypothesized neurochemical s ta t e  of TD (J e s te  & W yatt, 1979). In  
f a c t ,  dyston ic  reac tio n s  were once commonly re fe rre d  to  as t r a n s ie n t  
dysk inesias as th is  form of EPS p resen ts  in  a manner very  s im ila r  to  
TD. U nfortunate ly , d a ta  enough to  t e s t  th e  p o ssib le  ex is ten ce  o f a 
precursory  re la tio n s h ip  of dystonic  rea c tio n s  to  the  eventual develop­
ment of TD was not generated  by the  p re sen t study . N onetheless, th is  
f in a l  exp lanation  o f th e  fin d in g  of s ig n if ic a n t ly  more EPS incidences 
fo r  the No-TD group is  the  one a sse r te d  h e re in .
According to  the  find ings of Chouinard e t  a l .  (1979) concerning 
the  re la tio n s h ip  o f EPS type to  the even tual development of TD, the 
TD su b jec ts  should evidence a preponderance of extrapyram idal symptoms 
ra te d  as h y p erk in e tic  and the  co n tro l su b jec ts  extrapyram idal symptoms 
ra te d  as hypok ine tic . No s ig n if ic a n t  d iffe ren c es  were found between 
the  con tro l and experim ental groups on th e  ra tin g s  o f EPS inc idences. 
Trends, however, were no ted . As a group, th e  TD su b jec ts  d id  have more 
EPS incidences and more days o f h y p e rk in e tic  than hypokinetic  o r mixed 
extrapyram idal symptoms (see Table 8 ) . The co n tro l s u b je c ts , however, 
d id  no t have more hypokinetic  than  h y p e rk in e tic  o r mixed symptoms. 
Furtherm ore, such trends were not noted between th e  groups. Since 
Chouinard e t  a l .  (1979) in v e s tig a te d  only the  cu rren t EPS o f th e i r  
su b je c ts , the most recen t EPS occurrences of th is  s tu d y 's  su b jec ts  
were a lso  examined. The TD group again  evidenced a tren d  fo r  th e i r
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most recen t incidences o f EPS to  be ra te d  h y p e rk in e tic ; the  co n tro l 
group d id  not have a trend  o f t h e i r  recen t EPS episodes being ra te d  
hypok inetic . No s ig n if ic a n t  d iffe ren c es  between groups were found.
Due to  the  trends found fo r  the  TD group, some support fo r  Chouinard 
e t  a l . ' s  p o s tu la te  o f  h y p e rk in e tic  types o f EPS being p recu rso rs  o f 
TD is  provided. Due to  the  lack  o f s im ila r  trends fo r  the  co n tro l 
group, support was not found fo r Chouinard e t  a l . ' s  proposal th a t  
hypokinetic  types o f EPS might reduce th e  occurrence o f TD.
An exp lanation  of th is  s tu d y 's  lack  of support fo r  Chouinard 
e t  a l . ' s  find ings more than l ik e ly  i s  re la te d  to  th e i r  focus on EPS 
co ex is tin g  w ith TD and th is  s tu d y 's  focus on the  h i s to r ic a l  r e la t io n ­
sh ip  between EPS and the  development o f TD. Another fa c to r  th a t  may 
have produced th is  lack  o f support i s  the  f a c t  th a t  th is  study 
attem pted to  determ ine EPS occurrences from behav io ral n o ta tio n s  and 
d o c to r 's  no tes in  the  h o s p ita l  c h a r ts .  On th e  o th e r hand, Chouinard 
e t  a l .  were ab le  to  d i r e c t ly ,  and probably more a c c u ra te ly , a ssess  
the  c u rren t type o f EPS th e i r  su b jec ts  were experiencing . A f in a l  
exp lanation  is  th a t  in d iv id u a ls  d o n 't  always experience the same form 
o r type o f EPS each time they develop EPS. However, th is  exp lanation  
i s  doubtfu l as the  most re cen t EPS episodes of the  TD and No-TD groups 
h e re in  were te s te d  as was the  mean number o f days on which e x tra ­
pyramidal symptoms were experienced . These v a ria b le s  would have more 
than l ik e ly  tapped any inform ation  overlooked by the  broader v a r ia b le  
of EPS inc id en ces. Consequently, the  conclusion i s  drawn th a t ,  
although trends s im ila r  to  those o f Chouinard e t  a l .  were found fo r
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th e  TD group, the  design and methodology o f both th is  and Chouinard 
e t  a l . ' s  study a re  Inadequate. In  o rder to  determ ine the ex isten ce  
o f a p red isposing  or Inverse  re la tio n s h ip  between EPS h is to ry  and the  
development of TD, a p rospective  study Is  necessary . Confidence could 
then be gained about the  exact form and type o f extrapyram idal symptoms 
experienced by p a tie n ts  who subsequently  develop TD. Only then  could 
cau sa l re la tio n sh ip s  be proposed.
B. P sy c h ia tr ic  Behavior P a tte rn  (PBP)
The v a ria b le  o f p sy c h ia tr ic  behavior p a tte rn  was in v e s tig a te d  
to  guard a g a in s t d i f f e r e n t i a l  d iag n o stic  d i f f i c u l t i e s  th a t  a re  inheren t 
in  the  assessm ent o f EPS. Such assessm ent i s  obviously necessary  fo r  
an in v e s tig a tio n  o f the  re la tio n s h ip  between EPS and the  subsequent 
development o f TD (David & Cole, 1975; Donlon & Stenson, 1976; L esser 
& Fahn, 1975; R ifk in  e t  a l . ,  1975). Recognizing these  d i f f i c u l t i e s  
as p resen t fo r  diagnosing cu rren t EPS, i t  was re a liz e d  th a t  the  
d i f f i c u l t i e s  would be even g re a te r  when attem pting  to  determ ine h i s ­
to r i c a l  EPS episodes from h o s p ita l  reco rd s. Furthermore such records 
seldom la b e l EPS as such; in s tead  symptom d e sc rip tio n s  a re  provided.
P sy c h ia tr ic  behavior p a tte rn s  were ra te d  as hy p o k in e tic , 
h y p e rk in e tic , mixed, none, o r unknown. S ig n if ic a n tly  more o f th e  TD 
s u b je c ts ' p sy c h ia tr ic  behavior p a tte rn s  (n=242) were ra te d  unknown
as compared to  the  No-TD s u b je c ts ' p sy c h ia tr ic  behavior p a tte rn s  
2(n=173) (X =12.39; DF=1; p < .0 1 ) .  Consequently, c a lc u la tio n s  between 
th e  two groups were only c a rr ie d  out on th e  known p sy c h ia tr ic  behavior 
p a tte rn s  (see Table 8 ) .
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There were no s ig n if ic a n t  d iffe ren c es  between the  TD and No-TD 
groups' number o f known FBPs ra te d  hy p o k in e tic , h y p e rk in e tic , mixed, 
or none. In  f a c t ,  th e re  was a tren d  fo r  the  TD su b jec ts  to  have 
more PBPs ra te d  hypok inetic  than h y p e rk in e tic . This trend  i s  in  
d i r e c t  c o n tra s t to  the  p redisposing  and in v erse  re la tio n s h ip  o f , 
re sp e c tiv e ly , h y p e rk in e tic  and hypokinetic  extrapyram idal symptoms to  
th e  subsequent development of TD p o s tu la ted  by Chouinard e t  a l .  (1979).
As w ith the  EPS h i s to r ie s ,  th e  most recen t PBPs of th is  
s tu d y 's  su b jec ts  were examined due to  Chouinard e t  a l . ' s  in v e s tig a tin g  
only cu rren t EPS. A w ith in  group tren d  s im ila r  to  the re la tio n s h ip  
id e n t i f ie d  by Chouinard e t  a l .  was found fo r  the  TD su b jec ts  as more 
of the  recen t PBPs were ra te d  h y p e rk in e tic  than hypok inetic ; however, 
the  m ajority  o f th ese  PBPs were ra te d  mixed. Furtherm ore, the  No-TD 
g roup 's  m ajority  o f recen t PBPs were ra te d  h y p e rk in e tic , r a th e r  than 
hypokinetic  as could be expected from the  fin d in g s  of Chouinard e t 
a l .
More than l ik e ly  the  fa c t  th a t  467o of the  TD su b jec ts  and 35% 
o f the  No-TD su b jec ts  PBPs were ra te d  as unknown is  resp o n sib le  fo r 
th e  find ings on th is  v a r ia b le . Although c a lc u la tio n s  were co rrec ted  
fo r  th is  lack  o f inform ation  by using only known ra t in g s ,  th is  does 
no t change the  f a c t  th a t  a major amount of inform ation  was found 
lack ing  in  the h o s p ita l  c h a r ts . Consequently, not much weight can be 
given to  these  r e s u l t s .
C. I n i t i a l  P sy c h ia tr ic  Behavior P a tte rn  (IPBP)
The re la tio n s h ip  of i n i t i a l  p sy c h ia tr ic  behavior p a tte rn s  to  
subsequent extrapyram idal symptoms and p sy c h ia tr ic  behavior p a tte rn s  
was examined to  determine i f  p a r t ic u la r  behavior p a tte rn s  were re la te d  
to  the  presence o r absence of TD. Based on the  works of F ried h o ff e t  
a l .  (1960), Van P utten  (1978), Crane (1972,, 1978), and Chouinard e t 
a l .  (1979), i t  was hypothesized th a t p a tte rn s  involving hypokinetic  
IPBPs followed by h y p e rk in e tic  extrapyram idal symptoms or p sy c h ia tr ic  
behavior p a tte rn s  would be found more o ften  in  the h is to r ie s  o f TD 
su b je c ts . Likew ise, based on the same works c i te d ,  i t  was hypothe­
sized  th a t  p a tte rn s  involved in  h y p e rk in e tic  IPBPs followed by hypo­
k in e tic  extrapyram idal symptoms and p sy c h ia tr ic  behavior p a tte rn s  would 
be found more o f te n  in  the  h is to r ie s  o f the No-TD s u b je c ts . Evidence 
fo r the  ex is ten ce  of e i th e r  o f these  p a tte rn s  was no t provided by 
th is  study . Table 8 in d ic a te s  how compromising th e  r e s u l ts  a re . One 
exp lanation  fo r the  lack  o f s ig n if ic a n t  fin d ings is  the  la rg e  amount 
of inadequate inform ation  found fo r  the  PBPs.
Although th is  study fa i le d  to  dem onstrate th e  r e la t io n s h ip  of 
a  h i s to r ic a l  con tingen t i n i t i a l  p sy c h ia tr ic  behav io ral and extrapyram i­
d a l p a tte rn  to  th e  even tual development of TD, fu r th e r  in v e s t ig a tio n  
is  m erited  fo r  two reaso n s. F i r s t ,  th e  i n i t i a l  p sy c h ia tr ic  p a tte rn  
and subsequent p sy ch ia tric /ex trap y ram id a l p a tte rn s  did n o t in d ic a te  a 
predominant h y p o k in e tic -h y p erk in e tic  p a tte rn  fo r  the  TD su b jec ts  o r 
h y p e rk in e tic -h y p o k in e tic  p a tte rn  fo r  th e  No-TD su b jec ts  as hypothesized. 
However, trends fo r  th ese  hypothesized p a tte rn s  a re  noted when
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p sy ch ia tr ic  behavior and extrapyram idal symptom p a tte rn s  a re  examined 
(see Table 8 ) . TD su b jec ts  d isp lay  a p a tte rn  of hypokinetic  
p sy c h ia tr ic  behaviors^and h y p e rk in e tic  extrapyram idal symptoms. The 
No-TD su b jec ts  d isp lay  a p a tte rn  of h y p erk in e tic  p sy c h ia tr ic  behaviors 
and hypokinetic  extrapyram idal symptoms. Rather than i n i t i a l  p sych i­
a t r i c  p a tte rn , i t  is  p o ss ib le  th a t  p a t ie n ts ' predominant p sy c h ia tr ic  
behavior- - i . e . , predominant behavior p a tte rn  observed w hile not 
experiencing EPS—may in d ic a te  the  form of EPS they may develop and 
th e re fo re  th e i r  r i s k  fo r developing TD. Secondly, the  p re sen t s tu d y 's  
re tro sp e c tiv e  focus c le a r ly  may have led  to  compromising r e s u l t s . As 
w ith the  in v e s tig a tio n  of a re la tio n s h ip  between EPS h is to ry  and 
subsequent development of TD, a p ro sp ectiv e  study i s  the  design  
necessary  to  in v e s tig a te  the  ex isten ce  of con tingen t behav io ral and 
extrapyram idal p a tte rn s  w ith in  groups ev en tua lly  developing and not 
developing TD. Such a design would involve c u rre n t, on-going moni­
to rin g  of behav io ral and extrapyram idal p a tte rn s  and th e re fo re  provide 
much more accu ra te  and r e l ia b le  inform ation .
D. M iscellaneous C h a ra c te r is tic s
C rane 's (1978) a s s e r tio n  th a t  no d a ta  a re  a v a ila b le  on 
gen etic  v a r ia b le s  which could account fo r  d iffe ren ces  in  in d iv id u a l 
s u s c e p t ib i l i ty  to  TD i s  supported by the  p resen t s tu d y 's  fin d in g s .
No d iffe re n c e  was found between th e  TD and No-TD groups on eye co lo r 
or race  (see  Table 9 ) , which may have in d ica ted  a ro le  fo r  gen etics  
in  the  development of TD.
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The TD group was found to  d i f f e r  s ig n if ic a n t ly  from th e  No-TD 
group on the v a ria b le  o f d en ta l s ta tu s  (see Table 9 ) . One TD su b jec t 
had a l l  of h e r tee th  and 4 TD su b jec ts  had some m issing te e th ,  w ithout 
d en tu res. The remaining 21 su b jec ts  had no te e th  and no dentures as 
compared to  only 14 No-TD s u b je c ts . This find ing  supports those of 
Asnis e t  a l .  (1977) and Brandon e t  a l .  (1971) who found s ig n if ic a n t  
a sso c ia tio n s  between edentulousness and th e  presence of TD. The im p li­
cations of such find ings remain u n c lea r. I t  has been proposed th a t 
te e th  a c t  as a b a r r ie r  to  tongue p ro tru s io n , a primary symptom of 
the  b u cca l-lin g u a l-m astic a to ry  form of TD (BLM) (Sutcher e t  a l . ,  1971). 
Consequently, e a rly  BLM symptoms in  p a tie n ts  who have the  m ajo rity  of 
th e i r  te e th  may go unrecognized. D ental s ta tu s  o fte n  ra is e s  the  
question  of d i f f e r e n t ia l  d iagnosis as w e ll. Edentulous e ld e r ly  
p a tie n ts  may appear to  have TD in  the  BLM t r i a d  due to  the gumming 
movements th is  s ta te  o ften  p re c ip i ta te s .  The m ajo rity  of the  edentu­
lous TD su b jec ts  in  the p resen t study were ra te d  as d isp lay in g  TD 
symptomologies in  th e i r  limbs and ex trem itie s  as w ell as in  the  BLM 
t r i a d .  Therefore th is  fin d in g  on d en ta l s ta t e  is  not considered as 
in d ic a tin g  d i f f e r e n t ia l  d iag n o stic  problems. I t  i s  not p o ss ib le  to  
c la r i f y  the  in te rp re ta t io n  of th is  find ing  a t  th is  time as research  
in  th is  area  i s  ra re .  The conclusion i s  drawn, however, th a t  
c l in ic ia n s  need to  be aware of th is  re la tio n s h ip  of d en ta l s t a t e  to  
the  presence o f TD and no t dism iss BLM movements in  an edentulous 
p a tie n t as n o n -in d ica tiv e  o f the presence of TD.
Several o th e r non-hypothesized v a r ia b le s  were in v e s tig a te d .
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Chouinard e t  a l .  (1979) found a n tip sy ch o tic  in e ffe c tiv e n e s s—i . e . ,  
trea tm en t r e s is ta n t  psychosis—to  be s ig n if ic a n t ly  re la te d  to  the  
occurrence of TD. Consequently, any statem ents made about a n t i ­
psychotics being in e f fe c t iv e  fo r  su b jec ts  in  th is  study were recorded. 
Such statem ents were found fo r  5 o f the  TD su b jec ts  and 2 of the  No-TD 
s u b je c ts . This d iffe ren c e  is  no t s ig n if ic a n t ,  however, a trend  
s im ila r  to  th e  find ings o f Chouinard e t  a l .  i s  no ted . This lends 
credence to  the  recommendation o f Chouinard e t  a l .  th a t  p a tie n ts  not 
responding e f fe c t iv e ly  to  a n tip sy ch o tic  trea tm en t should probably be 
t r i e d  on ano ther treatm ent regimen.
The re la tio n sh ip  o f e lec tro co n v u ls iv e  therapy (ECT) to  the  
occurrence o f TD has been addressed by sev e ra l s tu d ie s  (Brandon e t  a l . ,  
1971; Pryce & Edwards, 1966). B rain damage was once thought to  
predispose p a tie n ts  to  the development of TD (Edwards, 1970); conse­
q u en tly , ECT treatm ent became im plicated  as w e ll. A re la tio n s h ip  
between ECT treatm ent and th e  development o f TD was n o t supported by 
the  p resen t study as 6 su b jec ts  in  each group had h is to r ie s  o f ECT 
trea tm en t. Furtherm ore, no s ig n if ic a n t  d iffe ren c es  were found in  
the  number o f ECT trea tm en ts received  by the  TD su b jec ts  (189) and 
No-TD su b jec ts  (200). This fin d in g , c o n s is te n t w ith those of Brandon 
e t  a l .  and Pryce & Edwards, im plies th a t  ECT i s  no t an in te rven ing  
v a r ia b le  in  the  development of TD.
L im ita tions
In  the case o f  ex te rn a l v a l id i ty ,  any re la tio n sh ip s  found can 
be r e l ia b ly  g en era lized  to  s im ila r ly  aged in p a t ie n ts ,  w ith severe  TD,
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and h o sp ita liz e d  in  s ta t e  m ental in s t i tu t io n s .  The ra t io n a le  fo r  such 
r e s t r i c te d  g e n e ra liz a tio n s  l i e s  in  th e  fa c t  th a t  any p a tie n ts  who were 
re le ased  from the  h o sp ita l  a re  obviously  not included  in  th is  study .
To inc lude  such in d iv id u a ls  i s  c le a r ly  beyond the  scope of th is  
study due to  th e  amount o f tim e i t  would involve to  tra c e  down such 
su b jec ts  in  order to  ensure they have not developed TD o r been tre a te d  
fo r  p sy c h ia tr ic  d is tu rbances s in ce  th e i r  re le a se  and consequently 
have in cu rred  the  r i s k  of developing TD. The ro le  th a t  chronic 
in s t i tu t io n a l iz a t io n  may play  in  the  development o f TD can th e re fo re  
n o t be addressed in  th is  study . As Crane (1973) p o in ts  o u t, i t  i s  
probably sa fe  to  assume th a t  " th e  c h ro n ic ity  o f a d isea se  and/or 
in s t i tu t io n a l iz a t io n  w ith the  a tte n d a n t em otional and physical 
d ep riv a tio n "  (p. 395) is  not re sp o n sib le  fo r motor abnorm alities  such 
as TD. This assumption i s  supported by Pryce & Edwards (1966) fin d in g  
the  incidence of TD and abnormal movements s im ila r  to  TD to  be h igher 
fo r  in p a tie n ts  tre a te d  w ith  a n tip sy ch o tic s  than fo r s im ila r  in p a tie n ts  
no t t re a te d  w ith a n tip sy c h o tic s . Thus, TD has come to  be understood 
as a r e s u l t  o f exposure to  a n tip sy ch o tic  m edications ra th e r  than a 
r e s u l t  o f c h ro n ic ity  or in s t i tu t io n a l iz a t io n .  Furtherm ore, TD does 
occur among o u tp a tie n t populations (Asnis e t a l . ,  1977; Chouinard e t  
a l . ,  1979). Given the  s t a t e  o f u n c e r ta in ty , however, concerning the  
e tio lo g y  of TD—even in  l ig h t  o f th e  above f in d in g s—the r e s u l ts  of 
th is  study can be gen era lized  r e l ia b ly  to  s im ila r ly  aged p a t ie n ts ,  
who have severe  TD, and a re  s t i l l  in s t i tu t io n a l iz e d .  Due to  the 
ex post fa c to  design of th is  in v e s t ig a tio n , th e  r e s u l ts  a re  considered
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in d ic a tiv e  of p o te n tia l  p recu rso rs  o f TD which need to  be more d i r e c t ly  
te s te d . Consequently, no conclusions about causa l re la tio n sh ip s  
between the  d e sc r ip tiv e  c h a r a c te r is t ic s  s tu d ied  h e re in  can be drawn 
on the b a s is  of th is  in v e s t ig a t io n 's  r e s u l t s .
Im plica tions fo r  F uture Research
As a sse r te d  by Simpson e t  a l .  (1978), th e  d ire c t  comparison 
w ith in  matched p a irs  of p a tie n ts  w ith TD and p a tie n ts  w ithout TD 
apparen tly  y ie ld s  more d e f in i t iv e  r e s u l t s .  Although no conclusions 
about c a u sa lity  can be drawn due to  th is  s tu d y 's  ex post fa c to  desig n , 
the  co n s is te n t find ings c le a r ly  in d ic a te  a reas  in  need of fu r th e r  
in v e s tig a tio n . Furtherm ore, the  fin d in g  o f s ig n if ic a n t  d iffe ren c es  
on v a ria b le s  p rev iously  d isp lay in g  only trends in  the d ire c tio n  of 
th is  s tu d y 's  r e s u l ts  in d ic a te s  th e  n e c e ss ity  of d iscon tinu ing  d a ta  
c o lle c tio n  w ith th e  emergence o f TD.
C onsisten t r e s u l ts  of g re a te r  q u a n tit ie s  on the  v a ria b le s  
concerning an tip sy ch o tic  usage, an tip a rk in so n  agent usage, and e x tra ­
pyramidal symptom incidence  were found fo r  the  co n tro l group. These 
find ings in d ic a te  th a t  fu tu re  resea rch  e f fo r t s  need to  be focused on 
the  p o s s ib i l i ty  o f in d iv id u a l d iffe ren c es  in  s u s c e p t ib i l i ty  to  th e  
development of TD. TD i s  c le a r ly  re la te d  to  exposure to  a n tip sy ch o tic  
m edications (Crane, 1978); however, th i s  s tu d y 's  find ings o f g re a te r  
an tip sy ch o tic  usage in  th e  co n tro l groups lends fu r th e r  support to  
the  p o s tu la tio n  th a t  in d iv id u a l v u ln e ra b il i ty  accounts fo r  the  occur­
rence o f TD more than g re a te r  q u a n tit ie s  of an tip sy ch o tic s  do (Simpson 
e t  a l . ,  1978). To in v e s t ig a te  the  ex is ten ce  o f  such a s i tu a t io n
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req u ire s  the m onitoring of plasma le v e ls . This i s  necessary  in  o rd er 
to  determ ine i f  in d iv id u a ls  developing TD do indeed have a lower 
to le ran ce  to  a n tip sy ch o tic  in g estio n , and thus a lower TD th resh o ld , 
than in d iv id u a ls  who d o n 't  develop TD (J e s te  & W yatt, 1979).
The most r e l ia b le  design by which TD precurso rs  could be 
in v es tig a ted  involves o b je c tiv e  d iag n o stic  c r i t e r i a  as w ell as 
p rospective  d a ta  c o lle c tio n . However, to  d a te , no such c r i t e r i a  have 
been d e lin ea ted  although th e  near fu tu re  may w itness such a d e lin e ­
a tio n  (Je s te  & W yatt, 1979). P rospective s tu d ie s  in cu r e th ic a l  
problems given the  p o s s ib i l i ty  o f i r r e v e r s ib le  TD and lack  of e f fe c t iv e  
trea tm en t. However, such a decision  must be weighted in  r e la t io n  to  
th is  r i s k  as w e ll as th e  b e n e f it  to  be gained from lo ca tin g  d e f in i te  
p recursors of TD. Only a p rospective  study i s  capable of determ ining 
the  ex istence  o f causal re la tio n sh ip s  between extrapyram idal symptom 
h is to r ie s  and/or in d iv id u a l v u ln e ra b il i ty —i . e . ,  s p e c if ic  plasma 
lev e ls  in  response to  an tip sy ch o tic  a d m in is tra tio n . The find ing  of 
such re la tio n sh ip s  would re p re sen t a g re a tly  needed method fo r 
preventing the development o f  TD. The pharm acological trea tm ent of 
p a tie n ts  determined to  be a t  high r is k  fo r th e  development of TD 
could be a lte re d  in  o rder to  reduce th is  r i s k  s ig n if ic a n t ly .  F u r th e r­
more, the  recen t find ings th a t  th e  id e n t i f ic a t io n  o f e a r ly  warning 
s igns can reduce the  occurrence o f severe and /o r i r r e v e r s ib le  TD 
brings g re a te r  credence to  a p rospective  design (B a ld essarin i & T arsy , 
1978). Under such a design p a tie n ts  would be monitored a t  le a s t  
bi-m onthly fo r ph y sio lo g ica l changes, the  development of EPS, and the
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development of ea r ly  TD symptoms. Such c lo se  m onitoring s p e c if ic a l ly  
d ire c ted  towards the d iagnosis o f TD is  f a r  g re a te r  a t te n tio n  than 
p a tie n ts  no t in  such a study would re c e iv e . In  l ig h t  of th is  c lo se  
sc ru tin y  and the  g rea t p o te n tia l  b e n e f i ts ,  the  question  o f e th ic s  
becomes a h ig h ly  r e la t iv e  is su e .
I f  such a design becomes a p o s s ib i l i ty ,  i t  i s  recommended 
th a t dyston ic  reac tio n s  be given sp e c if ic  a t te n t io n .  This suggestion 
is  based on th e i r  neurochemical s im ila r i ty  to  TD and th e i r  e a rly  
appearance in  response to  the  i n i t i a t i o n  o f an tip sy ch o tic  treatm ent 
(Sovner & DiMascio, 1978).
The re la tio n s h ip  of TD symptom s e v e r ity  to  the  an tip sy ch o tic  
v a r ia b le s  was not in v e s tig a te d  h e re in . However, in  l ig h t  of find ing  
g re a te r  usage o f an tip sy ch o tic s  in  the  co n tro l su b je c ts ' h i s to r ie s ,  
research  focus on the  re la tio n s h ip  of th ese  v a ria b le s  to  TD se v e rity  
is  recommended. S ev erity  has been found to  be s ig n if ic a n t ly  re la te d  
to  cum ulative an tip sy ch o tic  dose (Crane & Smeets, 1974) and maximum 
an tip sy ch o tic  dose per year (Smith e t  a l . ,  1978). I t  i s  p o ss ib le , 
th e re fo re , th a t  in d iv id u a l v u ln e ra b il i ty  to  th e  in g estio n  of a n t i ­
psychotics may determ ine the  development o f TD w hile s p e c if ic  q u a n tit ie s  
o f a n tip sy ch o tic  v a ria b le s  determ ine i t s  s e v e r ity . Consequently, such 
research  focus could a id  in  reducing the  s e v e r ity  o f TD, should i t  
develop, w hile  o th e r research  e f fo r t s  a re  d ire c te d  towards determ ining 
the  p recurso rs o f  TD.
Appendix A
DRUG HISTORY CODES
0 - D rug-free period : Documented time f re e  o f an tip sy ch o tic s  la s t in g
a t  l e a s t  two months.
1 - A ntipsychotic  + an tip sy ch o tic : 2 o r more an tip sy ch o tic s  fo r  a
period  o f a t  le a s t  two months where:
a . to ta l  combined CPZE i s  0 mg p er day,
b . to ta l
day,
combined CPZE is a t le a s t 100 mg per
c . to ta l combined CPZE is a t le a s t 500 mg per
day, and
d . to ta l
day.
combined CPZE is a t le a s t 1,000 mg per
2 - A n tip sy ch o tic (s) + Lithium: A ntipsychotic  p lus lith iu m  fo r  a
period  o f a t  le a s t  two months where:
a . to ta l  combined CPZE is  0 mg p er day,
b . to ta l
day,
combined CPZE is a t le a s t 100 mg per
c . to ta l combined CPZE is a t le a s t 500 mg per
day, and
d . to ta l combined CPZE is a t le a s t 1,000 mg per
day.
3 - A n tip sy ch o tic(s) + t r i c y c l i c  an tid e p re ssan t: A ntipsychotic  p lus a
t r i c y c l i c  a n tid e p ressan t fo r  a period  o f a t  le a s t  
two months where:
a . to ta l  combined CPZE is  0 mg per day,
b . to ta l
day,
combined CPZE is a t le a s t 100 mg per
c . to ta l combined CPZE is a t le a s t 500 mg per
day, and
d . to ta l combined CPZE is a t le a s t 1,000 mg per
day.
4 -  A n tip sy ch o tic (s) + an tip a rk in so n  agen t: A ntipsychotic  p lus an a n t i -
parkinson agent fo r  a  period  o f a t  le a s t  th re e  
months where:
a . to ta l  combined CPZE is  Q mg per day,
b . t o ta l  combined CPZE i s  a t  le a s t  100 mg per 
day,
c . to t a l  combined CPZE i s  a t  le a s t  500 mg per 
day, and
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d . t o t a l  combined CPZE Is  a t  l e a s t  1,000 mg per 
day.
CPZE = Chlorpromazine Equivalence
CPZE CONVERSION EQUATION: 1) Equivalence fa c to r  = 100 /an tip sy ch o tic
equ ivalen t
2) A ntipsycho tic  dosage X Equivalence
fa c to r
(See follow ing pages fo r  an tip sy ch o tic  equ iv a len ts)
CODES FOR OTHER MEDICATIONS:
L - Lithium  
ad - T r ic y c lic  an tid ep ressan t 
ap - A ntiparkinson agent
MEDICAL ABBREVIATIONS:
b . i . d .  - 2 times a day
t . i . d .  - 3 times a day
q . i . d .  - 4 times a day
p .o . - by mouth
h .s .  - a t  bedtime 
p . r .n .  - as needed 
s t a t  - immediately
NOTE: Any d iscrep an c ies  between p h y s ic ian s ' orders and n u rse s ' records
a re  to  be reso lved  in  fav o r o f th e  n u rse s ' re c o rd s .
ANTIPSYCHOTICS
AVG. DAILY
DOSE (mg)* GENERIC NAMES CODES TRADE NAMES CPZE*
(cpzslOOmg)
PHENOTHIAZINES
169 Acetophenazine ACE T indal 23
66 B utaperazine BUT Repoise 9
183 Carphenazine CAR Proketazine 25
734 Chlorpromazine CPZ Thorazine, Chlor-PZ, 
Prompapar, L a rg a c til
100
9 Fluphenazine PX P ro lix in , P e rm ltl l ,  
Moditen
1.2
5 Fluphenazine
Decanoate
PXD P ro lix in  decanoate, 
Modecate decanoate
.61
5 Fluphenazine
Enanthate
PXE P ro lix in  enan th a te , 
Moditen enanthate
.67
411 M esoridazine SNT S e re n ti l 56
66 Perphenazine TRL T rlla fo n 9
80 P lp erace taz ln e QD Qulde 11
103 Proch lo rperazine CPO Compazine, S tem etil 14
400 Promazine SPAR Sparine 100+
712 T hio ridazine ML M e lla r i l 97
20 T riflu o p e raz in e STL S te la z in e 2 .8
205 Trlfluprom azlne VES V esprin 28
NONPHENOTHIAZINES:
323 C hlorprothlxene TAR T aractan , Tarasan 44
12 H aloperido l HD H aldol 1.6
64 Loxapine LX L oxitane, Loxltane C, 
Loxapac, Daxolin
8.7
44 Molindone LID Lldone, Moban 6
32 Thiothixene NV Navane 4 .4
4 RESERPINE RES S e rp a s ll ,  S an d rll 2+
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AVERAGE DAILY
ANTI-PARKINSONISM AGENTS++ CODES TRADE NAMES DOSE MG**
P rocyclid ine  Hydrochloride K Kemadrin 6 - 2 0
Benztropine M esylate C Cogentine 1 - 6
Trihexyphenidyl A A rtane, A ntitrem , 
P ipano l, Tremln
5 - 1 5
Diphenhydramine B Benadryl 25 - 100
B lperlden AK Akineton 2 - 6
Amantadine S Symmetrel 100 - 300
Orphenadrlne N D is ip a l, N orflex 300
Ethopropazine P P ars id o l 50
ANTIDEPRESSANT DRUGS
Deslpramlne DS Norpramin, P e rto fran e  75 - 300
N o rtr ip ty lin e AV A ventyl, Pamelor 50 - 150
P ro tr ip ty l in e PRO V iv a c ti l ,  T r ip t i l 10 -  60
A m itrip ty lin e EL E la v il ,  Endep 75 - 300
Imipramine TOF T o fra n il , Im avate, 75 - 300 
Presamine, Janim ine, 
Tofranil-PM , SK-Pramine
Doxepin DX Sinequan, Adapin 75 - 300
ANTIMANIC DRUG++
Lithium  Carbonate L L ithane , L ith o n a te , 
L ith o tab s , E sk a lith
600 -  3600
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PSYCHOTROPIC DRUG COMBINATIONS-H- CODES
Perphenlzlne + A m itrip ty lin e  T r ia v il  TRI
Chlordiazepoxide + A m itrip ty lin e  L im bitro l LIM
* Davis & Garver (1978)
** B a ld essa rin i (1977)
+ Klerman (1974)
++ Newton e t  a l .  (1978)
T itra te d
T itra te d
Appendix B
MATCHING PROCEDURE
The TD su b jec ts  were matched w ith th e  co n tro l su b jec ts  on 
age, sex , and d iag n o sis . The A p ril 1980 P a tie n t Census o f E astern  
S ta te  H o sp ita l was used to  id e n tify  a p p ro p ria te  matches based on 
the  p rev iously  recorded co n tro l v a ria b le s  of th e  TD su b je c ts .
A random numbers ta b le  (Tuckman, 1978) was used to  sy s tem a tica lly  
choose p a tie n ts  and determ ine i f  th e i r  demographics matched any 
of the  TD s u b je c ts ' co n tro l v a r ia b le s .  I f  the  chosen p a tie n t  was 
u n su ita b le , th e  name was crossed  o f f  and ano ther p a t ie n t  was chosen 
a t  random. This procedure continued u n t i l  a l l  req u ired  co n tro l 
su b jec ts  were id e n t i f ie d .
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Appendix C
LISTING OF TARDIVE DYSKINESIA SYMPTOMS
Mouth hanging open w ith  tongue lo l l in g  out
Invo lun tary  tw itch ing  o f the  mouth th a t  stops when re s tin g
Constant chewing movements o f the  mouth
Tongue p ro trudes from mouth w ith  co n stan t d roo ling
Involun tary  tongue movements
Tongue cannot be co n tro lled
Tongue moves co n stan tly
Tongue s tic k s  ou t s l ig h t ly
Lip smacking o r puckering
Cheek puffing
Moves mouth co n stan tly
Choreiform movements of th e  trunk
Choreiform movements o f ex trem itie s
Involun tary  movements o f the  body
Jerk in g  of the  ex trem itie s  th a t  in c reases  w ith anx iety  
Invo lun tary  movements o f th e  hands and f e e t  
Constant rocking motion o f head and body 
Invo lun tary  movements or re s tle s s n e s s  o f limbs 
Constant je rk in g  movements o f  the  e n t i r e  body
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Date TD Diagnosed:
(fo r v a lid a tio n  purposes)
Appendix D
PATIENT INFORMATION SHEET
I .  GENERAL INFORMATION (use codes)
ID #: I n i t i a l  Admission Date:
Today's
Date:
B irth
Date (Age):______ (_____ 1 Sex:____  P sy c h ia tr ic  D iagnosis:
Race: Eye Color: D ental S ta tu s : L___1
F i r s t  TD Symptom, 
Mention o r D iagnosis: # of Drug-Free P eriods:
# of Drug-Free Days:
I I .  HISTORY OF EXTRAPYRAMIDAL SYMPTOMS: Record only symptoms coded
to  an tip a rk in so n  agents using  leng th  o f th e i r  a d m in is tra tio n  as 
o n -se t and o f f - s e t  d a te s . Record form, s p e c if ic  symptom, and 
type.
From: to
I I I .  PSYCHIATRIC BEHAVIOR PATTERN(S): For each 6 month p e rio d , a f t e r  
1953 or subsequent to  adm ission, read  In te rd is c ip l in a ry  no tes  and 
Semi-Annual Summaries; r a te  on R ating Form using  R ating D escrip to rs  
S h ee t.
IV. INITIAL PSYCHIATRIC BEHAVIOR PATTERN: Read Admission Notes and
r a te  on Rating Form using  R ating D escrip to rs  Sheet.
V. DRUG HISTORY: Record a l l  a n tip sy c h o tic s , an tip a rk in so n  ag en ts ,
a n tid e p ressan ts  and lith iu m  p resc rib ed  inc lud ing  d a tes  and doses. 
Use d a ta  sh ee ts  fo r c o lle c t io n . E nter computer c a lc u la tio n s  
below.
DATES FORM SPECIFIC SYMPTOMS TYPE
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ANTIPSYCHOTICS
______ _ Average d a ily  dose
__________ Cumulative dosages
. Cumulative leng th  of
ad m in is tra tio n
________ __Average maximum y early  dose
POLYPHARMACY
__________  # o f PP incidences
___________  # o f incidences o f PP by Category
2 3 4 5
__________  # o f  APs p rescrib ed  cum ulatively
__________  # o f aps p rescrib ed  cum ulatively
ANTIPARKINSON AGENTS (aps)
________ _ Average d a ily  dose
__________  Cumulative dose
 _________ Cumulative leng th  of
ad m in is tra tio n
Appendix E
GENERAL INFORMATION CODES
SEX RACE EYE COLOR
1 - Male 1 - Negro 1 - brown
2 - Female 2 - Caucasian 2 - b lu e
3 - Indian 3 - b lack
4 - O rien ta l 4 - green
DIAGNOSIS DENTAL STATUS
Use DSM-II code number; 
use  cu rren t and prim ary 
d iag n o sis .
1 - a l l  te e th
2 - m issing te e th  (record  number)
3 - edentulous (no te e th )
a . - w ith  dentures
b . - w ithout dentures
DATE TD DIAGNOSED: For v a lid a tio n  purposes; record  d a te  p s y c h ia tr is t
diagnosed TD.
FIRST TD SYMPTOM: Date o f f i r s t  recorded TD symptom mention or
d iag n o sis .
NUMBER OF DRUG-FREE PERIODS: Number o f two-month periods f r e e  of
a n tip sy c h o tic s .
NUMBER OF DRUG-FREE DAYS: T o tal number o f days f r e e  o f a n tip sy ch o tic s .
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Appendix F
EXTRAPYRAMIDAL DESCRIPTORS AND CODES
FORM:
1 - Pseudoparkinsonism
a - A kinesia 
b - Tremor 
c - R ig id ity
2 - A kath isia
3 - Acute Dystonic Reactions 
TYPE:*
0 - H ypokinetic: a k in e s ia , r i g i d i t y ,  acu te  dyston ic  re ac tio n s
R - H yperk inetic: a k a th is ia ,  tremor
N - n e i th e r ;  no p a tte rn  
M - mixed
NOTE: R efer to  fo llow ing pages fo r  s p e c if ic  symptom codes.
* Chouinard e t  a l .  (1979)
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Pseudoparkinsonism (F u lly  developed cases o f  parkinsonism  =
gen era lized  slowing of v o l i t io n a l  movements 
—a k in e s ia , tremor a t  r e s t —e sp e c ia lly  involving 
d i s t a l  upper e x tre m itie s , and r i g i d i t y . E lderly  
females most su sc e p tib le .)
A. A kinesia (Hypokinesia; reduction  in  p h y sica l a c t iv i ty ;  decreased
motor a c t i v i ty . )
1. Slowness in  i n i t i a t i n g  motor tasks (b rad y k in es ia ).
2 . F a tigue  when perform ing a c t iv i t i e s  re q u irin g  r e p e t i t iv e  
movements (b rad y k in es ia ).
3. Lessening of sp o n tan e ity ; apathy—b lu n tin g  o f in te r e s t  and 
d r iv e ; slow mental a c t i v i ty .
4 . P aucity  o f g e s tu re s .
5. Diminished conversa tion ; impairment o f v o c a liz a tio n s  
(mutism).
6. Cramped handw riting (m ierograph ia).
7. M ask-like, a p a th e tic  appearance w ith  l i t t l e  f a c ia l  
expression  (hypomimia).
8 . Zom bie-like appearance.
9 . Gross muscle weakness w ith  lo ss  o f a sso c ia te d  movements th a t  
accompany g a i t  (amimia).
10. J o in t  and muscle pa in  in  advanced form (p a re s th e s ia e ) .
11. Psychological s ta t e  w ithou t n eu ro lo g ica l signs s im ula ting  
d ep ress io n , d em ora liza tion , re s id u a l  sch izophren ia , and 
drug-induced sed a tio n  w ith  e f f e c t  o f  drow siness.
12. May have som atic over-concern.
B. Tremor (Rythmatic 4 -8 /s e c . ,  o s c i l la t in g  re s tin g  trem or.)
1. P i l l - r o l l i n g  trem or o f  hands and f in g e rs .
2 . O sc illa tin g  re s t in g  trem or in  head, trunk , o r  le g s .
3 . Rabbit syndrome: o s c i l la t in g  re s t in g  trem or o f th e
p e r io ra l  (mouth a re a ) .
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C. R ig id ity  ("Chemical s t r a i t  ja ck e t" )
1. S tif fn e s s  and slowness o f  v o lun tary  movements.
2 . Cogwheel r ig id i ty :  presence o f both trem or and r ig id i ty .
3 . S h u fflin g , f e s t in a t in g  g a i t  (an invo lun tary  a c c e le ra tio n  
o f g a i t  when w alk ing).
4 . Slow, monotonous speech.
5 . Stooped p o s tu re .
6 . D y sa rth ria : d i f f i c u l ty  in  a r t ic u la t in g  words.
7 . P la s t ic  h y p e rto n ic ity  o f both  a x ia l  and limb m usculature; 
" lead -p ip e"  v a r ie ty  o f  r ig id i ty  ( s ta te  o f t is s u e s  having 
excessive ten sio n  in  response to  s t im u li) .
D. D ysfunctions o f  the  Autonomic Nervous System
1. S ia lo rrh ea : excess o f s a l iv a t io n ;  d ro o lin g .
2 . H yperhidosis: gen era lized  o r lo c a liz e d  excessive sw eating.
3 . Heat in to le ra n c e .
4 . Seborrhea: fu n c tio n a l d is tu rb an ce  o f the  sebaceous g lands;
ch a rac te rized  by increased  s e c re tio n  and d ischarge  of sebum 
(o ily /g re a sy  m a te ria l)  th a t  produces an o i ly  appearance o f 
the  sk in  and th e  form ation o f greasy s c a le s .
5 . H ypertherm ia/H yperpyrexia: ex cep tio n a lly  h igh  fev e r e i th e r  
in  comparion to  fev e r u su a lly  accompanying a  p a r t ic u la r  
d isea se  o r  a b so lu te ly .
2 . A k a th is ia  (May be confused w ith  a g ita te d  dep ress io n , p sy c h ia tr ic
excitem ent, o r  an x ie ty ; su b je c tiv e  d e s ire  to  be in  co n stan t motion,
in a b i l i ty  to  s i t  o r  stand  s t i l l ;  favors no age group.)
1. Rocking and s h i f t in g  o f weight w hile  s tand ing .
2 . Tapping o f f e e t  w hile  s i t t i n g .
3 . Pacing.
4 . F id g e tin g .
5 . D isturbance in  s leep  w ith  i n i t i a l  insomnia.
6. H y p erac tiv ity —p a tie n ts  re p o r t worsening o f th e i r  d iscom fort 
w ith ph y sica l in a c t iv i ty .
7 . Complaints o f:
a . re s tle s s n e s s
b . im patience
c . j i t t e r s
d . nervousness
e . panic
f .  vague fe e lin g s  o f d iscom fort
Acute Dystonic Reactions (Approximately 90% of th e  rea c tio n s  occur
w ith in  72 hours of n eu ro lep tic  treatm ent 
in i t i a t i o n ;  occurs most freq u en tly  in  
ch ild ren  and young a d u lts ,  e sp e c ia lly  
m ales.)
1. Mild symptoms experienced as tig h tn e ss  o f th e  th ro a t o r tongue.
2 . Exaggerated and unusual p o stu rin g  o f th e  head, neck, and jaw 
th a t  may p resen t a s:
a . T o r t ic o l is :  wryneck; abnormal tw is tin g  of the  head; spasms
o f  the  neck.
b . impairment o f jaw movements.
c . spasms w ith  cram p-like p a in .
3 . Tongue p ro tru s io n  o r c u rlin g .
4 . F ac ia l d is to r t io n s  and grim acing.
5 . Spasms o f th e  m usculature of th e  face  o r th ro a t.
6 . Dysphagia: d i f f i c u l ty  in  swallowing.
7. Dysphasia: lo ss  o f  o r d e fic ien cy  in  use o f language.
8 . Oculogyric c r i s i s :  fixed  upward gaze; severe r o l l in g  o f th e  
eyes.
9. Less freq u e n tly , muscles o f the  ex tre m itie s  and back may be
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Involved and produce:
a . op istho tonus: spasm o f the muscles o f the  back causing
head and lower limbs to  bend backward and trunk  to  arch 
forward.
b . s c o lio s is :  l a t e r a l  (crooked) cu rva tu re  o f the  sp in e .
c . lo rd o s is : abnormally exaggerated forward cu rva tu re  o f the
sp ine .
d . b iz a r re  g a i t .
10. Dystonic symptoms may be accompanied by autom atic s ig n s , such
as:
a . p rofuse sweating
b . p a llo r
c . o ccas io n a lly , fev er
11. R ep e titio u s , a l te rn a t in g  rhythm of movements.
Appendix 6
SATING DESCRIPTORS SHEET
HYPOKINETIC (Abnormal reduction  in  movement)
Slowness in  i n i t i a t i n g  motor tasks 
Reduction in  ph y sica l a c t iv i ty  
Decreased motor a c t iv i ty
F atigue  when perform ing a c t i v i t i e s  req u irin g  r e p e t i t iv e  movements 
Lessening of spon tane ity  
Slow m ental a c t iv i ty
Apathy - b lu n tin g  o f in te r e s t  and d riv e
P aucity  o f g estu res
Diminished conversation
Mutism - Impairment o f v o c a liz a tio n
M icrographia - Cramped handw riting
Hypomimia - M ask-like, a p a th e tic  appearance w ith  l i t t l e  f a c ia l  expres­
sion
Zom bie-like appearance 
J o in t  and muscle pain
S tif fn e s s  and slowness o f v o lu n ta ry  movements 
Cogwheel r ig id i ty  
S h uffling  g a i t
F e s tin a tin g  g a i t  - An invo lun tary  a c c e le ra tio n  o f g a i t  when walking 
Slow, monotonous speech 
Stooped postu re
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D ysarth ria  -  D if f ic u lty  in  a r t ic u la t in g  words
"Lead-pipe" v a r ie ty  o f  r ig id i ty
Complaints o f tig h tn e ss  o f  the  th ro a t o r  tongue
Exaggerated and unusual p o s tu rin g  of th e  head, neck, o r jaw (frozen  
v s . rhythm ical)
Abnormal tw is tin g  o f the  head (frozen  v s . rhythm ical)
Spasms o f the  neck (frozen  v s . rhythm ical)
Impairment o f jaw movements (frozen  v s . rhythm ical)
B iza rre  g a i t
Spasms w ith  cram p-like p a in  (frozen  v s .  rhythm ical)
Spasms o f the  m usculature o f the  face o r  th ro a t  (frozen  v s . rhythm ical) 
Dysphagia - D if f ic u lty  in  swallowing
Oculogyric c r i s i s  - Fixed upward gaze; severe ro l l in g  of th e  eyes
HYPERKINETIC (Abnormal excess in  movement)
Rocking and s h if t in g  o f w eight w hile  s tand ing
Tapping of the  f e e t  w hile  s i t t i n g
Pacing
F idgeting
I n i t i a l  insomnia w /re s t le s s  behav io r(s) ( i . e . ,  n ig h t- tim e  a c t iv i ty  such
as pacing , chain-smoking, e tc . )
O v erac tiv ity
R estlessness
Im patience
J i t t e r s
Nervousness
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F eelings o f panic
Parkinsonian ( re s tin g )  tremor o f the  head, le g s , o r hands (In  the  hands, 
may be re fe rre d  to  as p i l l - r o l l i n g  trem or)
P a tie n t re p o rts  fe e lin g s  o f d iscom fort th a t  worsen w ith  p h y sica l 
in a c t iv i ty  ( i . e . ,  p a t ie n t  complains about d iscom fort th a t  r e s u l t s  i f  
she/he does no t remain co n stan tly  a c tiv e )
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Appendix H
TRAINING PROCEDURES FOR RATER
1. The r a te r  was given the  Rating D escrip to rs  Sheet to  read over.
2 . D ifferences between hypok inetic  (abnormal reduction  in  movement) 
and h y p e rk in e tic  (abnormal excess in  movement) d e sc r ip to rs  were 
d iscussed .
3. D escrip to rs  were defined  and d iscussed .
The follow ing in s tru c t io n s  were given:
4 . The in te r e s t  l i e s  in  b ehav io ra l d e sc rip tio n s  found in  the  reco rds;
NOT in  co g n itiv e  ( i . e . ,  thought d is o rd e rs ) , a f fe c t iv e  ( i . e . ,
in ap p ro p ria te  o r f l a t ) ,  o r ph y sio lo g ica l ( i . e . ,  incontinency) 
d e s c r ip tio n s .
5. The e tio lo g y  of the  movements i s  no t o f i n t e r e s t—i . e . ,  involun­
ta ry ,  c a ta to n ia , e tc .
6. The s ta r t in g  d a te  fo r  d a ta  c o lle c tio n  on " I n i t i a l  p sy c h ia tr ic  
behavior p a tte rn s"  is  th e  d a te  of the s u b je c ts ' f i r s t  adm ission 
to  a p sy c h ia tr ic  i n s t i tu t io n .  The da ta  used fo r  th is  p a tte rn  
a re  the adm ission n o te s ; th ese  no tes may span 2 days to  1 month.
7. The s ta r t in g  d a te  fo r  d a ta  c o lle c tio n  on "P sy ch ia tr ic  behavior
p a tte rn s"  is  January 1, 1953. I f  a su b jec t i s  adm itted a f t e r  
th is  tim e, s ta r t in g  d a te  i s  one month a f t e r  adm ission to  (1) 
avoid confusion of " I n i t i a l  p sy c h ia tr ic  behavior p a tte rn "  d a ta  
w ith "P sy ch ia tr ic  behavior p a tte rn "  d a ta  and (2) ensure in i t i a t i o n  
of a n tip sy ch o tic  m edication .
8. The c u t-o f f  d a te  w i l l  be given to  the  r a t e r  p r io r  to  the  s t a r t  of 
data  c o lle c tio n  fo r each su b je c t. The r a t e r  i s  no t to  look a t  
records subsequent to  th i s  d a te .
Note: The a s s i s ta n t  was inform ed, b efo re  c o lle c tin g  data  on a
su b jec t o f the  c u t-o f f  d a te  o f th a t  su b je c t. This way the  
a s s is ta n t  should not have encountered any mention o f TD o r i t s  
symptoms which could have confounded th e  da ta  and b iased  the  
r a t e r .  I n i t i a l l y  i t  was b e liev ed  th a t th e  r a te r  should be 
uninformed about TD. However, during tr a in in g  questions occurred 
on the  p a r t o f the  r a t e r  concerning TD mentions seen in  th e  reco rd s. 
Thus, to  avoid confounding the  ra tin g s  w ith  any p o ss ib le  TD 
symptoms overlooked, i t  was deemed b e s t to  in s t r u c t  the  r a t e r  on
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the  symptoms of TD as w ell as th is  s tu d y 's  lack  o f In te r e s t  In 
TD symptoms being Included In the  behav io ral r a t in g s .  This was 
needed as any ra t in g  of TD would more than l ik e ly  be ca tego rized  
as "H yperkinetic" and th e re fo re  confound the  pre-TD behav io ral 
r a t in g s . A lso, i t  was re a liz e d  th a t  the r a t e r 's  knowledge o f TD 
symptomology would b e t te r  ensure th a t  only pre-TD d a ta  was in c lu ­
ded in  th is  study by the  r a te r s  double-checking the  o r ig in a l  
determ ination  o f TD o n -se t, w hile  s t i l l  remaining b lin d  to  the 
purpose of th is  study . The r a te r  was in s tru c te d  to  record  any 
symptoms encountered which may have been re la te d  to  TD, as w ell 
as the da te  of the record  e n try , on ano ther sh ee t of paper. The 
reason fo r  th is  was explained as being p o te n tia l ly  in s tru c t iv e  
fo r  a  fu tu re  p ro je c t u n re la ted  to  th is  study . The TD symptom(s) 
and d a te  recorded by the  r a te r  were a c tu a lly  used by th e  au thor 
to  a d ju s t the d a ta  c u t-o f f  dates, p r io r  to  computer en try , in  
cases where the au thor overlooked e a r l i e r  recorded TD symptoms 
or diagnoses.
9. In  cases where records a re  m issing, in c lu s io n  dates a re  to  be 
recorded on the Rating Form in  a column.
10. Consistency is  im portant in  the  judgments o f the  r a t in g s .  The 
follow ing a re  g u id e lin es  fo r  the  use o f th e  four c a te g o rie s :
H yperk ine tic : M ajority  o f n o ta tio n s  a re  congruent w ith the  
d e sc r ip to rs  l i s t e d  under th is  category  on the 
Rating D escrip to rs  Sheet.
H ypokinetic:
Mixed:
M ajority  o f n o ta tio n s  a re  congruent w ith the 
d e sc r ip to rs  l i s t e d  under th is  category  on the 
Rating D escrip to rs  Sheet.
N otations a re  congruent w ith  the  d e sc r ip to rs  
under both h y p erk in e tic  and hypokinetic  on 
th e  Rating D escrip to rs  Sheet to  th e  p o in t th a t 
no judgment o f hyper- o r hypo- is  p o ss ib le .
None: N otations a re  n e ith e r  hyper- o r hypo-.
11. In  cases where d e ta i le d  inform ation  i s  a v a ila b le  but no behavioral 
d e sc rip tio n s  a re  provided in  the  records fo r  the  " I n i t i a l  psych­
i a t r i c  behavior p a tte rn "  o r  any 6 month p e rio d (s) of th e  "Psych­
i a t r i c  behavior p a t te rn ,"  a question  mark (?) i s  to  be placed in  
the  None category  as no inform ation  was provided on which to  make 
a r a t in g . This d ire c t iv e  a lso  a p p lie s  in  cases where no in fo r ­
mation i s  a v a ila b le —i . e . ,  no e n tr ie s  were made in  the  p a t ie n ts ' 
records during th ese  time p e rio d s .
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12. The r a te r  had no idea o f the  n a tu re  o r hypotheses o f th is  study .
The purpose o f the  ra tin g s  was simply explained as necessary  to  
determ ine the  s u b je c ts ' various behavior p a tte rn s  w hile rece iv in g  
m ediations. (The r a te r  understood he would be d e -b rie fed  a t  the  
completion o f th is  s tu d y .)
13. The r a te r  had no knowledge o f the m edications th e  su b jec t received  
during th e  time periods fo r which the  s u b je c t 's  behavior was being 
ra te d .
14. The r a te r  was tra in e d  fo r  5 hours in  the  follow ing manner:
a) Record usage was exp lained ; the  lo c a tio n  o f Admission N otes, 
Semi-Annual Summaries, and In te rd is c ip l in a ry  Notes was shown.
b) Using a su b jec t n o t in  th is  s tudy , the  r a t e r  ra te d  " I n i t i a l  
p sy c h ia tr ic  behavior p a tte rn "  and "P sy ch ia tr ic  behavior 
p a t te rn s ."  We d iscussed  the  ra tin g s  and once again  reviewed 
the  irre lev an cy  o f e tio lo g y  as w e ll as c o g n itiv e , a f f e c t iv e ,  
and ph y sio lo g ica l d e sc r ip tio n s .
c) The importance o f h is  being c o n s is te n t and s tay in g  w ith in  the 
d e sc rip to rs  provided—i . e . ,  not adding to  them, was emphasized.
In te rju d g e  Agreement
The o r ig in a l  r a te r  q u it  a f t e r  ra tin g  about 50% of each sample. 
Consequently, another r a te r  was h ired  and then tra in e d  by the  o r ig in a l 
r a te r  to  ensure consis tency . She re - ra te d  3 su b jec ts  p rev iously  ra te d  
by the  o r ig in a l r a te r  which equalled  58 ra tin g s  o r 29 years o f beha­
v io ra l  h i s to r ie s .  The ra tin g s  a re  d iscontinuous d a ta , thus an in te r r a te r  
c o r re la tio n  was not a p p ro p ria te . Of the  58 ra tin g s  44 were agreem ents, 
r e s u lt in g  in  an in te rju d g e  agreement r a t io  o f 76% (see  Table 11). Of 
the  14 disagreem ents, 72% (10) were h y p e rk in e tic  o r hypokinetic  ra tin g s  
ra te d  as n e ith e r ;  21% (3) were h y p e rk in e tic  o r  hypokinetic  ra tin g s  
ra te d  as mixed; 7% (1) was a d i r e c t  c o n tra d itio n  of r a t in g s —i . e . ,  a 
hypokinetic  r a t in g  ra te d  as h y p e rk in e tic .
Table 11
In te rju d g e  V ariance Graph
R ater 2 Hyper
R ater 1
Hypo Mixed N either
Hyper 1 1 5
Hypo 3
Mixed 2
N either 1 1
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The In te rju d g e  agreement r a t i o  is  deemed accep tab le  as only one 
in s ta n ce , ou t o f 58 p o s s ib i l i t i e s ,  involved a d i r e c t  c o n tra d ic tio n .
The o th e r disagreem ents involved one r a te r  judging the  behavior 
n o ta tio n s  as r e f le c t in g  h y p erk in e tic  o r  hypok inetic  behav io r, w hile 
the  o th e r ra te d  the  n o ta tio n s  as n e ith e r  o f o r  a m ixture o f  the  two 
behavior ty p es. These disagreem ents a re  most l ik e ly  th e  r e s u l t  o f 
d i f f i c u l t i e s  in  reading  th e  handw riting of th e  record  e n tr ie s  and in  
lo c a tin g  necessary  in fo rm ation . Many d if f e r e n t  in d iv id u a ls  recorded 
b ehav io ra l inform ation  in  the  records and i l l e g i b i l i t y  was a continuous 
problem. I t  was no t uncommon fo r  one o f us to  be ab le  to  read some­
th ing  ano ther could n o t.
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Appendix J
PSYCHOMOTOR SYMPTOM SCALE
For each d iso rd e r l i s t e d  below, check the  space provided in  the  
ap p ro p ria te  column fo r  symptom s e v e r ity .
ABSENT MILD MODERATE SEVERE
AKATHISIA
AKINESIA
None P a tie n t fe e ls  
nerved up or 
u p tig h t, may 
have r e s t le s s  
p o s tu ra l 
changes.
More in te n se  R estlessn ess  to  
su b jec tiv e  p o in t o f a g i ta -  
com plaints, t io n . Cannot 
in a b i l i ty  to  s i t  s t i l l  fo r  
f e e l  comfor- even a few 
ta b le  in  any m inutes, 
p o s itio n .
TREMOR
None P a tie n t fe e ls  
dead in s id e , 
t i r e d  a l l  the  
tim e, weakness. 
May appear, 
a p a th e t ic .
More in te n se  Loss o f fa c ia l  
su b je c tiv e  expression , 
com plain ts, Obvious decrease 
lo ss  o f a sso - of a sso c ia te d  
c ia te d  move- movements, d e f i -  
m ents, diminu- n i t e  motor 
tio n  o f f a c ia l  slow ing, 
expression , 
slow movements.
RIGIDITY
None Seldom or
in te rm it te n tly
p re sen t.
In te rm it te n t ly  U sually  p re sen t, 
p re s e n t .
DYSTONIA
None In te rm itte n t 
re s is ta n c e  to  
passage move­
ment.
Cogwheeling Strong re s is ta n c e  
e f f e c t  in  pas- to  p ass iv e  move- 
s iv e  movement ment o f th e  limbs 
o f the  lim bs, in  both  d ire c t io n s .
None O ccasional and 
s e l f - l im i t in g  
ocu logyric  
c r i s e s . Mild 
t o r t i c o l l i s ,  
tr ism u s .
More severe  P sy c h ia tr ic  
dyston ic  re a c - emergency th a t  
t io n  th a t  is  l i f e  th re a t-  
re q u ire s  IM or ening.
IV m edications.
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TARDIVE
DYSKINESIA
ABNORMAL
MOVEMENTS
NOT
ASSOCIATED 
WITH DRUGS
None Occasional
movements of
More frequen t C horeoatheto tic  
movements of movements of
tongue, verm i- tongue and lim bs, trunk ,
c u la r  movements, l i p s ,  b lephor- and o ro fa c ia l  
b lin k in g , cheek aspasm, occa- m uscles, 
p u ff in g . s io n a l choreo­
a th e to t ic  
movements in  
fin g e rs  or 
to e s .
None O ccasional t i c ,  More frequen t Severe and
tw itch , or 
rocking move­
ment . Would 
not be so c ia lly  
s tig m a tiz in g .
and s o c ia lly  
s tig m atiz in g  
movements.
obvious b iz a r re  
movements 
s tro n g ly  suggest­
ing a need fo r 
trea tm en t.
Adapted from Van P u tten  (1974)
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Abstract
DESCRIPTIVE CHARACTERISTICS OF INPATIENTS WITH TARDIVE DYSKINESIA AS 
DISTINGUISHED FROM INPATIENTS WITHOUT TARDIVE DYSKINESIA
Lucy Glover Savage, Ed.D.
The College o f W illiam and Mary, October 1980 
Chairman: Charles 0. Matthews, Ph.D.
The purpose of th is  study was to  in v e s t ig a te  the re la tio n sh ip  of 
the presence o r absence of ta rd iv e  dysk inesia  (TD) to  drug and beha­
v io ra l  h is to ry  v a r ia b le s . The au thor hoped to determ ine i f  th e re  were 
d e sc r ip tiv e  c h a r a c te r is t ic s ,  unique to  p a tie n ts  w ith TD, which could 
m erit fu r th e r  in v e s tig a tio n  as p recursors o f TD. Two samples, w ith 26 
su b jec ts  each, were drawn from p a tie n ts  id e n t i f ie d  a t  Eastern S ta te  
H osp ita l and screened by a p s y c h ia t r i s t .  The TD and No-TD groups were 
matched on age, sex, and d iag n o sis . E n tire  drug h is to r ie s  were recorded 
and e n t i r e  behav io ral (h o sp ita liz a tio n )  h is to r ie s  were ra te d . Data 
c o lle c tio n  was d iscon tinued , fo r  both su b je c ts , w ith  the emergence o f 
TD symptoms in  the  TD su b je c t. This was an ex p o st fac to  design .
I t  was hypothesized th a t s ig n if ic a n t  d iffe ren c es  would be found 
between th e  two groups on h is to ry  of a n tip sy ch o tic  and an tip a rk in so n  
m edications, h is to ry  o f polypharmacy, h is to ry  o f d rug -free  days and 
p e rio d s , h is to ry  of extrapyram idal symptoms (EPS), h is to ry  o f psychia­
t r i c  behavior p a tte rn s , ra ce , eye co lo r, and d e n ta l s ta tu s .  A trend  
was noted fo r  the  No-TD group to  have c o n s is te n tly  h igher means on a l l  
of the  drug v a r ia b le s . S ig n if ic a n tly  h igher means fo r  the No-TD group 
were found fo r  mean cum ulative and mean d a ily  dose o f a n tip sy c h o tic s , 
mean length  of an tipark in son  agent ad m in is tra tio n , and in  the number 
of EPS inc id en ces. The TD group had s ig n if ic a n t ly  more edentulous sub­
je c ts  than th e  No-TD groups.
Although TD is  c le a r ly  re la te d  to  a n tip sy ch o tic  in g e s tio n , appar­
e n tly  i t  i s  no t re la te d  to  the  q u a n tity  o f an tip sy ch o tic s  in g ested . 
Future study should, th e re fo re , focus on the  re la tio n s h ip  of in d iv idua l 
v u ln e ra b il i ty  to  the  development o f TD ra th e r  than  on drug v a ria b le s  
such as those in v e s tig a te d  in  th is  study. F u rth er in v e s tig a tio n  o f the 
behav io ral precursors i s  in d ic a ted . A p ro sp ec tiv e  design is  recommended 
in  o rder to  c la r i f y  re la t io n s h ip s , such as EPS h is to ry  and the  develop­
ment of TD, th a t  remain unclear in  re tro sp e c tiv e  in v e s t ig a tio n s .
